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ABSTRACT 
 
DESIGN, SYNTHESIS AND SUZUKI–MIYAURA CROSS-COUPLING 
REACTIONS OF POTASSIUM ORGANOTRIFLUOROBORATES 
 
Inji Shin 
 
Professor Gary A. Molander 
 
 The Suzuki–Miyaura cross-coupling reaction is one of the most efficient methods 
to form new carbon-carbon bonds, allowing a rapid increase in complexity among target 
molecules of interest. Among a variety of boron reagents utilized in Suzuki–Miyaura 
reactions, potassium organotrifluoroborates are of great interest because they have many 
advantages over other boron reagents. Organotrifluoroborates, which are tetracoordinate 
boron species, show better stability and reactivity, and they are much less prone to 
protodeboronation.  
α-Chiral β-arylated carbonyl compounds are important substructures in organic 
chemistry, and their preparations, such as benzylations, asymmetric hydrogenations, and 
conjugate additions, have been studied. However, these methods have limitations in terms 
of selectivity and functional group tolerance. We developed a more direct method that 
could overcome the problems. Enantiomerically enriched potassium α-chiral β-
trifluoroboratoamides were prepared, and the general conditions were found to couple 
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successfully with various aryl and hetaryl chlorides to afford the corresponding α-chiral β-
arylated carbonyl compounds. Moreover, the diastereoselectivities were greater than 95:5, 
and retained throughout the coupling reactions. 
 
 Aminomethyl moieties are readily encountered in biologically active compounds 
as well as in organic intermediates. Even though several synthetic methods have been 
reported, the means of preparation of these subunits are still limited. We developed a more 
efficient method to access aminomethyl substructures by preparation of air stable 
potassium Boc-protected primary and secondary aminomethyltrifluoroborates. The 
Suzuki–Miyaura cross-coupling reaction was investigated with these new 
aminomethylating boron reagents to provide the corresponding aminomethyl moieties. 
Aryl and hetaryl chlorides, mesylates, and sulfamates were proved to be effective 
electrophilic coupling partners under developed conditions. These methods provide a 
complementary way to access important building blocks that is more direct and general 
than currently available methods. 
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Chapter 1. Suzuki–Miyaura Cross-Coupling Reactions and Potassium 
Organotrifluoroborates 
 
1.1 Suzuki–Miyaura Cross-Coupling Reactions 
  Transition metal catalyzed cross-coupling reactions are one of the most powerful 
methods to prepare new carbon-carbon bonds.1 Many metal catalyzed coupling reactions, 
such as Kumada-Corriu,2  Negishi,3  Stille,4  and Suzuki–Miyaura reactions, 5  have been 
utilized to increase the complexity of molecular targets of interests (Equation 1.1). 
  
Equation 1.1 Transition Metal Catalyzed Cross-Coupling Reactions 
 
 
 Among them, the Suzuki–Miyaura cross-coupling reaction has been most widely 
used to construct carbon-carbon bonds because of the mild reaction conditions, lessened 
toxicity, and stability afforded by boron reagents compared to other coupling reactions.6 
In 1978, the first example of a palladium catalyzed Suzuki–Miyaura cross-coupling 
was demonstrated using organoboron reagents with an aryl iodide by Negishi and 
coworkers (Equation 1.2).7 In the presence of a Pd(PPh3)4 as the catalyst, an alkynylborate 
was successfully coupled with o-tolyl iodide to afford the desired product in 92% yield. 
 
2 
 
Equation 1.2 
 
 
 Later, Suzuki reported the palladium catalyzed coupling reaction with an 
alkenylboronate and alkenyl bromide (Equation 1.3).8  Previously, alkenylborons were 
known to be inefficient coupling partners due to their low nucleophilicity.9 However, the 
use of a tricoordinate organoboron species, instead of a tetracoordinate organoborate 
species, was demonstrated to overcome this problem. Thus, Suzuki and Miyaura revealed 
that the Suzuki–Miyaura cross-coupling reaction requires a base, unlike other 
organometallic reactions.10 In the absence of a base, the reactions failed to form the desired 
products. 
  
Equation 1.3 
 
 
 More recently, the Suzuki–Miyaura cross-coupling reaction is of great interest in 
both academia and industry. Even though Suzuki–Miyaura coupling reactions are efficient 
to form carbon-carbon bonds, many limitations exist in terms of efficiency and diversity. 
Therefore, many efforts have been made in this area to improve the reactions. Diverse 
3 
 
catalysts and ligands have been studied extensively by many research groups.11 Particularly, 
Buchwald ligands, dialkyl biaryl phosphine ligands, are one class of effective ligands used 
widely to allow many difficult transformations in coupling reactions (Figure 1.1).12  
 
 
Figure 1.1 Examples of Buchwald Ligands 
 
Moreover, the Buchwald group has developed preformed catalysts (Figure 1.2).13 
They show better reactivity, and the use of precatalysts have several advantages over 
traditional catalyst/ligand systems in terms of stability and activity. The coupling reactions 
can be more efficient because shorter reaction times, lower temperature, and lower catalyst 
loadings can be employed.  
 
 
Figure 1.2 Examples of Buchwald Precatalysts 
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1.2. Potassium Organotrifluoroborates 
 Traditionally, boronic acids or trialkylboroane species are frequently used as the 
nucleophilic partners in Suzuki–Miyaura coupling reactions. Although these borane 
substrates have been employed effectively, the reactions are limited due to the instability 
to air and moisture and incompatibility to many reaction conditions.14 Particularly, boronic 
acids exist as dimers or cyclic trimers rather than monomeric species, which are hard to 
purify. These organoboron species suffer from protodeboronation; therefore, excess boron 
reagents are required to complete the coupling reactions.11a 
 To overcome this limitation, several boronic acid surrogates, such as 1,8-
naphthalenediaminatoborane [B(dan)]15 and N-methyliminodiacetic acid (MIDA),16 have 
been reported (Figure 1.3). Even though these boron moieties have been proven to be 
effective as the nucleophilic partners in Suzuki–Miyaura cross-coupling reactions, 
additional synthetic steps, such as protection and deprotection, are required for their 
transformation in couplings. 
 
 
Figure 1.3 RB(dan) and MIDA Boronate 
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 More recently, tetracoordinate boronate salts, potassium organotrifluoroborates, 
have been considered one of the most effective organoboron species in terms of stability 
and reactivity.17 
 Chambers and coworkers reported the first synthesis of a potassium 
organotrifluoroborate in 1960. 18  However, the method was not general to prepare 
organotrifluoroborates. In 1995, Vedejs and coworkers demonstrated a simple preparative 
method for the synthesis of potassium organotrifluoroborate using inexpensive potassium 
hydrogen fluoride (KHF2) with the corresponding boronic acids (Equation 1.4).
19 These 
methods are widely used to prepare a large range of potassium organotrifluoroborates. 
  
Equation 1.4 
 
 
 In most cases, potassium organotrifluoroborates are crystalline solids or powders, 
and show indefinite air and moisture stability. Moreover, many organic transformations, 
such as oxidations, 20  Wittig reactions, 21  reductive aminations, 22  Cu-catalyzed carbon-
nitrogen bond formations, 23  selective cross-coupling reactions, 24  and 1,3-dipolar 
cycloadditions,25 have been studied in the presence of these salts, and organotrifluroborates 
remained intact throughout the reactions. 
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1.3 Use of Potassium Organotrifluoroborates in the Suzuki–Miyaura Reaction 
 One of the most important studies toward organotrifluoroborates is their use in the 
Suzuki–Miyaura cross-coupling reaction as the nucleophilic coupling partners. In 1997, 
Genet and coworkers reported the first palladium catalyzed cross-coupling reactions with 
potassium organotrifluoroborates and aryldiazonium tetrafluoroborate salts to provide the 
desired product (Equation 1.5).26 A few years later, Xia and Chen described the coupling 
reactions of organotrifluoroborates with diaryliodonium salts.27 In both cases, a base and a 
ligand were not required to obtain the product. 
 
Equation 1.5 
 
 
 In 2000, Fu and coworkers failed to obtain the desired cross-coupled product by 
reacting potassium o-tolyltrifluoroborate with an aryl bromide in the absence of a base 
(Equation 1.6).28  
 
Equation 1.6 
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 In 2001, the Molander group demonstrated that the cross-doupling reactions of 
potassium alkyltrifluoroborates with triflates as the electrophilic partners to provide the 
product effectively (Equation 1.7).29 Since this report, the Suzuki–Miyaura cross-coupling 
reaction with potassium organotrifluoroborates has been widely investigated. Particularly, 
the Molander group has contributed extensively to this area.30 
 
Equation 1.7 
 
  
1.4 Mechanism of Suzuki–Miyaura Reactions with Organotrifluoroborates 
 The general mechanism of metal catalyzed cross-coupling reactions include three 
steps: oxidative addition, transmetalation, and reductive elimination, to provide the 
corresponding product with a new carbon-carbon bond (Scheme 1.1).1 The oxidative 
addition of a halide or pseudohalide to a Pd(0) complex to generate RPd(II)X intermediate 
is followed by transmetalation with an organometallic species to give RPd(II)R’ complex. 
Finally, the corresponding coupled product is formed by reductive elimination, and the 
active Pd(0) complex is regenerated. 
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Scheme 1.1 General Mechanism of Transition Metal Catalyzed Cross-Coupling 
Reactions 
 
 
 In the case of the Suzuki–Miyaura cross-coupling reaction, a base is required to 
afford the desired product. In fact, the base, such as hydroxide or carbonate, plays an 
important role in the catalytic cycle.31 Hydroxide ions form RPd(II)(OH), which is the key 
intermediate for the transmetalation with the organoboron species (Scheme 1.2). Moreover, 
hydroxide ions promote the reductive elimination via a five-coordinate Pd species.31a 
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Scheme 1.2 Catalytic Cycle of the Suzuki–Miyaura Cross-Coupling Reaction 
 
 
 The Suzuki–Miyaura reaction with potassium organotrifluoroborates requires steps 
to generate the active organoboron species, a boronic acid, for the transmetalation. Several 
studies have demonstrated that RBF3
– or boronates are unreactive in the catalytic cycle, 
and require the use of a base to generate the corresponding boronic acids from unreactive 
boronates.29,31,32 In the presence of a base, such as hydroxide, RBF3
– is in equilibrium with 
RBFn(OH)3-n
– and the corresponding boronic acids (Equation 1.8). 
 
Equation 1.8 
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 In 2012, Lloyd-Jones and coworkers demonstrated an acid-base paradox in Suzuki–
Miyaura cross-coupling reactions of organotrifluoroborates.33 Even though the Suzuki–
Miyaura reaction requires a base, which makes the reaction media basic, acidity is 
important for the hydrolysis of organotrifluoroborates. Initially, the basic aqueous media 
suppresses the hydrolysis of organotrifluoroborates. Slowly generated HF/KHF2 lowers the 
pH of the organic layer, increasing the rate of the hydrolysis to the active boronic acid 
reagents (Scheme 1.3). Moreover, the vessel shape, material size, and stirring rate are 
important for effective hydrolysis under heterogeneous reaction conditions. 
 
Scheme 1.3 Hydrolysis of Organotrifluoroborates under Basic Heterogeneous 
Conditions 
 
[Reprinted with permission from (J. Am. Chem. Soc. 2012, 134, 7431).  
Copyright (2012) American Chemical Society.] 
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 Potassium organotrifluoroborates can be categorized into three groups depending 
on the nature of trifluoroborates (Scheme 1.4). The first group undergoes slow hydrolysis 
by the acid-catalyzed pathway i. This group includes simple aryl and benzyl 
trifluoroborates. The second group undergoes into rapid hydrolysis by direct equilibrium 
dissociation pathway ii. In this case, the R group, such as cycloalkyl or electron-rich aryl, 
is able to stabilize the boron species by π-overlap or hyperconjugation. Pathway iii 
represents a group of alkynyl or electron-poor aryltrifluoroborates that are hydrolyzed very 
slowly. 
 
Scheme 1.4 Hydrolysis Pathways Depending on the Nature of Organotrifluoroborates 
 
[Adapted with permission from (J. Am. Chem. Soc. 2012, 134, 7431).  
Copyright (2012) American Chemical Society.] 
 
 In 2012, Amatore and Jutand reported the important role of fluoride ions in 
coupling reactions of organotrifluoroborates.34 Similar to hydroxide ions, fluoride ions are 
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able to facilitate the catalytic cycle by the formation of an RPd(II)F complex, which allows 
transmetalation with boronic acids, and also promotes the reductive elimination via five-
coordinate intermediate with fluoride ion (Figure 1.4). 
 
 
Figure 1.4 Important Intermediates with Fluoride Ions 
 
1.5 Conclusions 
 The Suzuki–Miyaura cross-coupling reaction has proven to be one of the most 
effective coupling reactions among the many transition metal catalyzed reactions. Because 
of the mild reaction conditions and the commercial availability of organoboron species, the 
reactions have been widely utilized to construct new carbon-carbon bonds. Many 
optimizations, such as improvements in ligands and catalysts, have been made to facilitate 
the Suzuki–Miyaura reaction.  
 Recently, potassium organotrifluoroborates have been employed in coupling 
reactions, rather than traditional trivalent organoboron species. Organotrifluoroborates are 
prepared from inexpensive KHF2 and the corresponding organoboron reagent, and they 
have shown enhanced stability to air and moisture. Therefore, they are easier to handle and 
store compared to other organoboranes. 
 Unlike other metal catalyzed cross-coupling reactions, a base is crucial in the 
Suzuki–Miyaura cross-coupling reaction. More recently, mechanistic studies on the 
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Suzuki–Miyaura reaction of potassium organotrifluoroborates have been reported by 
several research groups. Hydroxide and fluoride ions play an important role in the catalytic 
cycles to generate the important transmetalating intermediate. Moreover, they facilitate the 
reductive elimination via formation of five-coordinate complexes. 
 Additionally, acid catalysis is required to release the active boronic acid reagents 
from unreactive organotrifluoroborates. Even though Suzuki–Miyaura coupling reactions 
are under heterogeneous basic conditions, the organic phase becomes acidic over the time, 
which hydrolyzes the organotrifluoroborates efficiently. 
 
1.6 References 
(1) Metal-Catalyzed Cross-Coupling Reactions, 2nd ed: de Meijere, A.; Diedrich, F., Eds.; 
Wiley-VCH: Weinheim, 2004. 
(2) Kumada, M. Pure Appl. Chem. 1980, 52, 669. 
(3) Negishi, E.; Hu, Q.; Huang, Z.; Quian, M.; Wang, G. Aldrichim. Acta 2005, 38, 71. 
(4) Stille, J. K. Angew. Chem., Int. Ed. Engl. 1986, 25, 508. 
(5) (a) Suzuki, A.: Brown, H. C. Organic Syntheses via Boranes: Volume 3 Suzuki–
Coupling, Aldrich Chemical Co.: Milwaukee, 2003. (b) Miyaura, N. Top. Curr. Chem. 
2002, 219, 11. (c) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457. 
(6) (a) Lepifre, F.; Buon, C.; Rabot, R.; Bouyssou, P.; Coudert, G. Tetrahedron Lett. 1999, 
40, 6373. (b) Maslak, V.; Tokic-Vujosevic, Z.; Saicic, R. N. Tetrahedron Lett. 2009, 
50, 1858. (c) Alonso, F.; Beletskaya, I. P. Yus, M. Tetrahedron 2008, 64, 3047. (d) Li, 
C. J. Chem. Rev. 2005, 105, 3095. (e) Lipshutz, B. H.; Ghorai, S. Aldrichim. Acta 2008, 
 
14 
 
 
41, 59. (f) Calo, V.; Nacci, A.; Monopoli, A. Eur. J. Org. Chem. 2006, 3791. (g) 
Rajagopal, R.; Jarikote, D. V.; Srinivasan, K. V. Chem. Commun. 2002, 616. (h) 
Leadbeater, N. E. Chem. Commun. 2005, 23, 2881. (i) Kabalka, G. W. Al-Masum, M. 
Mereddy, A. R.; Dadush, E. Tetrahedron Lett. 2006, 47, 1133. (j) Kabalka, G. W.; 
Zhou, L.-L.; Naravane, A. Tetrahedron Lett. 2006, 47, 6887. (k) Kabalka, G. W.; Pagni, 
R. M.; Wang, L.; Namboodiri, V.; Hair. C. M. Green Chem. 2000, 2, 120. 
(7) Negishi E. In Aspects of Mechanism of Organometallic Chemistry. Brewster, J. H.; Ed.; 
Plenum Press: New York, 1978, pp 285-317. 
(8) Miyaura, N.; Yamada, K.; Suzuki, A. Tetrahedron Lett. 1979, 3437. 
(9) Gropen, O.; Haaland, A. Acta Chim. Scan. 1973, 276, 521. 
(10) Miyaura, N; Suzuki, A. J. Chem. Soc. Chem. Commun. 1979, 866. 
(11) (a) Walker, S. D.; Barder, T. E.; Martinelli, J. R.; Buchwald, S. L. Angew. Chem. Int. 
Ed. 2004, 43, 1871. (b) Shen, W. Tetrahedron Lett. 1997, 38, 5575. (c) Galardon, E.; 
Ramdeehul, S.; Brown, J. M.; Cowley, A.; Hii, K. K.; Jutand, A. Angew. Chem. Int. 
Ed. 2002, 41, 1760. (d) Netherton, N. R.; Fu, G. C. Adv. Synth. Catal. 2004, 346, 1525. 
(e) Hartwig, J. F.; Paul, F. J. Am. Chem. Soc. 1995, 117, 5373. (f) Hartwig, J. F. Angew. 
Chem. Int. Ed. 1998, 37, 2046. 
(12) Martin, R.; Buchwald, S. L. Acc. Chem. Res. 2008, 41, 1461. 
(13) (a) Biscoe, M. R.; Fors, B. P.; Buchwald, S. L. J. Am. Chem. Soc. 2008, 130, 6686. (b) 
Kinwel, T.; Zhang, Y.; Buchwald, S. L. J. Am. Chem. Soc. 2010, 132, 14073. 
(14) Miyaura, N.; Yanagi, T.; Suzuki, A. Synth. Commun. 1981, 11, 513. 
15 
 
 
(15) (a) Noguchi, H.; Hojo, K.; Suginome, M. J. Am. Chem. Soc. 2007, 129, 758. (b) 
Noguchi, H.; Shioda, T.; Chou, C.-M.; Suginome, M. Org. Lett. 2008, 10, 377. (c) 
Iwadate, N.; Suginome, M. Org. Lett. 2009, 11, 1899. 
(16) Gillis, E. P.; Burke, M. D. J. Am. Chem. Soc. 2007, 129, 6716. 
(17) (a) Darses, S.; Genet, J.-P. Eur. J. Org. Chem. 2003, 4313. (b) Molander, G. A.; 
Figueroa, R. Aldrichim. Acta 2005, 38, 49. (c) Molander, G. A.; Ellis, N. Acc. Chem. 
Res. 2007, 40, 275. (d) Stefani, H. A.; Cella, R.; Vieira, A. S. Tetrahedron 2007, 63, 
3623. (e) Darses, S.; Genet, J.-P. Chem. Rev. 2008, 108, 288. (f) Molander, G. A.; 
Canturk, B. Angew. Chem. Int. Ed. 2009, 48, 9240. 
(18) Chambers, R. D.; Clark, H.S.; Willis, C.J. J. Am. Chem. Soc. 1960, 82, 5298. 
(19) Vedejs, E.; Chapman, R.W.; Fields, S.C.; Lin, S.; Schrimpf, M.R. J. Org. Chem. 1995, 
60, 3020. 
(20) (a) Molander, G. A; Petrillo, D. E. J. Am. Chem. Soc. 2006, 128, 9634. (b) Molander, 
G. A; Cooper, D. J. J. Org. Chem. 2007, 72, 3558-3560. 
(21) (a) Molander, G. A.; Figueroa, R. J. Org. Chem. 2006, 71, 6135. (b) Molander, G. A.; 
Ham, J.; Canturk, B. Org. Lett. 2007, 9, 821. (c) Molander, G. A.; Oliveira, R. A. 
Tetrahedron Lett. 2008, 49, 1266. 
(22) Molander, G. A.; Cooper, D. J. J. Org. Chem. 2008, 73, 3885. 
(23) (a) Cho, Y. A.; Kim, D.-S.; Ahn, H. R.; Canturk, B.; Molander, G. A.; Ham, J. Org. 
Lett. 2009, 11, 4330. (b) Lee, J.-H.; Kim, H.; Kim, T.; Song, J. H.; Kim, W.-S.; 
Ham. J. Bull. Korean Chem. Soc. 2013, 34, 42. 
16 
 
 
(24) (a) Molander, G. A.; Sandrock, D. L.  J. Am. Chem. Soc. 2008, 130, 15792. (b) 
Molander, G. A.; Sandrock, D. L.  Org. Lett. 2009, 11, 2369. 
(25) Molander, G. A.; Ham, J. Org. Lett. 2006, 8, 2767. 
(26) Darses, S.; Genet, J.-P.; Brayer, J.-L.; Demoute, J.-P. Tetrahedron Lett. 1997, 38, 4393. 
(27) Xia, M.; Chen, Z.-C. Synth. Commun. 1999, 29, 2465. 
(28) Littke, A. F.; Dai, C.; Fu, G. C. J. Am. Chem. Soc. 2000, 122, 4020. 
(29) Molander, G. A.; Ito, T. Org. Lett. 2001, 3, 393. 
(30) Molander, G. A.; Jean-Gerard, L. Cross-Coupling Reactions of Organotrifluoroborate 
Salts. In Organic Reactions; Denmark, S. E., Eds.; John Wiley & Sons, 2013; Vol. 79, 
pp 1–316. 
(31) (a) Amatore, C.; Jutand, A.; Le Duc, G. Chem.–Eur. J. 2011, 17, 2492. (b) Braga, A. 
A. C.; Morgon, N. H.; Ujaque, G.; Maseras, F.  J. Am. Chem. Soc. 2005, 127, 9298. 
(32) (a) Carrow, B. P.; Hartwig, J. F.; J. Am. Chem. Soc. 2011, 133, 2116. (b) Schmidt, A. 
F.; Kurokhtina, A. A.; Larina, E. V. Russ. J. Gen. Chem. 2011, 81, 1573. (c) Batey, R. 
A.; Quach, T. D. Tetrahedron Lett. 2001, 42, 9099. (d) Butters, M.; Harvey, J. N.; 
Lloyd-Jones, G. C. Angew. Chem. Int. Ed. 2010, 49, 5156. (e) Yuen, A. K. L.; Hutton, 
C. A. Tetrahedron Lett. 2005, 46, 7899. 
(33) Lennox, A. J. J.; Lloyd-Jones, G. C. J. Am. Chem. Soc. 2012, 134, 7431. 
(34) Amatore, C.; Jutand, A.; Le Duc, G. Angew. Chem. Int. Ed. 2012, 51, 1379. 
17 
 
Chapter 2. Enantiomerically Enriched Potassium β-Trifluoroboratoamides 
 
2.1 Preparation of α-Chiral β-Arylated Carbonyl Compounds 
 α-Chiral β-arylated carbonyls are encounted in many organic compoudns. They are 
one of the important substructures in synthetic organic chemistry. Several synthetic 
pathways have been reported to install these target substructures. The common approaches 
to these moieties are benzylation of enolates,1 conjugate additions of arylmetallics to α,β-
unsaturated carbonyl precusors,2 and catalytic asymmetric hydrogenation of α-substituted 
α,β-unsaturated carbonyl substrates (Scheme 2.1).3  
 
Scheme 2.1 Strategies for the Synthesis of α-Chiral β-Arylated Carbonyl Compounds 
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The benzylation approach is one of the highly attractive pathways because many 
chiral auxiliaries are readily available (Scheme 2.1, path a).1 However, only limited 
numbers of benzylic halide precursors are commercially available. Another drawback is 
the control of the chemoselectivity throughout the alkylation steps. 
 An alternative route is a 1,4-conjugate addition of arylmetallic reagents to α,β-
unsaturated carbonyl compounds (Scheme 2.1, path b).2 After the addition, the 
corresponding enolate requires to protonate enantioselectively to provide the target β-
arylated carbonyl compounds. However, this method is highly substrate dependent and 
lack of efficacy.4   
 Another way to prepare the β-arylated carbonyl substructure is transition metal 
catalyzed asymmetric hydrogenation of α-substituted α,β-unsaturated carbonyls (Scheme 
2.1, path c).3  Similar to the protonation process, enantioselective hydrogenation of carbon-
carbon double bonds is important. Therefore, access to a stereodefinded trisubstituted 
alkene substrate is required. 
 
2.2. Transition Metal Catalyzed Reactions of β-Metallohomoenolates 
 A more direct and efficient way to build α-chiral β-arylated carbonyl compounds is 
the transition metal catalyzed cross-coupling reactions of α-chiral β-metallo carbonyl 
reagents with aryl and hetaryl halides (Scheme 2.2). 
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Scheme 2.2 Cross-Coupling of β-Metallo Carbonyl Compounds 
 
  
 β-Metallo carbonyl species or metallohomoenolates possessing ‘umpolung’ 
reactivity have been demonstrated in synthetic chemistry. Zinc,5 titanium,6 silicon,7 tin, 8 
and boron homoenolates9 have been prepared by different synthetic strategies. However, 
only a few reports exist that demonstrate the coupling of previously prepared 
metallohomoenolates as the nucleophilic partners to provide the target β-arylated carbonyl 
substructures. 
 More recently, the preparation and Suzuki–Miyaura cross-coupling reactions of β-
trifluoroborato ketones, esters, and amides have been described by the Molander group 
(Scheme 2.3).10 These β-trifluoroborato carbonyl reagents proved to be efficient to install 
the β-arylated carbonyl compounds through coupling with various aryl and hetaryl halides. 
Particularly, aryl and hetaryl halides are more readily available compared to the benzyl 
halides required for the benzylation pathway. Moreover, the Suzuki–Miyaura reaction have 
proven to be efficient because it shows better functional group tolerance and minimal 
toxicity.11 Even though these β-trifluoroborato carbonyl substances have been studied, α-
chiral β-trifluoroborato carbonyl substances have not been investigated. 
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Scheme 2.3 Study of β-Trifluoroborato Carbonyl Reagents 
 
 
 α-Chiral β-arylated carbonyl compounds have previously been prepared with 
organozinc homoenolates through Negishi cross-coupling reactions (Sheme 2.4). 12 
Enantiomerically enriched α-chiral organozinc coupling partners have proven to be the 
effective coupling partners to build the target substructures. However, organozinc 
homoenolates are known to be unstable to moisture and air. Therefore, zinc reagents must 
be prepared in situ and also handled under an inert atmosphere. Moreover, sensitive 
functional groups may not be compatible with zinc species because they exhibit reactivity 
with various electrophiles.13 
  
Scheme 2.4 α-Chiral Organozinc Homoenolates in Negishi Cross-Coupling Reactions 
 
 
2.3 Results and Discussion 
 To expand the study of previous work on β-trifluoroboratoamides, we envisioned 
the synthesis and the Suzuki–Miyaura reaction of α-chiral β-trifluoroboratoamides using 
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chiral auxiliaries. This development would be a useful asymmetric synthetic pathway for 
the preparation of α-chiral β-arylated carbonyl compounds. To the best of our knowledge, 
this type of chiral boron reagent has not been prepared or applied in couplings (Scheme 
2.5). 
 
Scheme 2.5 Strategy for the Synthesis and the Suzuki–Miyaura Reaction of α-Chiral 
β-Trifluoroboratoamides 
 
 
 However, one of the concerns is retention of the stereocenter under the aqueous 
basic conditions at high temperature required for the organotrifluoroborate couplings. Only 
a few examples have been reported with the application of boron containing substances 
with a stereocenter in Suzuki–Miyaura coupling reactions;14 however, these examples do 
not involve α-chiral β-arylated carbonyl boron reagents. 
 
2.3.1 Synthesis of Enantiomerically Enriched Potassium β-Trifluoroboratoamides 
First, we employed several chiral auxiliaries, such as Evans oxazolidinone, 
Oppolzer’s sultam, and Meyers’ pseudoephedrine, to prepare α-chiral β-
trifluoroboratoamides. Even though we could prepare α-chiral β-trifluoroboratoamides 
using all of the auxiliaries, later, we found that Evans oxazolidinones and the Oppolzer’s 
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sultam derivatives were inefficient due to cleavage of auxiliaries during the cross-coupling 
reactions. 
Based on the Matteson’s enolate chemistry with chiral α-halo boronic esters15 and 
Meyers pseudoephedrine study, 16  enantiomerically enriched α-chiral β-
trifluoroboratoamides using (1S, 1S)-(+)-pseudoephedrine as the chiral auxiliary were 
successfully prepared through a two-step synthesis (Table 2.1). First, the steregenic center 
was installed via alkylation of the enolate using iodomethylpinacolboronate. The alkylated 
α-chiral β-pinacolboronates were obtained in good to excellent yields. The diastereomeric 
ratios of these intermediates were greater than 95:5 by 1H NMR. Addition of KHF2 to the 
solution of pinacolboronates provided the desired enantiomerically enriched α-chiral β-
trifluoroboratoamides in moderate to excellent isolated yields. Successfully prepared β-
trifluoroboratoamides were white solids, which were air stable and could be stored on the 
bench without decomposition or epimerization. 
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Table 2.1 Synthesis of α-Chiral β-Trifluoroboratoamides  
 
2.3.2 Suzuki–Miyaura Cross-Coupling Reaction with Aryl and Hetaryl Chlorides 
With these enantiomerically enriched β-trifluoroboratoamides in hand, their utility 
as the nucleophilic coupling partners in Suzuki–Miyaura coupling reactions was 
investigated. The optimization process was conducted with the α-methyl substituted β-
trifluoroboratoamide and chlorobenzene. Several ligands, bases, solvents, and times were 
screened, and the combination of 5 mol % of Pd(OAc)2, 10 mol % of RuPhos and 3 equiv 
of K2CO3 in a mixture of toluene / H2O (4:1, 0.25 M) at 85 °C for 22 h emerged as the best 
conditions (Equation 2.1). 
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Equation 2.1 Optimization of Cross-Coupling Reactions with α-Chiral β-
Trifluoroboratoamide 
 
To investigate the scope of the electrophiles, various electron-neutral and electron-
donating aryl chlorides were employed in cross-couplings using the optimized conditions 
(Table 2.2). All of the electrophiles successfully provided the desired products in moderate 
to good yields. Substrates with methyl substituents at the ortho position provided the 
expected products in lower yields (Table 2.2, entries 2, 3 and 6). In the case of 4-
chloroanisole as the electrophilic coupling partner, SPhos was used instead of RuPhos to 
obtain a better result (Table 2.2, entry 4). The electrophiles with electron-rich substituents 
on the ortho, meta, and para positions gave the corresponding products in moderate yields 
(Table 2.2, entries 4–7). Interestingly, the substrate containing more electron-donating 
substituents provided the desired product in the better yield compared to substrates 
processing only one electron-rich substituent (Table 2.2, entry 7), even though the electron-
rich electrophiles are known to be inefficient coupling partners in Suzuki–Miyaura 
coupling reactions.17     
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Table 2.2 Cross-Coupling of α-Chiral β-Trifluoroboratoamide with Various Aryl 
Chlorides 
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 Next, electrophiles containing an electron-withdrawing group on the aryl ring were 
studied using the same set of conditions (Table 2.3). The desired products were obtained 
in moderate to good yields. In general, electron-poor substrates showed relatively better 
results compared to electron-neutral and electron-rich coupling partners. Several functional 
groups, such as esters, nitriles, nitro groups, and aldehydes were compatible throughout the 
coupling reactions. It should be noted that these functional groups would not be tolerated 
with enolate alkylation method to prepare the target structure. In the case of the electrophile 
with a nitrile moiety on the aryl ring, SPhos was found to be more efficient than RuPhos 
to give a better yield (Table 2.3, entry 2). Unfortunately, p-trifluoromethylphenyl chloride 
as an electrophile provided the expected product in low yield, 43% (Table 2.3, entry 4).  
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Table 2.3 Cross-Coupling of α-Chiral β-Trifluoroboratoamide with Various Aryl 
Chlorides 
 
 
 To expand the scope of electrophiles, hetaryl chlorides were tested as the coupling 
partners employing the developed reaction conditions (Table 2.4). Various hetaryl 
chlorides, such as thiophenes, furans and pyridines, proved to be efficient coupling 
counterparts to provide the desired products in moderate to good yields, up to 80% isolated 
yield. Again, sensitive functional groups, such as esters and aldehydes, were tolerated 
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under coupling reactions. Interestingly, pyridine with an electron-poor substituent afforded 
the corresponding product in a higher yield compared to electron-rich pyridine derivative 
(Table 2.4, entries 5 and 6). 
 
Table 2.4 Cross-Coupling of α-Chiral β-Trifluoroboratoamide with Various Hetaryl 
Chlorides 
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 Then, various potassium β-trifluoroboratoamides were tested in the Suzuki–
Miyaura cross-coupling reaction as the nucleophilic coupling partners (Table 2.5). 
Different substituents α to the carbonyl affected the yields depending on the steric 
hindrance. Substrates with methyl and ethyl α to the carbonyl provided the desired products 
in good yields (Table 2.5, entries 1 and 2). However, the isolated yields were dramatically 
dropped with more sterically demanding substrates, such as n-butyl and isopropyl groups, 
and also longer reaction times were required for the reaction to go to completion (Table 
2.5, entries 3 and 4). 
 
Table 2.5 Cross-Coupling of Various α-Chiral β-Trifluoroboratoamides with 
Chlorobenzene 
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2.3.3 Diastereoselectivity of the Suzuki–Miyaura Reaction 
 After the cross-coupling reactions, the diastereomeric ratios of the coupled products 
needed to be determined. The method developed by Meyers using triflic anhydride and 
pyridine to form cyclic oxazolium triflates from pseudoephedrine derivatives was 
employed to determine the degree of stereoretention (Equation 2.2). 18  The 
diastereoselectivities were easily detectable by 1H NMR chemical shifts with the methyl 
substituent at the α stereocenter. 
 
Equation 2.2 Determining the Diastereomeric Ratios by the Meyers Method 
 
  
We applied this method to the final products to determine the diastereomeric ratios 
after the coupling reactions. Most of the products were tested and gave diastereomeric 
ratios greater than 95:5. Unfortunately, some of substrates, such as the compounds 
prossessing sensitive functional groups and hetayl derivatives, were incompatible with 
triflic acid, and their diastereoselectivities could not be determined in this manner. The 
stereochemistry of the major diastereomer was determined by comparison to the known 
compound (Figure 2.1).  
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Figure 2.1 Study of Diastereomeric Ratio 
 
 
 
Particularly, the diastereoselectivities gave different results depending on the 
substituents α to the carbonyl (Table 2.6). More sterically hindered substrates gave slightly 
better diastereomeric ratios (Table 2.6, entries 3 and 4). Finally, we concluded that the 
diastereoselectivities were retained throughout the coupling reactions. 
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Table 2.6. Determining the Diastereomeric Ratio of the Coupled Products 
 
 
2.4 Conclusions 
 Enantiomerically enriched potassium α-chiral β-trifluoroboratoamides were 
successfully prepared using pseudoephedrine as a chiral auxiliary employing Matteson’s 
chemistry. These β-trifluoroboratoamides were air stable white solids and could be stored 
on the bench without loss of stereochemistry. Subsequently, palladium catalyzed Suzuki–
Miyaura cross-coupling reactions were investigated with the β-trifluoroboratoamides. All 
of them proved to be efficient nucleophilic coupling partners with various aryl and hetaryl 
chlorides. This development provides a complementary approach to previous reports to 
build the target structures. Use of the β-trifluoroboratoamides, which afford an umpolung 
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pathway, proved superior to other routes, such as alkylation, conjugate 
addition/enantioselective protonation, and asymmetric hydrogenation, in terms of 
availability of reagents and compatibility of functional groups. Moreover, the 
diastereoselectivities were greater than 95:5 in all cases, and the stereochemistry was 
preserved under the aqueous basic conditions of cross-couplings. 
 
2.5 Experimental 
General.   
Pd(OAc)2, RuPhos, SPhos and K2CO3 were used as received. All halides were used as 
received. Lithium chloride was dried under vacuum at 150 °C for 24 h prior to use. Toluene 
was distilled from sodium/benzophenone prior to use. H2O was degassed prior to use. 
Melting points (°C) are uncorrected. 1H, 13C and 19F NMR spectra were recorded at 500.39, 
125.75, and 470.55 MHz, respectively. 19F NMR chemical shifts were referenced to 
external CFCl3 (0.0 ppm). 
11B NMR spectra at 128.4 MHz were obtained on a spectrometer 
equipped with the appropriate decoupling accessories. All 11B NMR chemical shifts were 
referenced to external BF3OEt2 (0.0 ppm) with a negative sign indicating an upfield shift. 
Analytical thin layer chromatography (TLC) was performed on TLC silica gel plates (250 
m) precoated with a fluorescent indicator. Standard flash chromatography procedures19 
were followed using 32–63 m silica gel. Visualization was effected with ultraviolet light, 
cerium ammonium molybdate (CAM), and KMnO4. 
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General Procedure for the Alkylation Reaction. 
 
 
(R)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-N,2-dimethyl-3-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)propanamide.  
A flame-dried round bottom flask was charged with LiCl (1.1 g, 27.1 mmol, 6.0 equiv), i-
Pr2NH (1.5 mL, 10.6 mmol, 2.4 equiv), and THF (13 mL). The solution was cooled to –78 
°C, and added to a solution of n-BuLi in hexanes (2.5 M, 4.4 mL, 9.5 mmol, 2.1 equiv). 
The resulting mixture was briefly warmed to 0 °C and cooled to –78 °C again. A cooled 
solution of amide (1.0 g, 4.5 mmol, 1.0 equiv) in THF (15 mL) was added to the reaction 
flask. The mixture was stirred at –78 °C for 1 h at 0 °C for 15 min, and at rt for 5 min and 
then cooled to 0 °C. Iodomethylpinacolboronate (1.8 g, 6.75 mmol, 1.5 equiv) was added 
to reaction mixture and stirred at 0 °C for 30 min, and then the reaction was quenched by 
the addition of saturated aq. NH4Cl solution (10 mL). The mixture was extracted with 
EtOAc (2 30 mL) and brine (10 mL). The organic layer was dried (MgSO4), concentrated 
in vacuo, and purified by column chromatography (hexanes:EtOAc = 1:1) to afford the 
product (1.4 g, 3.9 mmol) as a colorless oil in 86% isolated yield.  
[]20D +60.8 (c 1.20, CHCl3); 1H NMR (1.2:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 7.39–7.06 (m, 5H), 4.72 (br, 1H), 4.42 (d, J = 9.0 Hz, 1H), 4.14* 
(d, J = 1.5 Hz, 1H), 4.12–4.02* (m, 1H), 4.02–3.94 (m, 1H), 3.34–3.27 (m, 1H), 2.77 (s, 
3H), 2.69–2.63* (m, 1H), 2.37* (s, 3H), 1.71 (dd, J = 16.0, 10.0 Hz, 1H), 1.25 (dd, 1H, J 
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= 15.5, 7.0 Hz, 1H), 1.14* (s, 12H), 1.12–1.11 (m, 15H), 1.03 (d, 3H, J = 7.0 Hz, 3H), 
0.60* (d, 3H, J = 6.5 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) 179.7*, 178.8 128.8, 142.5*, 
141.1, 128.6, 128.3*, 128.1*, 127.5*, 127.1, 126.6, 83.2*, 82.9, 76.2*, 75.5, 58.8, 33.1*, 
32.3, 26.9, 25.9, 24.7*, 24.5, 20.3, 19.4*, 15.8, 14.2*; 11B NMR (128.4 MHz, C6D6) δ 31.8; 
IR (neat) 3369, 2976, 1617 cm-1; HRMS (ES+) calcd. for C20H32BNO4Na [M+Na]
+ 
383.2322, found 383.2314. 
 
 
(S)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-N-methyl-2-{(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)methyl}butanamide.  
The reaction was carried out with the corresponding amide (4.1 g, 17.4 mmol, 1.0 equiv) 
according to the general alkylation procedure to obtain the product (6.5 g, 17.2 mmol) as a 
colorless oil in 99% yield. 
[]20D +72.0 (c 1.54, CHCl3); 1H NMR (1:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 7.39 (t, J = 8.0 Hz, 2H), 7.22–7.06 (m, 3H), 4.80–4.74 (m, 1H), 
4.71* (br, 1H), 4.42 (d, J = 9.0 Hz, 1H), 4.11–4.02 (m, 1H), 3.27–3.18* (m, 1H), 2.80 (s, 
3H), 2.62–2.53 (m, 1H), 2.45* (s, 3H), 1.84–1.73 (m, 1H), 1.70–1.62* (dd, J = 16.0, 10.0 
Hz, 1H), 1.61–1.40 (m, 2H), 1.32–1.25 (m, 1H), 1.13* (d, J = 10.5 Hz, 12H), 1.10 (s, 12H), 
1.08 (d, J = 7.0 Hz, 3H), 0.86* (t, J = 7.5 Hz, 3H), 0.81 (t, J = 7.5 Hz, 3H), 0.64* (d, J = 
7.0 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ179.2*, 178.2, 142.6*, 141.2, 128.7, 128.4, 
128.2*, 127.7*, 127.2, 126.8*, 83.5, 83.1*, 78.4*, 75.7, 59.0, 39.7*, 38.8, 28.0, 27.7*, 26.9, 
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25.0, 24.8*, 24.6, 16.1, 14.5*, 11.9*, 11.9; 11B NMR (128.4 MHz, C6D6) δ 31.9; IR (neat) 
3435, 1638 cm-1; HRMS (ES+) calcd. for C21H35NO4 [M+H]
+ 376.2659, found 376.2653. 
 
 
(S)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-N-methyl-2-{(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)methyl}hexanamide.  
The reaction was carried out with the corresponding amide (1.1 g, 4.18 mmol, 1.0 equiv) 
according to the general alkylation procedure to obtain the product (1.4 g, 3.47 mmol) as a 
colorless oil in 83% yield. 
[]20D +61.8 (c 1.23, CHCl3); 1H NMR (1:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 7.39 (dd, J = 7.0, 5.0 Hz, 2H), 7.22–7.07 (m, 3H), 4.77* (s, 1H), 
4.46 (d, J = 9.0 Hz, 1H), 4.36 (s, 1H), 4.18–4.08 (m, 1H), 3.36–3.28* (m, 1H), 2.82 (s, 3H), 
2.72–2.63 (m, 1H), 2.51* (s, 3H), 1.82–1.73* (m, 1H), 1.65 (dd, J = 16.0, 10.0 Hz, 1H), 
1.60–1.43 (m, 2H), 1.32–1.17 (m, 5H), 1.14* (d, J = 10.0 Hz, 12H), 1.11 (s, 12H), 0.87* 
(t, J = 7.0 Hz, 3H), 0.76 (t, J = 7.0 Hz, 3H), 1.37 (d, J = 7.0 Hz, 3H); 13C NMR (125.6 
MHz, CDCl3) δ 179.4*, 178.4, 142.7*, 141.3, 128.7, 128.4, 128.3*, 127.7*, 127.3, 126.8*, 
83.5, 83.2*, 76.5*, 75.8, 59.0, 38.2*, 37.1, 34.7, 34.5*, 29.7*, 29.4, 26.9, 25.0, 24.8*, 24.6, 
22.9*, 22.7, 16.1, 14.5*, 14.1*, 14.0; 11B NMR (128.4 MHz, C6D6) δ 31.7; IR (neat) 3436, 
1634 cm-1; HRMS (ES+) calcd. for C23H39NO4B [M+H]
+ 404.2972, found 404.2984. 
 
37 
 
 
(R)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-N,3-dimethyl-2-{(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)methyl}butanamide.  
The reaction was carried out with the corresponding amide (1.4 g, 5.62 mmol, 1 equiv) 
according to the general alkylation procedure to obtain the product (1.5 g, 3.85 mmol) as a 
colorless oil in 69% yield.  
[]20D +73.5 (c 2.04, CHCl3); 1H NMR (1:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 7.40 (dd, J = 15.0, 7.5 Hz, 2H), 7.23–7.07 (m, 3H), 4.83–4.78* 
(m, 1H), 4.76* (s, 1H), 4.47 (d, J = 8.0 Hz, 2H), 4.18–4.08 (m, 1H), 3.25–3.19* (m, 1H), 
2.80 (s, 3H), 2.56* (s, 3H), 2.55–2.47 (m, 1H), 2.08–1.99* (m, 1H), 1.89–1.78 (m, 1H), 
1.70–1.61* (m, 1H), 1.35* (dd, J = 16.0, 9.0 Hz, 1H), 1.12* (d, J = 14.0 Hz, 12H), 1.10 (s, 
12H), 1.00 (ddd, J = 21.0, 16.5, 5.0 Hz, 2H), 0.89 (dd, J = 11.5, 6.5 Hz, 6H), 0.83 (d, J = 
7.0 Hz, 3H), 0.66* (d, J = 6.5 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ178.8*, 177.6, 
142.6*, 141.2, 128.7, 128.3, 128.1*, 127.6*, 127.2, 126.8*, 83.5, 83.1*, 76.4*, 75.7, 59.1, 
44.4*, 43.0, 31.7, 31.5*, 26.8*, 24.9, 24.7*, 24.5, 21.5, 21.1*, 19.0*, 18.5, 16.2, 14.3*; 11B 
NMR (128.4 MHz, C6D6) δ 32.3; IR (neat) 3435, 1620 cm-1; HRMS (ES+) calcd. for 
C22H37NO4B [M+H]
+ 390.2816, found 390.2797. 
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General Procedure for the Preparation of Enantiomerically Enriched Potassium α-
Chiral β-Trifluoroboratoamides. 
 
 
Potassium (R)-3-(Trifluoroborato)-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N,2-
dimethylpropanamide.  
The corresponding boronate ester (4.4 g, 12.2 mmol, 1.0 equiv) was dissolved in MeCN 
(24 mL) and cooled to 0 °C. KHF2 (2.9 g, 36.5 mmol, 3.0 equiv) in H2O (8 mL) was added. 
The reaction mixture was stirred for 20 min at 0 °C. The solution was concentrated in vacuo 
and then dried in vacuo overnight. The crude mixture was extracted with acetone (2  20 
mL), and the extracts were combined and concentrated. Et2O (30 mL) was added to 
precipitate the product. The product (3.7 g, 11.0 mmol) was filtered and dried in vacuo and 
obtained as a white solid in 90% isolated yield.  
[]20D +48.2 (c 1.42, MeOH); mp: 124–129 °C; 1H NMR (2:1 rotamer ratio, asterisk 
denotes minor rotamer peaks, with less than 5% of pinacol, 500 MHz, DMSO-d6) δ 7.47–
7.19 (m, 5H), 5.31–5.18 (m, 1H), 5.07–4.99* (m, 1H), 4.68–4.54 (m, 1H), 4.54–4.45 (m, 
1H), 4.25–4.15* (m, 1H), 2.82 (s, 3H), 2.70* (s, 3H), 2.59–2.51 (m, 1H), 0.94* (d, J = 6.0 
Hz, 3H), 0.88 (d, J = 6.5 Hz, 3H), 0.79 (d, J = 6.5 Hz, 3H), 0.68–0.65* (m, 1H), 0.23–0.12 
(m, 1H), 0.07– –0.11 (m, 1H); 13C NMR (125.6 MHz, DMSO-d6) δ 179.5, 179.4*, 143.9, 
143.8*, 128.0*, 127.8, 127.5*, 127.3*, 127.0, 126.9, 74.2, 74.0, 73.5*, 56.2, 32.3, 32.0*, 
29.5*, 26.0*, 25.0, 20.0*, 18.9, 15.4*, 13.9; 19F NMR (470.8 MHz, DMSO-d6) δ –135.2*, 
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–136.1; 11B NMR (128.4 MHz, DMSO-d6) δ 3.92; IR (KBr) 3505, 2970, 1615 cm-1; HRMS 
(ES-) calcd. for C15H22BNO2F3 [M–K]– 302.1539, found 302.1547. 
 
 
Potassium (S)-2-{(Trifluoroborato)methyl}-N-{(1S,2S)-1-hydroxy-1-phenylpropan-
2-yl}-N-methylbutanamide.  
The reaction was carried out with the corresponding boronate ester (6.1 g, 16.3 mmol, 1.0 
equiv) according to the general procedure for the preparation of enantiomerically enriched 
potassium α-chiral β-trifluoroboratoamides to obtain the product (4.2 g, 11.8 mmol) as a 
white solid in 72% yield. 
[]20D +52.3 (c 1.21, MeOH); mp: 185–186 °C; 1H NMR (2:1 rotamer ratio, asterisk 
denotes minor rotamer peaks, 500 MHz, DMSO-d6) δ 7.63–7.29 (m, 5H), 5.36 (s, 1H), 
5.03* (s, 1H), 4.76 (br, 1H), 4.70–4.68 (m, 1H), 4.62–4.58* (m, 1H), 4.39–4.38* (m, 1H), 
2.95 (s, 3H), 2.86* (s, 3H), 2.65–2.57 (m, 1H), 1.67–1.55* (m, 2H), 1.55–1.44 (m, 2H), 
0.99 (d, J = 6.5 Hz, 3H), 0.92* (d, J = 6.0 Hz, 3H), 0.77* (t, J = 7.0 Hz, 3H), 0.70 (t, J = 
7.0 Hz, 3H), 0.65–0.58* (m, 1H), 0.30–0.18 (m, 1H), 0.18–0,07 (m, 1H); 13C NMR (125.6 
MHz, DMSO-d6) δ 178.7, 178.5*, 143.9, 143.8*, 128.0, 127.8, 127.5*, 127.3*, 126.8*, 
126.7, 74.4*, 74.1, 56.2, 53.5*, 40.1, 30.2, 27.9, 26.8, 25.9*, 15.5*, 13.9, 12.9*, 12.7; 19F 
NMR (470.8 MHz, DMSO-d6) δ –134.9*, –136.0; 11B NMR (128.4 MHz, DMSO-d6) δ 4.5; 
IR (KBr) 3504, 2968, 1611 cm-1; HRMS (ES-) calcd. for C15H22BNO2F3 [M–K]– 316.1696, 
found 316.1707. 
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Potassium (S)-2-{(Trifluoroboryl)methyl}-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-
yl}-N-methylhexanamide.  
The reaction was carried out with the corresponding boronate ester (1.2 g, 3.00 mmol, 1.0 
equiv) according to the general procedure for the preparation of enantiomerically enriched 
potassium α-chiral β-trifluoroboratoamides to obtain the product (590 mg, 1.54 mmol) as 
a white solid in 61% yield.  
[]20D +44.9 (c 1.02, MeOH); mp: 64–68 °C; 1H NMR (2:1 rotamer ratio, asterisk denotes 
minor rotamer peaks, with less than 5% of pinacol, 500 MHz, DMSO-d6) δ 7.56–7.24 (m, 
5H), 5.32 (s, 1H), 5.01–4.94* (m, 1H), 4.76–4.66 (m, 1H), 4.66–4.59 (m, 1H), 4.57–4.49* 
(m, 1H), 4.37–4.28* (m, 1H), 2.88 (s, 3H), 2.80* (s, 3H), 2.67–2.59* (m, 1H), 2.57 (s, 1H), 
1.62–1.37 (m, 2H), 1.36–1.17 (m, 2H), 1.11–0.97 (m, 2H), 0.95 (d, J  = 6.5 Hz, 3H), 0.87 
(dd, J  = 14.0, 7.5 Hz, 3H), 0.65–0.53* (m, 1H), 0.23–0.11 (m, 1H), 0.11–0.00 (m, 1H); 
13C NMR (125.6 MHz, DMSO-d6) δ 178.9, 178.7*, 143.9, 128.0, 127.7, 127.5*, 127.3*, 
126.8*, 126.7, 74.5, 74.2, 73.6*, 56.3, 38.0, 34.8*, 33.8, 30.4*, 29.9, 26.0*, 25.0, 22.6, 
15.5*, 14.1, 14.0*, 13.9; 19F NMR (470.8 MHz, DMSO-d6) δ –134.9*, –136.0; 11B NMR 
(128.4 MHz, DMSO-d6) δ 4.19; IR (KBr) 3400, 2931, 1611 cm-1; HRMS (ES-) calcd. for 
C17H26BNO2F3 [M–K]– 344.2009, found 344.2017. 
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Potassium (S)-2-{(Trifluoroboryl)methyl}-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-
yl}-N,3-dimethylbutanamide. 
The reaction was carried out with the corresponding boronate ester (1.3 g, 3.44 mmol, 1.0 
equiv) according to the general procedure for the preparation of enantiomerically enriched 
potassium α-chiral β-trifluoroboratoamides to obtain the product (1.1 g, 2.98 mmol) as a 
white solid in 83% yield. 
[]20D +49.6 (c 1.21, MeOH); mp: 70–75 °C; 1H NMR (3:2 rotamer ratio, asterisk denotes 
minor rotamer peaks, with less than 5% of pinacol, 500 MHz, DMSO-d6) δ 7.51–7.18 (m, 
5H), 5.01 (s, 1H), 4.74–4.64* (m, 1H), 4.61–4.48 (m, 2H), 4.45–4.38* (m, 1H), 4.32–4.24* 
(m, 1H), 2.85 (s, 3H), 2.71* (s, 3H), 2.28–2.24* (m, 1H), 2.24–2.17 (m, 1H), 1.64–1.54* 
(m, 1H), 1.54–1.45 (m, 1H), 0.82 (ddd, J = 29.0, 14.0, 7.5 Hz, 6H), 0.70* (d, J = 6.5 Hz, 
3H), 0.64 (d, J = 7.0 Hz, 3H), 0.34–0.26 (m, 1H), 0.22–0.06 (m, 1H); 13C NMR (125.6 
MHz, DMSO-d6) δ 178.5, 178.3*, 144.0*, 143.9, 127.9, 127.7, 127.5*, 127.2*, 126.8, 
74.9*, 74.2, 56.5, 44.7, 44.4*, 33.2*, 32.4, 26.0, 24.9*, 21.5*, 21.0, 20.6*, 20.5, 15.4*, 
13.7; 19F NMR (470.8 MHz, DMSO-d6) δ –134.3*, –135.9; 11B NMR (128.4 MHz, DMSO-
d6) δ 3.58; IR (KBr) 3512, 2964, 1611 cm-1; HRMS (ES-) calcd. for C16H24BNO2F3 [M–
K]– 330.1852, found 330.1855. 
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General Procedure for the Suzuki–Miyaura Cross-coupling Reaction. 
A sealed tube was charged with chiral potassium α-chiral β-trifluoroboratoamides (90 mg, 
0.263 mmol, 1.05 equiv), an aryl or hetaryl chloride (0.25 mmol, 1.0 equiv), Pd(OAc)2 (3 
mg, 0.013 mmol, 0.05 equiv), RuPhos ligand (0.03 mmol, 0.1 equiv) and K2CO3 (104 mg, 
0.75 mmol, 3.0 equiv).  The mixture was then was purged 3 times with N2.  (Liquid 
electrophiles were added last, after purging with N2).  Toluene / H2O (4:1, 0.8 mL/0.2 mL) 
was then added to the reaction tube. The reaction mixture was stirred for 22 h at 85 °C and 
then cooled to rt. A solution of pH 7 buffer (2 mL) was added, and the resulting mixture 
was extracted with EtOAc (2  3 mL). The organic layer was combined, dried (MgSO4) 
and filtered. The solvent was removed in vacuo and the product was purified by column 
chromatography. 
 
 
(R)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-N,2-dimethyl-3-
phenylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (54 
mg, 0.18 mmol) was obtained as a white solid in 70% yield after column chromatography 
(hexanes/EtOAc = 2:1). 
1H NMR (3:1 rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, C6D6) δ 7.33–
6.98 (m, 10H), 4.70 (br, 1H), 4.57–4.36 (m, 2H), 4.22* (dd, J = 8.0, 3.0 Hz, 1H), 3.96–
3.87* (m, 1H), 3.39* (dd, J = 13.5, 6.0 Hz, 1H), 3.01 (dd, J = 13.0, 8.0 Hz), 2.80* (s, 3H), 
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2.65–2.55 (m, 1H), 2.39 (dd, J = 13.5, 6.5 Hz, 1H), 2.15 (s, 3H), 1.06* (d, J = 6.5 Hz, 3H), 
1.03 (d, J = 6.5 Hz, 3H), 0.83 (d, J = 6.0 Hz, 3H), 0.68* (d, J = 7.0 Hz, 3H).  
Data is consistent with that reported in the literature.16b 
 
 
(R)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-N,2-dimethyl-3-(o-
tolyl}propanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (33 
mg, 0.1 mmol) was obtained as a colorless oil in 40% yield.  
[]20D +10.6 (c 1.60, CHCl3); 1H NMR (3:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 7.38–6.91 (m, 9H), 4.85 (br, 1H), 4.60 (br, 1H), 4.53 (d, J = 6.5 
Hz, 1H), 4.33* (d, J = 8.5 Hz, 1H), 4.00–3.92* (m, 1H), 3.80* (br, 1H), 3.39* (dd, J = 13.5, 
5.5 Hz, 1H), 3.32–3.24* (m, 1H), 3.00 (dd, J = 13.5, 8.0 Hz, 1H), 2.94* (dd, J = 13.5, 8.5 
Hz, 1H), 2.82* (s, 3H), 2.74–2.70 (m, 1H), 2.59 (dd, J = 14.0, 6.0 Hz, 1H), 2.38* (s, 3H), 
2.20 (s, 3H), 2.14 (s, 3H), 1.08 (d, J = 6.5 Hz, 3H), 0.86 (d, J = 6.5 Hz, 3H), 0.72* (d, J = 
7.0 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 178.5, 177.4*, 142.5, 141.3*, 138.6*, 138.1, 
136.5*, 136.1, 130.4*, 130.3, 130.1*, 129.7, 128.7*, 128.4, 127.6, 126.9*, 126.5, 126.4, 
126.4*, 125.9 76.5, 75.1*, 58.3, 37.5, 37.2, 37.1*, 36.6*, 32.2, 27.1*, 19.6*, 19.5, 17.9*, 
17.7, 15.6*, 14.3; IR (neat) 3370, 2972, 2933, 1618 cm-1; HRMS (ES+) calcd. for 
C21H28NO2 [M+H]
+ 326.2120, found 326.2115. 
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(R)-3-(2,6-Dimethylphenyl)-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N,2-
dimethylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (32 
mg, 0.09 mmol) was obtained as a colorless oil in 38% yield.  
[]20D –10.1 (c 1.05, CHCl3); 1H NMR (5:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 7.32–6.84 (m, 8H), 4.59 (br, 1H), 4.43 (d, J = 7.5 Hz, 1H), 4.16* 
(d, J = 9.0 Hz, 1H), 3.87–3.78* (m, 1H), 3.39–3.25* (m, 2H), 3.19–3.10* (m, 1H), 3.03 
(dd, J = 14.0, 8.5 Hz, 1H), 2.82–2.72 (m, 1H), 2.78* (s, 3H), 2.68 (dd, J = 14.0, 6.0 Hz, 
1H), 2.42* (s, 6H), 2.18 (s, 6H), 2.06 (s, 3H), 1.08 (d, J = 6.5 Hz, 3H), 1.07* (d, J = 6.5 
Hz, 3H), 0.79 (d, J = 7.0 Hz, 3H), 0.60* (d, J = 6.5 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) 
δ 179.2, 142.5, 137.4*, 137.0, 136.8, 128.8*, 128.5*, 128.5, 128.4, 127.8, 127.0*, 126.6, 
126.3, 76.7, 58.5, 36.2, 35.8*, 34.0, 33.4*, 29.8, 27.0*, 20.6*, 20.5, 17.8, 15.8*, 14.4; IR 
(neat) 3369, 2929, 1617 cm-1; HRMS (ES+) calcd. for C22H30NO2 [M+H]
+ 340.2277, found 
340.2275. 
 
 
(R)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-3-(4-methoxyphenyl)-N,2-
dimethylpropanamide.  
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According to the general procedure for Suzuki–Miyaura cross-coupling, SPhos instead of 
RuPhos, the product (44 mg, 0.13 mmol) was obtained as a colorless oil in 51% yield.  
[]20D +18.1 (c 1.38, CHCl3); 1H NMR (3:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 7.37–6.71 (m, 9H), 4.96 (br, 1H), 4.60 (br, 1H), 4.53 (d, J = 7.5 
Hz, 1H), 4.41* (d, J = 8.0 Hz, 1H), 4.04–3.97* (m, 1H), 3.35* (s, 3H), 3.33 (s, 3H), 3.16–
3.09* (m, 1H), 2.97 (dd, J = 13.5, 8.5 Hz, 1H), 2.84* (s, 3H), 2.97* (dd, J = 13.5, 9.0 Hz, 
1H), 2.68–2.60 (m, 1H), 2.47 (dd, J = 13.5, 6.0 Hz, 1H), 2.26 (s, 3H), 1.07* (d, J = 6.5 Hz, 
3H), 1.04 (d, J = 6.5 Hz, 3H), 0.86 (d, J = 6.5 Hz, 3H), 0.76* (d, J = 7.0 Hz, 3H); 13C NMR 
(125.6 MHz, CDCl3) δ178.3, 177.3*, 158.1, 158.0*, 142.4, 141.5*, 132.6*, 132.1, 130.2*, 
129.9, 128.6*, 128.3, 128.2*, 127.6, 127.0*, 126.5, 113.8*, 113.7, 76.4, 75.3*, 58.0, 55.2, 
39.5, 39.1, 38.2*, 32.2, 27.3*, 24.8*, 17.5*, 17.4, 15.5*, 14.3; IR (neat) 3377, 2971, 1614 
cm-1; HRMS (ES+) calcd. for C21H28NO3 [M+H]
+ 342.2069, found 342.2065. 
 
 
(R)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-3-(2-methoxyphenyl)-N,2-
dimethylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (47 
mg, 0.14 mmol) was obtained as a colorless oil in 55% yield.  
[]20D  2.6 (c 1.50, CHCl3); 1H NMR (3:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 7.36–7.00 (m, 7H), 6.86* (d, J = 7.5 Hz, 1H), 6.78 (d, J = 7.0 
Hz, 1H), 6.60* (d, J = 8.0 Hz, 1H), 6.50 (d, J = 8.0 Hz, 1H), 5.00 (br, 1H), 4.58–4.52 (m, 
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1H), 4.46–4.37 (m, 1H), 4.31* (d, J = 7.5 Hz, 1H), 4.20–4.12* (m, 1H), 3.56* (dd, J = 13.0, 
6.0 Hz, 1H), 3.42* (s, 3H), 3.28 (s, 3H), 3.05–2.95 (m, 2H) (m, 1H), 2.84–2.75 (m, 1H), 
2.78* (s, 3H), 2.34 (s, 3H), 1.12 (d, J = 6.0 Hz, 3H), 0.91 (d, J = 6.5 Hz, 3H), 0.69* (d, J = 
6.5 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 179.0, 177.7*, 157.6*, 157.5, 142.6, 141.3*, 
131.6*, 131.3, 128.6, 128.0*, 127.7, 127.5, 127.2*, 126.5, 120.4, 110.3*, 110.1, 76.5, 75.2*, 
58.9*, 58.1, 55.3*, 55.2, 36.1, 35.5, 35.4*, 32.7, 26.8*, 17.7*, 17.1, 15.4*, 14.4; IR (neat) 
3370, 2970, 1616 cm-1; HRMS (ES+) calcd. for C21H28NO3 [M+H]
+ 342.2069, found 
342.2075. 
 
 
(R)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-3-(4-methoxy-2,6-dimethylphenyl)-
N,2-dimethylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (38 
mg, 0.10 mmol) was obtained as a colorless oil in 41% yield.  
[]20D +0.6 (c 0.69, CHCl3); 1H NMR (3.5:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ7.33 (d, J = 7.5 Hz, 2H), 7.22–7.04 (m, 3H), 6.70* (s, 2H), 6.57 
(s, 2H), 4.66 (br, 2H), 4.48 (br, 1H), 4.28* (d, J = 9.0 Hz, 1H), 3.93–3.85* (m, 1H), 3.49–
3.42* (m, 1H), 3.40* (s, 3H), 3.37 (s, 3H), 3.34–3.27* (m, 2H), 3.00 (dd, J = 14.0, 8.5 Hz, 
1H), 2.85* (s, 3H), 2.81–2.74 (m, 1H), 2.65 (dd, J = 14.0, 6.0 Hz, 1H), 2.42* (s, 6H), 2.18 
(s, 6H), 2.13 (s, 3H), 1.13 (d, J = 6.5 Hz, 3H), 1.10* (d, J = 6.5 Hz, 1H), 0.83 (d, J = 6.5 
Hz, 3H), 0.65* (d, J = 6.5 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 179.1, 177.9*, 157.5, 
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142.5, 141.4*, 138.7*, 138.2, 129.5, 129.0*, 128.7*, 128.4, 127.7, 126.9*, 126.6, 113.7*, 
113.6, 76.6, 75.1*, 58.4, 57.6*, 55.1, 36.4, 36.0*, 33.4, 32.5*, 31.7, 27.0*, 20.9*, 20.7, 
17.8*, 17.7, 15.7*, 14.4; IR (neat) 3381, 2966, 1616 cm-1; HRMS (ES+) calcd. for 
C23H31NO3Na [M+Na]
+ 392.2202, found 392.2199. 
 
  
(R)-3-(3,5-Dimethoxyphenyl)-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N,2-
dimethylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (57 
mg, 0.15 mmol) was obtained as a colorless oil in 62% yield.  
[]20D +26.4 (c 2.25, CHCl3); 1H NMR (3:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 7.40–6.34 (m, 8H), 4.60–4.48 (m, 1H), 4.50 (d, J = 7.0 Hz, 1H), 
4.28* (d, J = 8.5 Hz, 1H), 4.01–3.90* (m, 1H), 3.43* (s, 6H), 3.36 (s, 6H), 3.21–3.12* (m, 
1H), 3.04 (dd, J = 13.0, 8.5 Hz, 1H), 2.82* (s, 3H), 2.75–2.64 (m, 1H), 2.51 (dd, J = 13.5, 
6.0 Hz, 1H), 2.24 (s, 3H), 1.14* (d, J = 7.0 Hz, 3H), 1.05 (d, J = 6.5 Hz, 3H), 0.79 (d, J = 
6.0 Hz, 3H), 0.71* (d, J = 6.5 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 178.4, 177.2*, 
160.9*, 160.8, 142.5, 142.5, 141.5*, 128.7*, 128.4, 127.7, 127.3*, 127.0*, 126.6, 107.3*, 
107.2, 98.4*, 98.2, 77.4, 76.6, 75.5*, 58.2*, 55.4, 40.7, 40.5*, 38.8, 38.0*, 27.3*, 25.0, 
17.9*, 17.6, 15.6*, 14.5; IR (neat) 3370, 2971, 2930, 1607 cm-1; HRMS (ES+) calcd. for 
C22H29NO4Na [M+Na]
+ 394.1994, found 394.1993. 
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Methyl 3-[(R)-3-[{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}(methyl)amino]-2-
methyl-3-oxopropyl]benzoate.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (53 
mg, 0.14 mmol) was obtained as a colorless oil in 57% yield.  
[]20D +13.6 (c 2.06, CHCl3); 1H NMR (2.5:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 8.24–6.97 (m, 9H), 4.69 (br, 1H), 4.61 (br, 1H), 4.50 (d, J = 7.0 
Hz, 1H), 4.36* (d, J = 7.5 Hz, 1H), 3.98* (br, 1H), 3.96–3.89* (m, 1H), 3.53* (s, 3H), 3.50 
(s, 3H), 3.28* (dd, J = 13.5 Hz, 5.5 Hz, 1H), 3.11–3.02* (m, 1H), 2.99 (dd, J = 13.0 Hz, 
8.5 Hz, 1H), 2.84* (s, 3H), 2.79–2.71* (m, 1H), 2.64-2.55 (m, 1H), 2.44 (dd, J = 13.5 Hz, 
5.5 Hz, 1H), 2.22 (s, 3H) 0.96 (d, J = 6.5 Hz, 3H), 0.82 (d, J = 6.5 Hz, 3H), 0.75* (d, J = 
7.0 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 177.5, 176.8*, 167.3*, 167.1, 142.3, 141.7*, 
140.9*, 140.4, 130.3*, 133.8, 130.1, 129.8, 128.6*, 128.4, 128.2, 128.2*, 128.0*, 127.8*, 
127.5, 127,5, 127.3*, 126.8*, 126.4, 76.2, 75.3, 57.9, 57.4*, 52.0, 39.9, 39.4*, 38.6, 37.5*, 
31.9, 27.4*, 17.4, 15.6*, 14.2; IR (neat) 3401, 2974, 1720, 1618 cm-1; HRMS (ES+) calcd. 
for C22H27NO4Na [M+Na]
+ 392.1838, found 392.1838. 
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(R)-3-(4-Cyanophenyl)-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N,2-
dimethylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, SPhos instead of 
RuPhos, the product (63 mg, 0.19 mmol) was obtained as a white solid in 75% yield.  
[]20D +27.8 (c 1.29, CHCl3); mp: 140–142 °C; 1H NMR (3:1 rotamer ratio, asterisk 
denotes minor rotamer peaks, 500 MHz, C6D6) δ 7.35–6.76 (m, 9H), 4.53 (d, J = 6.5 Hz, 
1H), 4.48 (br, 1H), 4.23* (d, J = 8.0 Hz, 1H), 3.93–3.85* (m, 1H), 3.29* (dd, J = 13.5, 7.0 
Hz, 1H), 3.14–3.05* (m, 1H), 2.93 (dd, J = 13.5, 8.5 Hz, 1H), 2.84* (s, 3H), 2.64* (dd, J 
= 13.5, 6.5 Hz, 1H), 2.52–2.43 (m, 1H), 2.33 (dd, J = 13.5, 6.0 Hz, 1H), 2.22 (s, 3H), 1.02* 
(d, J = 7.0 Hz, 3H), 0.98 (d, J = 7.0 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H), 0.77* (d, J = 6.5 Hz, 
3H); 13C NMR (125.6 MHz, CDCl3) δ 177.0, 176.2*, 146.5*, 145.9, 142.2, 141.5*, 132.1, 
132.0*, 130.1*, 129.9, 128.7*, 128.3, 127.7, 126.8*, 126.4, 119.2*, 119.0, 110.1, 109.7*, 
76.2, 75.2*, 57.9, 40.1, 39.8*, 38.5, 37.4*, 32.2, 27.4*, 17.7*, 17.6, 15.6*, 14.3; IR (neat) 
3430, 1622 cm-1; HRMS (ES+) calcd. for C21H25N2O2 [M+H]
+ 337.1916, found 337.1931. 
 
 
(R)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-N,2-dimethyl-3-(4-
nitrophenyl)propanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (67 
mg, 0.19 mmol) was obtained as a yellow solid in 75% yield.  
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[]20D +40.0 (c 1.01, CHCl3); mp: 161–164 °C; 1H NMR (2:1 rotamer ratio, asterisk 
denotes minor rotamer peaks, 500 MHz, C6D6) δ 7.93* (d, J = 8.5 Hz, 2H), 7.83 (d, J = 8.5 
Hz, 2H), 7.30–7.03 (m, 5H), 6.73 (d, J = 8.0 Hz, 2H), 4.43 (br, 2H), 4.14* (d, 8.0 Hz, 1H), 
3.87–3.68* (m, 1H), 3.22* (dd, J = 13.5, 7.5 Hz, 1H), 3.09–3.00* (m, 1H), 2.96 (br, 1H), 
2.86 (dd, J = 13.5, 8.5 Hz, 1H), 2.74* (s, 3H), 2.56* (dd, J = 13.5, 6.5 Hz, 1H), 2.47–2.35 
(m, 1H), 2.26 (dd, J = 13.5, 5.5 Hz, 1H), 2.15 (s, 3H), 0.93* (d, J = 7.0 Hz, 3H), 0.89 (d, J 
= 7.0 Hz, 3H), 0.80 (d, J = 5.0 Hz, 3H), 0.68* (d, J = 7.0 Hz, 3H); 13C NMR (125.6 MHz, 
CDCl3) δ 177.1, 176.2*, 148.7*, 148.2, 146.7, 146.5*, 142.3, 130.1*, 129.9, 128.9*, 128.6*, 
128.5, 127.8, 126.9*, 126.4, 123.7, 123.5*, 76.4, 75.4*, 58.0, 39.9, 39.7*, 38.7, 37.6*, 32.4, 
27.4*, 18.0*, 17.8, 15.7*, 14.5; IR (neat) 3370, 2976, 2932, 1619, 1517, 1346 cm-1; HRMS 
(ES+) calcd. for C20H25N2O4 [M+H]
+ 357.1814, found 357.1823. 
 
 
(R)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-N,2-dimethyl-3-{4-
(trifluoromethyl)phenyl}propanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (41 
mg, 0.11 mmol) was obtained as a white solid in 43% yield.  
[]20D +11.0 (c 1.10, CHCl3); mp: 118–120 °C; 1H NMR (3:1 rotamer ratio, asterisk 
denotes minor rotamer peaks, 500 MHz, C6D6) δ 7.42–6.85 (m, 9H), 4.63 (br, 1H), 4.55–
4.40 (m, 1H), 4.45 (s, 1H), 4.27* (d, 8.0 Hz, 1H), 3.94–3.84* (m, 1H), 3.67* (s, 1H), 3.09–
3.00* (m, 1H), 2.90 (dd, J = 13.5, 8.5 Hz, 1H), 2.79* (s, 3H), 2.67* (dd, J = 13.5, 7.5 Hz, 
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1H), 2.52–2.41 (m, 1H), 2.34 (dd, J = 13.0, 6.0 Hz, 1H), 2.16 (s, 3H), 0.93 (d, J = 7.0 Hz, 
3H), 0.79 (d, J = 5.5 Hz, 3H), 0.73* (d, J = 6.5 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 
177.4, 176.6*, 144.9*, 144.3, 142.3, 141.7*, 129.6, 129.4*, 129.3, 128.7, 128.4*, 128.3, 
127.6, 126.9*, 126.4, 125.2 (q, J = 3.8 Hz), 123.3*, 76.2, 75.4*, 57.9, 39.9, 39.5*, 38.6, 
37.5*, 32.1, 27.5*, 17.5, 17.5*, 15.5*, 14.2; IR (neat) 3380, 2976, 1619, 1326 cm-1; HRMS 
(ES+) calcd. for C21H24NO2Na [M+Na]
+ 402.1657, found 402.1649. 
 
 
(R)-3-(4-Formylphenyl)-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N,2-
dimethylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (70 
mg, 0.21 mmol) was obtained as a colorless oil in 82% yield.  
[]20D +35.7 (c 1.71, CHCl3); 1H NMR (3:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 9.71* (s, 1H), 9.70 (s, 1H), 7.64–7.06 (m, 9H), 4.55–4.34 (br, 
3H), 4.22* (d, J = 8.0 Hz, 1H), 3.93–3.84* (m, 1H), 3.31* (dd, J = 13.5, 6.5 Hz, 1H), 3.16–
3.07* (m, 1H), 2.95 (dd, J = 13.0, 8.5 Hz, 1H), 2.78* (s, 3H), 2.70* (dd, J = 13.5, 7.5 Hz, 
1H), 2.56–2.45 (m, 1H), 2.38 (dd, J = 13.5, 6.0 Hz, 1H), 2.16 (s, 3H), 0.98* (d, J = 7.0 Hz, 
3H), 0.95 (d, J = 6.5 Hz, 3H), 0.82 (d, J = 5.5 Hz, 3H), 0.70* (d, J = 6.5 Hz, 3H); 13C NMR 
(125.6 MHz, CDCl3) δ 192.2, 192.0*, 177.5, 176.6*, 148.3*, 147.6, 142.3, 141.4*, 134.89*, 
134.9, 130.0*, 130.0*, 129.9, 129.8, 128.8*, 128.4, 128.3*, 127.8, 126.9*, 126.5, 76.4, 
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75.4*, 58.1, 40.4, 40.0*, 38.7, 37.7*, 27.4, 17.8*, 17.7, 15.7*, 14.4; IR (neat) 3401, 1607 
cm-1; HRMS (ES+) calcd. for C21H25NO3Na [M+Na]
+ 362.1732, found 362.1740. 
 
 
(R)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-N,2-dimethyl-3-(thiophen-2-
yl)propanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (42 
mg, 0.13 mmol) was obtained as a white solid in 53% yield.  
[]20D +25.6 (c 0.80, CHCl3); mp: 100–103 °C; 1H NMR (3:1 rotamer ratio, asterisk 
denotes minor rotamer peaks, 500 MHz, C6D6) δ 7.34–6.64 (m, 8H), 4.48 (s, 2H), 4.22* (d, 
J = 8.0 Hz, 1H), 3.95–3.86* (m, 1H), 4.00* (dd, J = 14.5, 6.0 Hz, 1H), 3.26 (dd, J = 13.5, 
7.5 Hz, 1H), 3.17–3.07* (m, 1H), 3.04–2.95* (m, 1H), 2.79* (s, 3H), 2.71–2.57 (m, 2H), 
2.24 (s, 3H), 1.33* (d, J = 6.5 Hz, 3H), 0.97 (d, J = 6.5 Hz, 3H), 0.86 (d, J = 6.0 Hz, 3H), 
0.68* (d, J = 6.5 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 177.8, 176.8*, 143.1*, 142.6, 
142.4, 141.2*, 128.8*, 128.4, 127.7, 127.0*, 127.0*, 126.9, 126.6, 125.8*, 125.6, 123.7*, 
123.6, 76.7, 75.5*, 58.2, 39.6, 38.8*, 34.2, 34.1*, 32.5, 27.4*, 17.7*, 17.5, 15.6*, 14.4 ; IR 
(neat) 3429, 1634 cm-1; HRMS (ES+) calcd. for C18H23NO2SNa [M+Na]
+ 340.1347, found 
340.1333. 
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(R)-3-(5-Acetylthiophen-2-yl)-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N,2-
dimethylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (66 
mg, 0.18 mmol) was obtained as a yellow oil in 73% yield.  
[]20D +47.3 (c 1.04, CHCl3); 1H NMR (2.5:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 7.39–6.97 (m, 6 H), 6.69* (d, J = 3.5 Hz, 1H), 6.56 (d, J = 3.5 
Hz, 1H), 4.46 (s, 2H), 4.30 (br, 1H), 4.22* (d, J = 8.5 Hz, 1H), 3.91–3.82* (m, 1H), 3.37* 
(dd, J = 14.5, 6.5 Hz, 1H), 3.19 (dd, J = 13.5, 8.0 Hz, 1H), 3.12–3.03* (m, 1H), 2.88* (dd, 
J = 14.5, 8.0 Hz, 1H), 2.80* (s, 3H), 2.61–2.51 (m, 1H), 2.50 (dd, J = 14.0, 5.5 Hz, 1H), 
2.25 (s, 3H), 2.07* (s, 3H), 2.05 (s, 3H), 1.00* (d, J = 7.0 Hz, 3H), 0.89 (d, J = 6.5 Hz, 3H), 
0.87 (d, J = 6.5 Hz, 3H), 0.71* (d, J = 7.0 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 190.7*, 
190.6, 177.1, 176.2*, 153.4*, 152.8, 142.8, 142.7*, 142.3, 141.3*, 133.0*, 132.9, 128.9*, 
128.5*, 128.5, 127.8, 127.3*, 127.2, 126.9*, 126.5, 76.5, 75.6*, 58.1, 39.3, 38.4*, 34.8, 
34.7*, 43.4, 27.6*, 26.6, 25.0*, 17.7*, 17.6, 15.7*, 14.5 ;IR (neat) 3401, 2974, 2935, 1656, 
1620 cm-1; HRMS (ES+) calcd. for C20H25NO3SNa [M+Na]
+ 382.1453, found 382.1436. 
 
 
(R)-3-(5-Formylthiophen-2-yl)-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N,2-
dimethylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (52 
mg, 0.15 mmol) was obtained as a light yellow oil in 60% yield.  
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[]20D +8.6 (c 1.74, CHCl3); 1H NMR (2:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 9.53* (s, 1H), 9.50 (s, 1H), 7.40–7.04 (m, 5H), 7.01* (d, J = 3.0 
Hz, 1H), 6.92 (d, J = 3.5 Hz, 1H), 6.69* (d, J = 3.0 Hz, 1H), 6.92 (d, J = 3.0 Hz, 1H), 4.51 
(br, 1H), 4.48–4.42 (m, 1H), 4.30 (br, 1H), 4.25* (d, J = 7.5 Hz, 1H), 3.88–3.79* (m, 1H), 
3.45* (br, 1H), 3.32* (dd, J = 145, 6.5 Hz, 1H), 3.15 (dd, J = 14.0, 8.5 Hz, 1H), 3.08–2.99* 
(m, 1H), 2.89–2.78* (m, 1H), 2.81* (s, 3H), 2.55–2.47 (m, 1H), 2.44 (dd, J = 14.5, 5.5 Hz, 
1H), 2.25 (s, 3H), 0.94* (d, J = 6.5 Hz, 3H), 0.84 (d, J = 6.0 Hz, 6H), 0.73* (d, J = 6.5 Hz, 
3H); 13C NMR (125.6 MHz, CDCl3) δ 182.8*, 182.8, 176.7, 175.9*, 155.2*, 154.6, 142.3, 
141.5, 137.1*, 137.0, 128.8*, 128.4, 127.8, 127.5*, 127.4, 126.8*, 126.5, 76.4, 75.5*, 58.0, 
39.2, 38.2*, 34.9, 34.8*, 27.6*, 25.0, 17.7*, 17.6, 15.7*, 14.4 ; IR (neat) 3411, 1661, 1620 
cm-1; HRMS (ES+) calcd. for C19H24NO3S [M+H]
+ 346.1477, found 346.1486. 
 
 
(R)-3-(5-Formylfuran-2-yl)-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N,2-
dimethylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (57 
mg, 0.17 mmol) was obtained as a yellow oil in 69% yield.  
[]20D +21.5 (c 1.43, CHCl3); 1H NMR (2:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 9.82* (s, 1H), 9.25 (s, 1H), 7.39–7.02 (m, 5H), 6.60* (s, 1H), 
6.53 (d, J = 3.0 Hz, 1H), 6.01* (d, J = 3.5 Hz, 1H), 5.81 (d, J = 3.0 Hz, 1H), 4.49 (br, 3H), 
4.32* (d, J = 8.5 Hz, 1H), 3.99–3.89* (m, 1H), 3.32–3.21 (m, 1H), 2.92 (dd, J = 14.5, 8.5 
55 
 
Hz, 1H), 2.80* (s, 3H), 2.77–2.70* (m, 1H), 2.64* (dd, J = 14.0, 6.5 Hz, 1H), 2.41 (dd, J 
= 15.0, 6.0 Hz, 1H), 2.31 (s, 3H), 0.94* (d, J = 7.0 Hz, 3H), 0.87 (d, J = 7.0 Hz, 3H), 0.85 
(d, J = 7.0 Hz, 3H), 0.70* (d, J = 7.0 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 176.9*, 
176.8, 176.7, 175.9*, 162.2*, 161.5, 152.0, 151.8*, 142.3, 141.5*, 128.8, 128.4, 128.3*, 
127.7*, 127.6*, 126.9, 126.4, 126.3*, 110.3, 110.0*, 76.2, 75.3*, 58.2, 35.6, 34.8*, 32.5, 
27.3, 18.0*, 17.4, 15.7*, 14.3; IR (neat) 3412, 1636 cm-1; HRMS (ES+) calcd. for 
C19H23NO4Na [M+Na]
+ 352.1525, found 352.1510. 
 
 
(R)-N-{(1S,2S)-1-Hydroxy-1-phenylpropan-2-yl}-3-(6-methoxypyridin-3-yl)-N,2-
dimethylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (47 
mg, 0.14 mmol) was obtained as a light yellow oil in 55% yield.  
[]20D +26.3 (c 1.70, CHCl3); 1H NMR (3:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 8.23* (d, J = 2.0 Hz, 1H), 8.03 (d, J = 2.5 Hz, 1H), 7.40–7.03 
(m, 6H), 6.67* (d, J = 8.5 Hz, 1H), 6.58 (d, J = 8.5 Hz, 1H), 4.69 (br, 1H), 4.75–4.50 (m, 
1H), 4.48 (d, J = 7.0 Hz, 1H), 4.27* (d, 1H, J = 8.0 Hz, 1H), 3.93–3.86* (m, 1H), 3.82 (s, 
3H), 3.14* (dd, J = 13.5, 6.5 Hz, 1H), 3.05–2.96* (m, 1H), 2.83 (dd, J = 13.5, 8.5 Hz, 1H), 
2.78* (s, 3H), 2.60* (dd, J = 13.5, 8.0 Hz, 1H), 2.51–2.42 (m, 1H), 2.28 (dd, J =13.5,  6.0 
Hz, 1H), 2.19 (s, 3H), 0.98* (d, J = 6.9 Hz, 3H), 0.93 (d, J = 6.7 Hz, 3H), 0.83 (d, J = 6.6 
Hz, 3H), 0.72* (d, J = 6.8 Hz, 3H); 13C NMR (125.6 MHz, CDCl3) δ 177.6, 176.8*, 162.9, 
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162.8*, 146.9, 146.7, 142.4, 141.7*, 139.9*, 139.6, 128.7, 128.5*, 128.3, 128.2*, 128.1*, 
127.6, 126.9*, 126.4, 110.3, 110.2*, 76.3, 75.3*, 57.9, 53.4, 38.9, 37.7*, 36.3, 35.9*, 32.4, 
27.4*, 17.4, 15.6*, 14.3; IR (neat) 3422, 1618 cm-1; HRMS (ES+) calcd. for C20H26N2O3Na 
[M+Na]+ 365.1841, found 365.1827. 
 
 
(R)-3-(6-Fluoropyridin-3-yl)-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N,2-
dimethylpropanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (66 
mg, 0.20 mmol) was obtained as a light yellow oil in 80% yield.  
[]20D +32.2 (c 0.75, CHCl3); 1H NMR (2:1 rotamer ratio, asterisk denotes minor rotamer 
peaks, 500 MHz, C6D6) δ 8.10* (s, 1H), 7.86 (s, 1H), 7.39–7.02 (m, 6H), 6.47–6.42* (m, 
1H), 6.40–6.33 (m, 1H), 4.66 (br, 1H), 4.52 (s, 1H), 4.48 (s, 1H), 4.29* (d, J = 7.5 Hz, 1H), 
4.16* (s, 1H), 3.90–3.80* (m, 1H), 3.12–2.98 (m, 1H), 2.74* (s, 3H), 2.52–2.44* (m, 1H), 
2.44–2.33 (m, 1H), 2.01 (s, 3H), 2.22–2.14 (m, 1H), 0.92* (d, J = 6.5 Hz, 3H), 0.86 (d, J = 
6.5 Hz, 3H), 0.81 (d, J = 6.5 Hz, 3H), 0.72* (d, J = 6.5 Hz, 3H), 13C NMR (125.6 MHz, 
CDCl3) δ 177.0, 176.2*, 162.5 (d, J = 236.3 Hz), 162.3* (d, J = 236.3 Hz), 147.7* (d, J = 
13.8 Hz), 147.5* (d, J = 15.0 Hz), 142.3, 142.0 (d, J = 30.0 Hz), 142.0* (d, J = 60.0 Hz), 
133.6* (d, J = 3.8 Hz), 133.3 (d, J = 3.8 Hz), 128.7*, 128.4, 128.3*, 127.7, 126.8*, 126.4, 
109.0 (d, J = 37.5 Hz), 108.8* (d, J = 37.5 Hz), 76.2, 75.1*, 57.9, 38.8, 37.6*, 36.1, 35.8*, 
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27.4, 17.7*, 17.6, 15.6*, 14.3; IR (neat) cm-1; HRMS (ES+) calcd. for C19H23N2O2FNa 
[M+Na]+ 353.1641, found 353.1642. 
 
 
(R)-2-Benzyl-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N-methylbutanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (57 
mg, 0.18 mmol) was obtained as a white solid in 70% yield.  
[]20D +7.4 (c 1.37, CHCl3); mp: 85–88 °C; 1H NMR (4:1 rotamer ratio, asterisk denotes 
minor rotamer peaks, 500 MHz, C6D6) δ 7.40–6.84 (m, 10H), 4.62 (br, 1H), 4.57–4.38 (m, 
2H), 4.26* (d, J = 8.0 Hz, 1H), 4.12–4.01* (m, 1H), 3.42–3.31* (m, 2H), 3.12–3.02* (m, 
1H), 2.95 (dd, J = 11.5, 8.5 Hz, 1H), 2.88–2.78* (m, 1H), 2.81* (s, 3H), 2.66–2.49 (m, 2H), 
2.16 (s, 3H), 1.90–1.77 (m, 1H), 1.51–1.42* (m, 1H), 1.42–1.31 (m, 1H), 0.81 (t, J = 7.5 
Hz, 3H), 0.76 (d, J = 6.5 Hz, 3H), 0.71* (d, 3H, J = 6.5 Hz, 3H); 13C NMR (125.6 MHz, 
CDCl3) δ 177.7, 176.5*, 142.4, 141.4*, 140.7*, 140.1, 129.3*, 129.0, 128.7*, 128.5*, 128.4, 
128.3, 128.3*, 127.7, 127.0*, 126.6, 126.4*, 126.3, 76.4, 75.2*, 58.3, 46.5, 45.5*, 39.4, 
39.1*, 32.3, 27.2*, 26.2, 26.0*, 15.6*, 14.4, 12.1*, 12.0; IR (neat) 3370, 2965, 1615 cm-1; 
HRMS (ES+) calcd. for C21H27NO2Na [M+Na]
+ 348.1939, found 348.1927. 
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(R)-2-Benzyl-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N-methylhexanamide.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (42 
mg, 0.12 mmol) was obtained as a white solid in 47% yield.  
1H NMR (4:1 rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, C6D6) δ 7.40–
6.99 (m, 10H), 4.58 (br, 1H), 4.50 (d, J = 7.5 Hz, 1H), 4.20* (d, J = 8.5 Hz, 1H), 4.11–
4.03* (m, 1H), 3.40* (dd, J = 13.5, 6.5 Hz, 1H), 3.18–3.07* (m, 1H), 2.98 (dd, J = 12.5, 
9.0 Hz, 1H), 2.85* (dd, J = 13.0, 7.5 Hz, 1H), 2.79* (s, 3H), 2.72–2.63 (m, 1H), 2.58 (dd, 
J = 13.0, 5.0 Hz, 1H), 2.17 (s, 3H), 1.92–1.82 (m, 1H), 1.51–1.06 (m, 6H), 2.92* (t, J = 7.5 
Hz, 3H), 0.89 (t, J = 7.5 Hz, 3H), 0.76 (d, J = 7.5 Hz, 3H), 0.72* (d, J = 6.5 Hz, 3H).  
Data is consistent with that reported in the literature.16b  
 
 
(S)-2-Benzyl-N-{(1S,2S)-1-hydroxy-1-phenylpropan-2-yl}-N,3-dimethylbutanamide. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (25 
mg, 0.08 mmol) was obtained as a white solid in 30% yield.  
1H NMR (10:1 rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, C6D6) δ 
7.42–6.96 (m, 10H), 4.63 (br, 1H), 4.37 (d, J = 7.5 Hz, 1H), 4.02–3.81 (m, 1H), 3.34* (dd, 
J = 12.5, 10.0 Hz, 1H), 2.99 (dd, J = 11.5, 11.5 Hz, 1H), 2.85* (dd, J = 13.0, 4.5 Hz, 1H), 
2.72 (dd, J = 12.5, 3.5 Hz, 1H), 2.63* (s, 3H), 2.51–2.41 (m, 1H), 2.09 (s, 3H), 2.07–2.01 
(m, 1H), 0.95 (dd, J = 13.5, 6.5 Hz, 6H), 0.64* (d, J = 6.5 Hz, 3H), 0.60 (d, J = 7.0 Hz, 
3H).  
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Data is consistent with that reported in the literature.16b  
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Chapter 3. Potassium Boc-Protected Aminomethyltrifluoroborates 
 
3.1 Introduction 
Aminomethylated arenes can be considered privileged substructures because they 
appear in many bioactive natural products and drugs, such as ceforanide and a potent DPP-
4 inhibitor (Figure 3.1). 1  Moreover, aminomethyl arenes are also readily found as 
important intermediates in synthetic organic chemistry.2 
 
 
Figure 3.1 Bioactive Molecules Containing the Aminomethyl Moiety 
 
3.1.1 Traditional Preparation of Aminomethylated Compounds 
 Because of the importance of aminomethyl moieties in organic and pharmaceutical 
chemistry, many different ways to install aminomethyl substructures have been studied. 
Reduction of cyanides3 or oximes,4 reductive amination,5 Staudinger reaction,6 and N-
alkylation 7  are representative ways to prepare aminomethyl moieties (Scheme 3.1). 
However, these approaches do not provide a general synthesis of target subunits, and many 
limitations exist. 
63 
 
Scheme 3.1 Traditional Ways to Prepare Aminomethyl Moieties 
 
 
Reductions of aryl cyanides or oximes are often applied to the synthesis of 
aminomethylated arenes (Scheme 3.1, path a).3,4 However, many reducible functional 
groups, such as esters or aldehydes, are not compatible with this method. Another way to 
prepare aminomethyl substructures is reductive amination using the corresponding 
aldehyde and an amine (Scheme 3.1, path b).5 This method is one of the most popular ways 
to build such a moiety. However, similar to the reduction pathway of cyanides and oximes, 
many functional groups cannot be embedded in desirable substrates because of the harsh 
reduction conditions required. Therefore, the scope of functional groups are limited by 
these two methods. 
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An alternative route to install the aminomethyl moieties is the Staudinger reaction 
using organic azides with phosphorus compounds (Scheme 3.1, path c).6 The Staudinger 
reaction has been widely utilized in many organic syntheses over several decades. Reaction 
of an azide and a trivalent phosphorus compound produces the iminophosphorane 
intermediate, an aza-ylide, which is followed by hydrolysis to give the corresponding 
aminomethyl moiety and phosphine oxide (Scheme 3.2). Unfortunately, some azides 
exhibit significant thermal or shock sensitivity.8 Therefore, these chemicals are avoided in 
many laboratories. Moreover, the benzylic or pseudobenzylic halide precursors required to 
prepare the azides are often not readily available.  
 
Scheme 3.2 Staudinger Reaction 
 
 
Lastly, another conventional approach is the N-alkylation of primary amines 
(Scheme 3.1, path d).7 One of the drawbacks of this pathway is polyalkylation, which is 
frequently hard to control.7a N-Alkylation methods often give a mixture of secondary 
amines, tertiary amines, and even ammonium salts (Scheme 3.3). 
 
 
 
65 
 
Scheme 3.3 N-Alkylation 
 
 
3.1.2 Amidomethylation and Aminomethylation in Suzuki–Miyaura Reactions 
 A more straightforward route to the synthesis of aminomethyl substructures is 
transition metal catalyzed cross-coupling reactions of aminomethylmetallic reagents 
(Scheme 3.4).  
 
Scheme 3.4 Synthesis of Aminomethyl Moieties by Transition Metal Catalyzed Cross-
Coupling Reactions 
 
 
Particularly, Suzuki–Miyaura cross-coupling reactions compared to other cross-
coupling reactions are more functional group tolerant.9 A wide range of functional groups 
can be utilized in Suzuki–Miyaura coupling reactions which provides an advantage over 
the reduction or reductive amination methods to build aminomethyl substructures. 
Therefore, the reactions are not limited by sensitive functional groups.  Additionally, there 
is a much greater diversity of commercially available aryl and hetaryl halides for cross-
coupling reactions compared to corresponding substrate partners for reductive amination, 
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Staudinger reaction, or N-alkylation. Furthermore, the preparation of sensitive reagents, 
such as azides, is not required in cross-coupling reactions. In general, fewer synthetic steps 
are required in cross-coupling approaches and reaction conditions are much milder and 
more efficient compared to other synthetic pathways of aminomethyl subunits. 
Syntheses and transition metal catalyzed cross-coupling reactions of aminomethyl 
organometallics or their equivalents are rare. Recently, Molander and co-workers have 
demonstrated the synthesis and Suzuki–Miyaura cross-coupling reactions of 
amidomethyltrifluoroborates 10  and sulfonamidomethyltrifluoroborates. 11  They also 
reported the synthesis and cross-coupling reactions of secondary 
ammoniomethyltrifluoroborates 12  and tertiary aminomethyltrifluoroborates (Scheme 
3.5).13 Development of these methods have proven to be efficient to prepare primary, 
secondary, and tertiary aminomethyl moieties by transition metal catalyzed coupling 
reactions. 
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Scheme 3.5 Amidomethylation and Aminomethylation in Suzuki–Miyaura Cross-
Coupling Reactions 
 
 
Amidomethyl arenes can be easily installed in organic compounds using 
amidomethyltrifluoroborates (Scheme 3.5, path a).10 Amidomethyltrifluoroborates have 
been prepared by a ‘one-pot’ process using chloromethyl pinacol boronate and also 
explored as the nucleophiles in Suzuki–Miyaura reactions. A wide range of 
amidomethyltrifluoroborates have proven to be efficient nucleophilic partners in cross-
coupling reactions with aryl and hetaryl chlorides. 
Primary aminomethyl substructures can be prepared from 
sulfonamidomethyltrifluoroborate derivatives (Scheme 3.5, path b).11 Among these various 
aryl sulfonamidomethyltrifluoroborates, the p-toluenesulfonyl (tosyl) group as an amine 
protecting group is utilized in synthesis and also tested in Suzuki–Miyaura cross-coupling 
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reactions. Although cross-coupling has successfully been performed with the tosyl group, 
the removal of this protecting group requires the use of harsh conditions.14 Therefore, use 
of tosyl group is not ideal for preparation of primary aminomethyl moieties. 
On the other hand, several reports exist that refer to the use of the N-phthalimido 
group as an amine protecting group (Scheme 3.6). 15  Although the preparation of 
phthalimidomethyltrifluoroborates and their application in Suzuki–Miyaura coupling 
reactions have been studied several times, the reactions are not efficient due to longer 
reaction times and low yields. Furthermore, hydrazine is often used to remove the 
phthalimido group,14a and its toxicity and instability to storage and handling prevent its 
routine use in this capacity. 
 
Scheme 3.6 Phthalimidomethyltrifluoroborates in Suzuki–Miyaura Cross-Coupling 
Reactions 
 
 
 Secondary aminomethylated moieties have been prepared using secondary 
ammoniomethyltrifluoroborates (Scheme 3.5, path c).12 This method proved to be a good 
synthetic pathway to access the secondary aminomethyl moieties, but the scope of the 
coupling reactions is limited to bromides as the electrophiles, which are more expensive 
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and appear in a less diverse range of substructures compared to chlorides. Furthermore, 
this previously developed method proved effective for only a few select hetaryl bromides. 
 To the best of our knowledge, only one Suzuki–Miyaura reaction has been reported 
to prepare the tertiary aminomethyl arenes from N,N-dialkyl aminomethyltrifluoroborates 
(Scheme 3.5, path d).13 A variety of N,N-dialkyl aminomethyltrifluoroborates have been 
synthesized in this report and have been shown to be good nucleophiles in cross-coupling 
reactions with aryl bromides as the electrophiles.  
 
3.2 Results and Discussion 
Several synthetic procedures have been studied to prepare aminomethyl 
substructures. However, many limitations exist in terms of the stability of reagents, 
inefficient protecting groups, and reaction conditions.  
Particularly, we were interested in development of primary and secondary 
aminomethylating reagents or their equivalents. The sulfonamidomethylating10 and 
phthalimidomethylating15 procedures by the Molander and Tanaka laboratories led us to 
investigate the synthesis of alternative protected primary and secondary 
aminomethyltrifluoroborates. Although tosyl and phthalimido groups as amine protecting 
groups have already been developed, the removal of these groups requires the use of harsh 
reaction conditions as discussed above.  
The Boc group is a good candidate for an amine protecting group. The Boc 
protecting group is commonly found in many organic synthetic steps, and also can be easily 
removed under either acidic or basic conditions.14a,16 After deprotection of a Boc group, 
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the corresponding primary or secondary aminomethyl arenes are readily accessed. 
Therefore, the development of Boc-protected aminomethyltrifluoroborates as 
aminomethylating reagents and their applications in Suzuki–Miyaura coupling reactions 
could be envisioned (Scheme 3.7). 
 
Scheme 3.7 Boc-Protected Aminomethyltrifluoroborates and Suzuki–Miyaura 
Reactions 
 
 
3.2.1 Synthesis of Potassium Boc-Protected Primary Aminomethyltrifluoroborate 
 Previously, the Molander group reported the synthesis of N,N-dialkyl 
aminomethyltrifluoroborates by a direct nucleophilic displacement of 
bromomethyltrifluoroborate with primary or secondary amines (Scheme 3.8).13 
Unfortunately, Boc-protected aminomethyltrifluoroborate could not be prepared by this 
method using halomethyltrifluoroborates. 
 
Scheme 3.8 Synthesis of N,N-Dialkyl Aminomethyltrifluoroborates 
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 Instead of halomethyltrifluoroborates, we were inspired by one-carbon 
homologation of halomethylboronate esters developed by Matteson.17 In this chemical 
process, boronate esters are not prepared by simple SN2 displacement of halogen with a 
nucleophile. A nucleophile attacks the boron center instead of the carbon attached to the 
halogen, and, an ‘ate’ complex is generated as the reaction intermediate. Next, the 
nucleophile on the boron atom is α-transferred to the neighboring carbon to provide the 
corresponding boronate ester (Scheme 3.9). 
 
Scheme 3.9 Matteson’s One-Carbon Homologation of Boronate Esters 
 
 
Recently, Molander and Hiebel applied Matteson’s method effectively for the 
synthesis of amidomethyltrifluoroborates from chloromethyl pinacol boronate ester 
(Scheme 3.10).10 Several amidomethyltrifluoroborates were prepared by a ‘one-pot’ 
synthetic process, and these moieties were successfully employed as nucleophiles in 
Suzuki–Miyaura coupling reactions. 
 
Scheme 3.10 Preparation of Amidomethyltrifluoroborates 
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As an adaptation of Matteson’s homologation and amidomethyltrifluoroborates 
synthesis, we designed our synthesis of potassium Boc-protected primary 
aminomethyltrifluoroborate. First, reaction of 2-(chloromethyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane and potassium hexamethyldisilazide (KHMDS) gave the disilylated 
aminoboronate ester as the intermediate, which was followed by deprotection of silyl 
groups using methanol. After 1 h stirring at 0 °C, the corresponding primary amine was 
protected with a Boc group by addition of di-tert-butyl dicarbonate. Then, all solvents were 
removed after overnight stirring at rt. The crude reaction mixture was dissolved in 
methanol, and saturated KHF2 solution was added to afford the desired Boc-protected 
aminomethyltrifluoroborate (Scheme 3.11).  
 
Scheme 3.11. Preparation of Boc-Protected Primary Aminomethyltrifluoroborate 
 
 
The desired potassium Boc-protected primary aminomethyltrifluoroborate, which 
is a primary aminomethyl equivalent, was obtained in 75% overall yield over four steps in 
a ‘one-pot’ process (Equation 3.1). The aminomethyltrifluoroborate was revealed to be air 
stable and could be stored on the bench without decomposition. Moreover, this Boc-
protected primary aminomethyltrifluoroborate is now commercially available. 
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Equation 3.1 ‘One-Pot’ Synthesis of Potassium Boc-Protected Primary 
Aminomethyltrifluoroborate 
 
 
3.2.2 Synthesis of Potassium Boc-Protected Secondary Aminomethyltrifluoroborates 
 To extend the study of aminomethyltrifluoroborates, the development of Boc-
protected secondary aminomethyltrifluoroborates would be envisioned to allow the 
synthesis of secondary aminomethyl moieties. Based on the synthesis of Boc-protected 
primary aminomethyltrifluoroborate, the ‘one-pot’ process was tested first for the 
preparation of secondary aminomethyltrifluoroborates. Unfortunately, all attempts were 
unsuccessful. Only traces of the desired products were detected.  
As an alternative, we designed the two step synthesis of the secondary 
aminomethyltrifluoroborates from Boc-protected primary amines. First, N-alkylation was 
conducted with Boc-protected primary amines and iodomethylpinacol boronate in the 
presence of n-butyllithium at –78 °C. After stirring overnight at room temperature, the 
aminomethylpinacol boronates were purified by column chromatography. Then, addition 
of KHF2 gave the expected secondary aminomethyltrifluoroborates as white solids 
(Equation 3.2).  
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Equation 3.2 Two-Step Synthesis of Potassium Boc-Protected Secondary 
Aminomethyltrifluoroborates 
 
 
Pleasingly, seven different Boc-protected secondary aminomethyltrifluoroborates 
were prepared over two steps in moderate to good yields (Table 3.1). However, initial 
attempts to prepare a trifluoroborate bearing an acetal protecting group failed. Although 
the corresponding aminomethyl pinacol boronate was successfully prepared in 75% 
isolated yield, conversion to the trifluoroborate by addition of KHF2 led to low yields due 
to the acidic reaction media. By modifying the reaction conditions to include the addition 
of 1 equiv of K2CO3 before addition of KHF2, the expected acetal derivative trifluoroborate 
was obtained as a white solid in 53% isolated yield (Table 3.1, entry 7). An aniline 
derivative was also tried, however, attempted conversions from the pinacol boronate to the 
corresponding trifluoroborate with KHF2 provided a mixture of the desired Boc-protected 
trifluoroborate as well as Boc-deprotected trifluoroborate, even buffering with K2CO3. 
These two trifluoroborates were inseparable with many attempts of purifications (Table 3.1, 
entry 8). All of the prepared secondary aminomethyltrifluoroborates were white solids. 
They were air stable and could be stored at room temperature without decomposition over 
several months. 
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Table 3.1 Preparation of Potassium Boc-Protected Secondary 
Aminomethyltrifluoroborates 
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3.2.3 Suzuki–Miyaura Reactions with Aryl and Hetaryl Chlorides 
 
3.2.3.1 Cross-Coupling with Primary Aminomethyltrifluoroborate 
 With the successfully prepared Boc-protected primary aminomethyltrifluoroborate, 
its application in Suzuki–Miyaura cross-coupling reactions was investigated. Optimization 
was conducted with 4-chlorobenzonitrile and 4-chloroanisole as the electrophilic coupling 
partners. After extensive screening with several catalysts, ligands, bases, and reaction times, 
the combination of 5 mol % of Pd(OAc)2, 10 mol % of SPhos or XPhos, and 3 equiv of 
K2CO3 in toluene / H2O (4:1, 0.25 M) for 22 h emerged as the best reaction conditions. 
Two different ligands, SPhos and XPhos, were required depending on the substrates. 
Moreover, the trifluoroborate was required only in a stoichiometric amount, 1.05 equiv, in 
the cross-coupling reactions (Equation 3.3). 
 
Equation 3.3 Optimization of Cross-Coupling Reactions with Boc-Protected Primary 
Aminomethyltrifluoroborate 
 
 
 First, we applied these conditions to explore cross-couplings with a variety of aryl 
chlorides as electrophiles (Table 3.2). Electron neutral, electron donating, and electron 
withdrawing groups were all successfully coupled  to provide the corresponding products 
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using the optimized conditions. More sterically hindered di-ortho substituted electrophiles 
provided the desired products in high yields as the less hindered electrophiles (Table 3.2, 
entries 2 and 3). In the case of 4-chloroanisole as an electrophile, the expected product was 
obtained in 88% isolated yield using XPhos as the ligand on a 0.25 mmol scale. When the 
scale was increased to 4.0 mmol, a lower catalyst loading (2 mol %, instead of 5 mol %) 
was required to provide the desired product in 78% isolated yield (Table 3.2, entry 4).  
Various functional groups were compatible to coupling reactions (Table 3.2, entries 8–12). 
Importantly, aminomethylated arenens with various functional groups, such as nitrile, 
aldehyde, ketone, ester, and nitro group, could be prepared by this developed coupling 
pathway, which can not be accessed by traditional preparations, such as reduction and 
reductive amination. Therefore, this protocol could be a complementary synthetic pathway 
to build such substrates with functional groups. 
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Table 3.2 Cross-Coupling of Boc-Protected Primary Aminomethyltrifluoroborate 
with Various Aryl Chlorides 
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Then, various hetaryl chlorides were employed as electrophilic coupling partners. 
Sulfur and oxygen containing hetaryl chlorides, such as thiophenes and furans, were 
successfully coupled to provide the desired products (Table 3.3). Several sensitive 
functional groups, such as aldehydes and ketones, were tolerated under these conditions, 
providing the desired products in moderate to good yields (Table 3.3, entries 2, 3 and 5).  
When 3-chlorothiophene was applied to coupling reactions, XPhos provided the product 
in mcuh higher yield compared to SPhos (Table 3.3, entry 4), even though other substrates 
showed a resonable range of yield differences. 
 
Table 3.3 Cross-Coupling of Boc-Protected Primary Aminomethyltrifluroborate with 
Various Hetaryl Chlorides 
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Moreover, pyridine, quinoline and indole derivatives proved to the efficient 
coupling partners as electrophiles to provide the coupled products in moderate to good 
yields (Table 3.4). 2-Chloropyridine provided much lower yield compared to other hetaryl 
chlorides (Table 3.4, entry 3). Presumably, oxidative addition of Pd(0) to 2-halopyridines 
forms a dimeric metalated pyridine species (Figure 3.2).18 This complex have been utilized 
as an precatalyst in Suzuki-Miyaura cross-coupling reactions with boronic acid derivatives. 
However, we assumed that this complex in some way inhibits effective cross-coupling in 
our transformations. In the case of indoles as the electrophiles, protection of free amines 
was not required, and also the coupling reactions proceeded effectively to provide the 
desired products in good yields (Table 3.4, entries 9 and 10). 
 
 
Figure 3.2 Dimeric Metalated Pyridine 
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Table 3.4 Cross-Coupling of Boc-Protected Primary Aminomethyltrifluoroborate 
with Various Hetaryl Chlorides 
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 We then examined electrophile compatibility using the developed conditions, but 
only with SPhos as a ligand (Table 3.5). Phenyl bromide and phenyl triflate gave moderate 
yields, 72% and 70%, respectively (Table 3.5, entries 2 and 4). In the case of iodobenzene, 
the desired product was prepared in only 41% isolated yield (Table 3.5, entry 3). 
Unfortunately, phenyl mesylate and tosylate proved to be inefficient coupling partners 
under the same set of reaction conditions (Table 3.5, entries 5 and 6).  Presumably, a 
different set of conditions would have to be developed to successfully couple with these 
substrates. 
 
Table 3.5 Electrophile Compatibility 
 
 
3.2.3.2 Cross-Coupling with Secondary Aminomethyltrifluoroborates 
 Based on the development of the Suzuki–Miyaura reaction with Boc-protected 
primary aminomethyltrifluoroborate, the optimizations of Boc-protected secondary 
aminomethyltrifluoroborate cross-coupling reactions were investigated. n-Butyl Boc-
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protected aminomethyltrifluoroborate as a nucleophile and 4-chloroanisole as an 
eletrophile were selected for the optimization study. Reaction conditions were screened 
with various palladium catalysts, ligands, bases, solvents, concentrations, temperatures, 
and times. Buchwald’s second generation preformed catalyst with XPhos, XPhos-Pd-G2, 
proved to be most efficient (Figure 3.3).19  
 
 
Figure 3.3 Buchwald’s Preformed Catalyst 
 
The best combination for the cross-coupling reations was 4 mol % of XPhos-Pd-
G2 and 3 equiv of Cs2CO3 in toluene / H2O (4:1, 0.5 M) at 85 °C. Use of Buchwald’s 
preformed catalyst allowed the completion in only 3 h (Equation 3.4). 
 
Equation 3.4 Optimization of Cross-Coupling Reactions with Boc-Protected 
Secondary Aminomethyltrifluoroborate 
 
84 
 
 First, we employed these optimized conditions with various aryl chlorides as the 
electrophile (Table 3.6). A variety of aryl chlorides was successfully cross-coupled to 
provide the expected products in good to excellent yields. In general, electrophiles with 
electron-neutral (Table 3.6, entries 1–3) and electron-donating groups (Table 3.6, entries 
4–6) gave slightly better results than electrophiles containing electron-withdrawing 
functional groups (Table 3.6, entries 7–11). Particularly, more sterically demanding 
substrates at the ortho position gave higher yields than less hindered electrophiles (Table 
3.6, entries 3 and 5). Once again, sensitive functional groups, such as esters, nitriles, and 
nitro groups, were compatible with the reaction conditions to provide the corresponding 
products in excellent yields (Table 3.6, entries 7–10). These functional groups are not able 
to survive under harsh reduction conditions. Therefore, cross-coupling reactions could be 
an ideal and more direct way to install the aminomethyl moieties. A larger scale reaction 
(4 mmol) with 4-chloroanisole was tested under same set of reaction conditions. Luckily, 
the catalyst loading was lowering to 2 mol % to provide the desired product in 93% isolated 
yield (Table 3.6, entry 4). 
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Table 3.6 Cross-Coupling of Boc-Protected Secondary Aminomethyltrifluoroborate 
with Various Aryl Chlorides 
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 Next, hetaryl chlorides were tested as the electrophilic coupling partners (Table 3.7 
and Table 3.8). Even though most of the reactions went to completion under the same set 
of reaction conditions, some of substrates were not complete in 3 h. In these cases, a longer 
reaction time, 18 h, was required.  
Sulfur and oxygen containing hetaryl chlorides proved to be good coupling partners 
with n-butyl Boc-protected secondary aminomethyltrifluoroborate (Table 3.7). As shown, 
sensitive functional groups, such as aldehydes and esters, remained intact throughout the 
coupling reactions (Table 3.7, entries 3, 4, and 5). 
 
Table 3.7 Cross-Coupling of Boc-Protected Secondary Aminomethyltrifluoroborate 
with Various Hetaryl Chlorides 
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 Nitrogen containing hetaryl chlorides were also investigated as the electrophilic 
coupling partners (Table 3.8). 3-Chloropyridine and 5-chloro-2-methoxypyridine provided 
the desired products in 85% and 92% isolated yields, respectively (Table 3.8, entries 1 and 
2). Moreover, the expected product was obtained in 49% isolated yield with 2-chloro-6-
methoxypyridine (Table 3.8, entry 3). However, the product was not detected when the 2-
chloropyridine was applied. For some reason, 2-chloropyridine derivatives might require a 
substituent on the pyridine ring to afford the products. Quinolines and isoquinolines were 
also good coupling partners (Table 3.8, entries 3–6), although quinoline with a methyl 
substituent on the ring gave a slightly lower yield even after 18 h (Table 3.8, entry 6). In 
case of indole derivatives, a protecting group was required to obtain the desired products. 
When the reactions were performed with chloroindoles without the protecting groups, the 
products were not formed. After Boc-protection of indoles, the corresponding products 
were successfully formed in good to excellent yields (Table 3.8, entries 7 and 8). As an 
additional note, cross-coupling reactions of Boc-protected primary 
aminomethyltrifluoroborate with indole derivatives did not require any protecting groups. 
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Table 3.8 Cross-Coupling of Boc-Protected Secondary Aminomethyltrifluoroborate 
with Various Aryl Chlorides 
 
 
Moreover, mesylates were tested as the electrophiles under the same set of 
conditions (Equation 3.5). Even though two different mesylates were applied, the desired 
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products were not obtained after 3 h and 18 h stirring at 85 °C. Only starting mesylates 
were observed. Therefore, a different set of conditions would have to be developed to 
couple these electrophiles effectively. 
 
Equation 3.5 Cross-Coupling of Boc-Protected Secondary 
Aminomethyltrifluoroborate with Aryl Mesylates 
 
  
Next, coupling reactions with seven different Boc-protected secondary 
aminomethyltrifluoroborates were examined as the nucleophiles under the same reaction 
conditions (Table 3.9). All of them gave the expected products in good to excellent isolated 
yields. Aliphatic alkyl (Table 3.9, entries 1 and 2) and cyclic alkyl groups, cyclohexyl 
(Table 3.9, entry 3) and cyclopropyl groups (Table 3.9, entry 4), on the nitrogen proved to 
be good nucleophiles. A benzyl group on the nitrogen gave the desired product in 90% 
isolated yield (Table 3.9, entry 5). However, a benzyl group with an electron-donating 
substituent on the aryl ring provided the corresponding product in a lower yield, 73% 
(Table 3.9, entry 6). The acetal-containing trifluoroborate also proved to be a good 
coupling partner to afford the desired product in 85% isolated yield, and the acetal group 
was tolerated under the coupling reactions (Table 3.9, entry 7). 
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Table 3.9 Cross-Coupling of Various Boc-Protected Secondary 
Aminomethyltrifluoroborates with 4-Chloroanisole 
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3.2.4 Suzuki–Miyaura Reactions with Aryl and Hetaryl Mesylates 
 
3.2.4.1 Introduction 
 Aryl and hetaryl halides, such as chlorides, bromides, and iodides, have been 
widely studied as the electrophilic partners in cross-coupling reactions. A wide range of 
halides are commercially available, and their substrate scope is broad. More recently, 
pseudo-halides, such as sulfonated groups, have been utilized successfully in Suzuki–
Miyaura coupling reactions as alternative coupling partners.20 Among several sulfonated 
phenolic derivatives, tosylates or mesylates are more attractive because they are easily 
prepared from the corresponding phenol with tosyl or mesyl chloride, respectively. These 
sulfonated counterparts are easy to handle and show high stability. Particularly, mesylates 
are of great interest in terms of atom economy and low cost.21 Even though mesylates show 
the lowest reactivity among sulfonated derivatives, they have proven to be good coupling 
partners in cross-coupling reactions. 
 Recently, the Molander22 and Kwong groups23 have reported the Suzuki–Miyaura 
reaction of potassium organotrifluoroborates with mesylates as the electrophilic coupling 
partners. Organotrifluoroborate salts have proven to be efficient coupling partners with 
mesylates in the presence of transition metals (Scheme 3.12).   
 
Scheme 3.12 Cross-Coupling Reactions of Organotrifluoroborate Salts and Mesylates 
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3.2.4.2 Cross-Coupling with Primary Aminomethyltrifluoroborate 
 Boc-Protected primary aminomethyltrifluoroborate proved to be a good 
nucleophile with aryl and hetaryl chlorides in Suzuki–Miyaura cross-coupling reactions. 
To expand the scope of reactivity of aminomethyltrifluoroborate, we explored the Suzuki–
Miyaura reaction with mesylates as an electrophile.  
 Initially, we applied the previously developed coupling conditions of primary 
aminomethyltrifluoroborate with aryl and hetaryl chlorides to reactions with mesylates. 
Unfortunately, only trace amounts of product were detected. This results showed that a 
new set of conditions would have to be developed for effective couplings with mesylates. 
Based on the coupling reaction conditions with mesylates reported previously, K3PO4 was 
chosen as the base, and a mixture of t-BuOH / H2O was selected as the solvent system. 
Next, we screened extensively with palladium catalysts, ligands, reaction concentrations, 
ratio of two solvents, and temperature. After optimization, the combination of 5 mol % of 
PdCl2(cod), 10 mol % of SPhos or RuPhos, and 7 equiv of K3PO4 in t-BuOH / H2O (1:1, 
0.2 M) at 95 °C for 22 h emerged as the best conditions (Equation 3.6). Two different 
ligands, SPhos and RuPhos, were used because reactions with various substrates were not 
general. 
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Equation 3.6 Optimization of Cross-Coupling Reactions with Boc-Protected Primary 
Aminomethyltrifluoroborate with Mesylates 
 
  
We employed these optimized conditions for various aryl mesylates containing 
electron-neutral and electron-donating substituents on the aryl ring (Table 3.10). Both 
electron-neutral (Table 3.10, entries 1–6) and electron-rich mesylates (Table 3.10, entries 
7 and 8) proved to be good electrophilic partners in this process. RuPhos was the most 
efficient ligand for all these cases. The yields dropped dramatically with substrates 
possessed more steric hindrance ortho to the mesylates compared to less hindered 
substrates (Table 3.10, entries 4, and 5). The di-ortho substituted aryl mesylate gave the 
desired product in only 22% isolated yield. When the scale was increased to 4 mmol of 
mesylated 1-naphthol, a lower catalyst loading, 3 mol %, could be employed to give the 
expected product in 87% isolated yield (Table 3.10, entry 1). 
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Table 3.10 Cross-Coupling of Boc-Protected Primary Aminomethyltrifluoroborate 
with Various Aryl Mesylates 
 
 
 To expand the scope of the aryl mesylates, electron-deficient aryl mesylates were 
tested (Table 3.11). Two different ligands, SPhos and RuPhos, were used to obtain the 
optimal depending on substrates. All electron-poor electrophilic coupling partners 
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provided the corresponding products in moderate to good yields. Several functional groups, 
such as nitriles, aldehydes, esters, and ketones, were tolerated under coupling reaction 
conditions. However, the aldehyde and methyl ester substituted aryl mesylates gave lower 
yields compared to other substrates (Table 3.11, entries 2 and 3). 
 
Table 3.11 Cross-Coupling of Boc-Protected Primary Aminomethyltrifluoroborate 
with Various Aryl Mesylates 
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 Various hetaryl mesylates were also investigated as the electrophilic coupling 
partners with the same set of reaction conditions (Table 3.12). Once again, for better results 
two ligands, SPhos and RuPhos, were used depending on the substrates. Pyridine, quinoline, 
isoquinoline, indole and thiazole were successfully coupled with Boc-protected primary 
aminomethyltrifluoroborate to provide the desired products in moderate to good yields 
(Table 3.12, entries 1–7). In the case of the mesylated indole, protection of the free amine 
was not required, and the expected product was obtained in 75% isolated yield (Table 3.12, 
entry 6). As an additional note, coupling reactions of primary aminomethyltrifluoroborate 
with chloroindoles did not require protection, while those of secondary 
aminomethyltrifluoroborates couplings did require protection prior to cross-coupling 
reactions. Moreover, sulfur containing hetaryl mesylates proved to be efficient coupling 
partners to give the desired products in good yields (Table 3.12, entries, 7 and 8). 
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Table 3.12 Cross-Coupling of Boc-Protected Primary Aminomethyltrifluoroborate 
with Various Hetaryl Mesylates 
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3.2.5 Suzuki–Miyaura Reactions with Aryl and Hetaryl Sulfamates 
 
3.2.5.1 Introduction 
 Transition metal catalyzed Suzuki–Miyaura couplings with phenolic derivatives 
have often been demonstrated because these substrates are inexpensive and easy to prepare 
from the corresponding phenols. Phenol derivatives are readily found in many natural 
compound syntheses, and can be utilized as the coupling partners after protection. More 
recently, sulfamates are of interest in terms of easy preparation and further 
functionalization. 24 The direct installation of functional groups ortho or para to the 
sulfamate have also been reported, because these substrates are known to be stable to 
various reaction conditions (Scheme 3.13). Moreover, the cross-coupling reactions, such 
as Kumada 25  and Suzuki–Miyaura coupling reactions,24, 26  have been demonstrated. 
Therefore, more complex molecules can be synthesized by further functionalizations and 
couplings. 
 
Scheme 3.13 Utilities of Sulfamates 
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 Previously, sulfamates have been utilized as the coupling partners in Kumada 
couplings (Scheme 3.14).25 In general, many functional groups, such as esters and ketones, 
are not compatible with Grignard reagents for Kumada couplings. Therefore, Kumada 
couplings cannot be widely applied to build new carbon-carbon bonds.  
 
Scheme 3.14 Kumada Couplings with Sulfamates 
 
 
Recently, Suzuki–Miyaura reactions with sulfamates have been reported by Garg, 
Snieckus and Percec (Scheme 3.15).24,26 Several boron reagents, such as boronic acids and 
neopentylglycolboronates, are successfully utilized in nickel-catalyzed Suzuki–Miyaura 
reactions with sulfamates. Even though carbon(sp2)-carbon(sp2) bonds can be effectively 
formed under these processes, the reaction conditions are harsh and inefficient due to high 
temperatures required and longer reaction times. Moreover, since palladium catalysts are 
known to be inefficient for coupling reactions with sulfamates, only nickel catalyzed 
reactions have been studied.24a 
 
Scheme 3.15 Suzuki–Miyaura Couplings with sulfamates 
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To the best of our knowledge, palladium catalyzed Suzuki–Miyaura coupling 
reactions with potassium organotrifluoroborates and sulfamates have not been reported.  
 
3.2.5.2 Cross-Coupling with Primary Aminomethyltrifluoroborate 
 To extend our study of phenolic derivatives in the Suzuki–Miyaura reaction with 
aminomethyltrifluoroborates, sulfamates were chosen as the electrophilic coupling 
partners with potassium Boc-protected primary and secondary 
aminomethyltrifluoroborates. The carbon(sp3)-carbon(sp2) bonds could be prepared by this 
development, which were previously demostrated only with carbon(sp2)-carbon(sp2) bond 
formation.24,26 To the best of our knowledge, potassium organotrifluoroborates have not 
been reported as the nucleophilic coupling partner in Suzuki–Miyaura coupling reactions 
of sulfamates. 
The coupling reactions were screened with the 1-naphthol sulfamate and Boc-
protected primary aminomethyltrifluoroborate. After the screening of various palladium 
catalysts, ligands, bases, solvents, and reaction times, the combination of 4 mol % of 
XPhos-Pd-G2 and K2CO3 in t-BuOH / H2O (1:1, 0.5 M) at 85 °C for 3 h emerged as the 
optimal conditions (Equation 3.7). Again, use of Buchwald’s second generation preformed 
catalysts allowed the reaction times shortened to 3 h. Moreover, the reactions could be 
concentrated to 0.5 M.  
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Equation 3.7 Optimization of Cross-Coupling Reactions with Boc-Protected Primary 
Aminomethyltrifluoroborate with Sulfamates  
 
 
 Then, we applied these optimized conditions to aryl sulfamates as electrophiles. 
First, electron-neutral and electron-rich aryl sulfamates were applied (Table 3.13). 
Electron-neutral sulfamates, such as 1-naphthol and phenol derivatives, were effectively 
coupled to provide the desired products in 93% and 85% isolated yields (Table 3.13, entries 
1 and 2). In the case of phenolic substrates required a slightly higher amount of base, 5 
equiv instead of 3 equiv. Methyl substituted derivatives on the aryl ring, such as the ortho 
or para to sulfamates, were observed in low conversions and yields by 1H NMR (Table 
3.13, entries 3 and 4). Unfortunately, electron-donating aryl sulfamates were not efficient 
coupling partners because only low conversions and yields were detected (Table 3.13, entry 
5). 
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Table 3.13 Cross-Coupling of Boc-Protected Primary Aminomethyltrifluoroborate 
with Various Aryl Sulfamates 
 
  
We then studied electron-deficient aryl sulfamates as the electrophilic coupling 
partners (Table 3.14). All sulfamates with electron-withdrawing groups provided the 
desired products in good to excellent yields. In general, electron-poor aryl sulfamates 
showed better results than the electron-neutral and electron-rich substrates. A mixture of t-
BuOH / H2O gave low conversion and yields when the fluoro substituted aryl sulfamate 
was applied. After optimization the solvent system again, a mixture of n-PrOH / H2O was 
better for this substrate to provide the corresponding product in a higher yield with a better 
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conversion (Table 3.14, entry 3). Several functional groups, such as ketones, esters, nitriles, 
and nitro groups, were compatible throughout the coupling reactions. In the case of aryl 
sulfamate with both electron-donating and electron-withdrawing groups on the aryl ring, 
the desired product was obtained in 90% isolated yield with full conversion (Table 3.14, 
entry 5). As shown above, low yields and low conversion were observed with electron-rich 
substituted aryl sulfamates (Table 3.13, entry 5). Unfortunately, a slightly lower yield and 
conversion were obtained with a nitro group on the aryl ring compared to other electron-
poor substrates (Table 3.14, entry 6). 
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Table 3.14 Cross-Coupling of Boc-Protected Primary Aminomethyltrifluoroborate 
with Various Aryl Sulfamates 
  
Then, we tested 4-chlorophenyl N,N-dimethylsulfamate as the electrophilic 
coupling partner using the same set of conditions (Equation 3.8). Initially, we expected the 
product from the coupling of the sulfamate site. However, the aminomethyltrifluoroborate 
was coupled only with the chloride instead of the sulfamate. The other site coupled product 
was not detected at all. We also applied the modified conditions of couplings with aryl 
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chlorides and primary aminomethyltrifluoroborate, but the same result was observed. 
Therefore, we assumed oxidative addition to chlorides is faster than sulfamates if the two 
substrates exist on the same aryl ring. 
 
Equation 3.8 Cross-Coupling Reactions with Boc-Protected Primary 
Aminomethyltrifluoroborate with 4-Chlorophenyl Dimethylsulfamate 
 
 
 Next, hetaryl sulfamates were investigated as the electrophilic coupling partners 
(Table 3.15). Various hetaryl sulfamates proved to be good electrophiles. The proctection 
was not required to effectively couple with indole derivatives, the desired product was 
obtained in 68% isolated yield (Table 3.15, entry 3). Even though 2-pyridyl sulfamate gave 
the product, the isolated yield was a lot lower compared to other substrates (Table 3.15, 
entry 5). Unfortunately, indazole derivatives were not efficient coupling partners using the 
same set of conditions (Table 3.15, entry 7). 
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Table 3.15 Cross-Coupling of Boc-Protected Primary Aminomethyltrifluoroborate 
with Various Hetaryl Sulfamates 
 
 
3.2.5.3 Cross-Coupling with Secondary Aminomethyltrifluoroborates 
 We screened the coupling reactions of Boc-protected secondary 
aminomethyltrifluoroborates with various bases, solvents and times. The combination of 4 
mol % of XPhos-Pd-G2 and 7 equiv of K2CO3 in t-BuOH / H2O (1:1, 0.5 M) at 85 °C for 
18 h was optimal for the secondary aminomethyltrifluoroborates couplings (Equation 3.9). 
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Only 7 equiv of base was more efficient in the case of secondary 
aminomethyltrifluoroborates. Moreover, the longer reaction time, 18 h, was required for 
the better results. 
 
Equation 3.9 Optimization of Cross-Coupling Reactions with Boc-Protected 
Secondary Aminomethyltrifluoroborate with Sulfamates 
 
 
 We first studied aryl sulfamates as the electrophilic coupling partners using the 
optimized conditions (Table 3.16). The coupling reactions were not effective as the 
coupling reactions of primary aminomethyltrifluoroborate. Several functional groups, such 
as nitrile, ketones, and esters, were intact throughout the coupling reactions. In the case of 
an acyl substituted sulfamate, the corresponding product was obtained in only 42% isolated 
yield even though full conversion was detected (Table 3.16, entry 5). A sulfmate with 
nitrile group on the ring required a lower amount of base, 5 equiv of K2CO3 (Table 3.16, 
entry 3). Although a sulfamate with only an electron-donating substituent proved to be an 
inefficient electrophilic coupling partner (Table 3.16, entry 10), an aryl sulfamate with both 
electron-rich and electron-poor substituents on the same ring gave the better result, 63% 
isolated yield (Table 3.16, entry 4). Sulfamates with fluoro and trifluoromethyl groups on 
the aryl rings, the desired products were obtained in lower yields, 47% and 42%, 
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respetively (Table 3.16, entries 7 and 8). Unfortunately, a nitro group-containing aryl 
sulfamate proved to be an inefficient coupling partner (Table 3.16, entry 9).  
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Table 3.16 Cross-Coupling of Boc-Protected Secondary Aminomethyltrifluoroborate 
with Various Aryl Sulfamates 
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 Then, various sulfur and nitrogen containing hetaryl sulfamates were tested as the 
electrophiles (Table 3.17). Unfortunately, only a few hetaryl sulfamates were successfully 
coupled to provide the desired products. The expected products were obtained in good 
yields when quinoline, isoquinoline, and thiazole derivatives were applied (Table 3.17, 
entries 1–3). Unfortunately, pyridines and indoles were not efficient, and did not afford the 
corresponding products under the developed conditions, even though more studies were 
conducted (Table 3.17, entries 4–6). 
 
Table 3.17 Cross-Coupling of Boc-Protected Secondary Aminomethyltrifluoroborate 
with Various Hetaryl Sulfamates 
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 The scope of the reactions were expanded seven Boc-protected secondary 
aminomethyltrifluoroborates (Table 3.18). The same set of coupling conditions were 
applied. The desired products were prepared in good yields with full conversions, when 
the aliphatic alkyl substrates on the nitrogen were tested (Table 3.18, entries 1 and 2).  Even 
though cyclohexyl substrate provided the expected product in 68% isolated yield (Table 
3.18, entry 3), the desired product was not detected by 1H NMR with a cyclopropyl group 
on the nitrogen (Table 3.18, entry 4). Benzyl groups, even with electron-rich substituent 
on an aryl ring, afforded the corresponding products in 74% and 82% isolated yields, 
respectively (Table 3.18, entries 5 and 6). The acetal derivative trifluoroborate was also 
effectively coupled to provide the desired product in 86% isolated yield (Table 3.18, entry 
7). 
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Table 3.18 Cross-Coupling of Boc-Protected Secondary 
Aminomethyltrifluoroborates with N,N-Dimethylsulfamated 1-Naphthol 
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3.3 Conclusions 
 We successfully synthesized Boc-protected primary aminomethyltrifluoroborate, 
the primary aminomethyl equivalent, in 75% isolated yield over four steps through a ‘one-
pot’ process. Moreover, seven Boc-protected secondary aminomethyltrifluoroborates were 
prepared in a two-step synthesis. All of the prepared trifluoroborates are air stable and 
could be stored at room temperature without decomposition. Then, the Suzuki–Miyaura 
cross-coupling reaction of these aminomethyltrifluoroborates were investigated with 
various electrophilic coupling partners. Aryl and hetaryl chlorides, mesylates, and 
sulfamates all proved to be effective electrophiles in Suzuki–Miyaura cross-couplings 
under developed reaction conditions. The development of the aminomethyltrifluoroborates 
and applications in coupling reactions allowed access to the aminomethyl moieties more 
efficiently. Moreover, this proved to be a complementary way to build such substructure 
compared to traditional pathways. 
 
3.4 Experimental  
General.  
Pd(OAc)2, PdCl2(cod), SPhos, XPhos, RuPhos and K2CO3 were used as received. 
All halides were used as received. XPhos-Pd-G2 was synthesized prior to use.19 Toluene 
was distilled from sodium/benzophenone prior to use or used from Grubbs distillation.27 
tert-Butanol and H2O was degassed prior to use. Melting points (°C) are uncorrected. 
1H, 
13C and 19F NMR spectra were recorded at 500, 125.8, and 470.8 MHz, respectively. 19F 
NMR chemical shifts were referenced to external CFCl3 (0.0 ppm). 
11B NMR spectra at 
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128.4 MHz were obtained on a spectrometer equipped with the appropriate decoupling 
accessories. All 11B NMR chemical shifts were referenced to external BF3OEt2 (0.0 ppm) 
with a negative sign indicating an upfield shift. Analytical thin layer chromatography (TLC) 
was performed on TLC silica gel plates (250 m) precoated with a fluorescent indicator. 
Standard flash chromatography procedures28 were followed using 32–63 m silica gel. 
Visualization was effected with ultraviolet light and ninhydrin and p-anisaldehyde solution. 
 
Procedure for the Preparation of Potassium Boc-Protected Primary 
Aminomethyltrifluoroborate. 
 
Potassium tert-Butoxycarbonyl Aminomethyltrifluoroborate. 
KHMDS (4.0 g, 19.8 mmol, 1.0 equiv) in THF (40 mL) was added slowly to 2-
(chloromethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (3.5 g, 19.84 mmol, 1.0 equiv) in 
THF (40 mL) at –78 °C. The reaction mixture was stirred for 15 min at –78 °C and then 
stirred for an additional 2 h at rt. The reaction mixture was cooled to 0 °C. MeOH (1.3 g, 
39.7 mmol, 2.0 equiv) was added to the flask at 0 °C. After stirring for 1 h at 0 °C, (Boc)2O 
(8.7 g, 39.7 mmol, 2.0 equiv) was added in one portion. The reaction flask was warmed to 
rt and stirred overnight at rt. The reaction mixture was concentrated under reduced pressure. 
The residue was dissolved in MeOH (40 mL), and then KHF2 in H2O (4.5 M, 18 mL, 4.0 
equiv) was added slowly at 0 °C. After vigorous stirring for 30 min at rt, the solution was 
concentrated in vacuo and then dried in vacuo overnight. The crude mixture was extracted 
with acetone (3 × 30 mL), and the extracts were combined and concentrated. Et2O (60 mL) 
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was added to precipitate the product. The resulting precipitate (3.5 g, 14.9 mmol) was 
filtered and dried in vacuo to provide the product as a white solid in 75% yield.  
mp (transition): 178–181 °C; 1H NMR (500 MHz, DMSO-d6) δ 4.57 (s, 1H), 1.81, (s, 2H), 
1.33 (s, 9H); 13C NMR (125.8 MHz, DMSO-d6) δ 156.4, 76.4, 28.3, one carbon was not 
detected; 19F NMR (470.8 MHz, acetone-d6) δ –145.5; 11B NMR (128.4 MHz, acetone-d6) 
δ 4.13; IR (neat) 3426, 1680 cm-1; HRMS (ES–) calcd. For C6H12BF3NO2 [M–K]– 
198.0913, found 198.0906. 
 
General Procedure for Boc Protection of Amines. 
 
tert-Butyl Cyclopropylcarbamate. 
A round bottomed flask was charged with (Boc)2O (1.6 g, 7.22 mmol, 1.0 equiv). 
Cyclopropanamine (412 mg, 0.5 mL, 7.22 mmol, 1.0 equiv) was slowly added to the flask 
at rt. The reaction mixture was stirred at rt for 2 h. The crude reaction mixture was purified 
by column chromatography (hexanes/EtOAc = 10:1 to 3:1) to afford the product (1.09 g, 
6.95 mmol) as a white solid in 96% yield. 
mp: 60–62 °C; 1H NMR (500 MHz, CDCl3)  4.78 (br, 1H), 2.53 (s, 1H), 1.45 (s, 9H), 0.68 
(d, J = 6.0 Hz, 2H), 0.49 (s, 2H); 13C NMR (125.8 MHz, CDCl3)  156.8, 79.5, 28.5, 22.9, 
6.8; IR (neat) 3360, 1687, 1508, 1160 cm–1; HRMS (CI+) calcd. for C8H16NO2 [M+H]
+ 
158.1181, found 158.1180. 
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tert-Butyl 2-Methoxybenzylcarbamate. 
The reaction was carried out with 2-methoxybenzylamine (1.05 g, 1.0 mL, 7.66 mmol, 1.0 
equiv) according to the general procedure for Boc protection of amines to obtain product 
(1.82 g, 7.66 mmol) as a colorless oil in quantitative yield after column chromatography 
(hexanes/EtOAc = 6:1).  
1H NMR (500 MHz, CDCl3)  7.31–7.21 (m, 2H), 6.91 (dd, J = 7.5, 7.5 Hz, 1H), 6.84 (d, 
J = 7.5 Hz, 1H), 5.06 (br, 1H), 4.30 (d, J = 6.0 Hz, 2H), 3.82 (s, 3H), 1.44 (s, 9H); 13C 
NMR (125.8 MHz, CDCl3)  157.5, 156.0, 129.4, 128.7, 127.1, 120.6, 110.2, 79.2, 55.3, 
40.5, 28.5; IR (neat) 3357, 2976, 1699, 1493, 1242, 1168 cm–1; HRMS (ES+) calcd. for 
C13H19NO3Na [M+Na]
+ 260.1263, found 260.1253. 
 
General Procedure for the Preparation of Boc-Protected Secondary Aminomethyl 
Pinacolborates. 
 
tert-Butyl n-Butyl{(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl}carbamate. 
A round bottomed flask was charged with tert-butyl n-butylcarbamate (5.9 g, 34.2 mmol, 
1.2 equiv) in THF (171 mL). The solution was cooled to –78 ºC, and n-BuLi in hexanes 
(2.5 M, 14 mL, 34.2 mmol, 1.2 equiv) was added slowly to the solution at –78 ºC. The 
resulting mixture was stirred at rt for 10 min. Iodomethylpinacolboronate (7.4 g, 27.6 mmol, 
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1.0 equiv) was added to reaction mixture at rt, and stirred at rt overnight. Then the reaction 
was quenched by the addition of saturated aq. NH4Cl solution (30 mL). The mixture was 
extracted with EtOAc (2 ×40 mL). The organic layer was dried (MgSO4), concentrated in 
vacuo, and purified by column chromatography (hexanes/EtOAc = 9:1 to 1:1) to afford the 
product (5.6 g, 18.0 mmol) as a colorless oil in 65% yield. 
1H NMR (500 MHz, CDCl3)  3.18 (t, J = 7.0 Hz, 2H), 2.35 (s, 2H), 1.59–1.40 (m, 11H), 
1.31–1.19 (m, 14H), 0.89 (t, J = 7.5 Hz, 3H); 13C NMR (125.8 MHz, CDCl3)  161.1, 85.3, 
80.5, 46.3, 29.2, 28.5, 25.2, 19.8, 13.7, one carbon was not detected; 11B NMR (128.4 MHz, 
CDCl3)  15.2; IR (neat) 2972, 1682, 1613, 1369, 1161, 1143 cm–1; HRMS (ES+) calcd. 
for C16H32NO4BNa [M+Na]
+ 336.2322, found 336.2328. 
 
 
tert-Butyl Isopropyl{(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl}carbamate. 
The reaction was carried out with tert-butyl isopropylcarbamate (705 mg, 4.43 mmol, 1.2 
equiv) according to the general procedure for the preparation of Boc-protected secondary 
aminomethyl pinacolborates to obtain product (761 mg, 2.54 mmol) as a white solid in 69% 
yield after column chromatography (hexanes/EtOAc = 7:1 to 3:1).  
 mp: 54–58 °C; 1H NMR (500 MHz, CDCl3)  4.12–3.88 (m, 1H), 2.23 (s, 2H), 1.52 (s, 
9H), 1.19 (s, 12H), 1.09 (d, J = 6.5 Hz, 6 H); 13C NMR (125.8 MHz, CDCl3)  160.8, 86.2, 
80.0, 45.4, 28.6, 25.2, 19.9, one carbon was not detected; 11B NMR (128.4 MHz, CDCl3) 
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 13.1; IR (neat) 2975, 1688, 1602, 1523, 1371, 1162 cm–1; HRMS (ES+) calcd. for 
C15H30BNO4Na [M+Na]
+ 322.2166, found 322.2173. 
 
 
tert-Butyl Cyclohexyl{(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methyl}carbamate. 
The reaction was carried out with tert-butyl cyclohexylcarbamate (1.5 g, 7.53 mmol, 1.2 
equiv) according to the general procedure for the preparation of Boc-protected secondary 
aminomethyl pinacolboronates to obtain product (1.45 g, 4.27 mmol) as a colorless oil in 
68% yield after column chromatography (hexanes/EtOAc = 8:1 to 2:1).  
1H NMR (500 MHz, CDCl3)  3.52–3.44 (m, 1H), 2.56 (s, 2H), 1.82–1.74 (m, 2H), 1.66–
1.57 (m, 3H), 1.52 (s, 9H), 1.46–1.35 (m, 2H), 1.33–1.20 (s, 2H), 1.19 (s, 12H), 1.13–1.02 
(m, 1H); 13C NMR (125.8 MHz, CDCl3)  161.0, 86.2, 79.9, 53.9, 30.2, 28.6, 25.5, 25.4, 
25.2, one carbon was not detected; 11B NMR (128.4 MHz, CDCl3)  13.9; IR (neat) 2932, 
1600, 1519, 1158, 1124 cm–1; HRMS (ES+) calcd. for C18H35BNO4 [M+H]
+ 340.2659, 
found 340.2659. 
 
 
tert-Butyl Cyclopropyl{(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methyl}carbamate. 
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The reaction was carried out with tert-butyl cyclopropylcarbamate (641 mg, 4.08 mmol, 
1.2 equiv) according to the general procedure for the preparation of Boc-protected 
secondary aminomethyl pinacolborates to obtain product (556 mg, 1.87 mmol) as a 
colorless oil in 55% yield after column chromatography (hexanes/EtOAc = 6:1 to 3:1).  
1H NMR (500 MHz, CDCl3)  2.55 (s, 1H), 2.35 (s, 2H), 1.51 (s, 9H), 1.20 (s, 12H), 0.69–
0.61 (m, 4H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, CDCl3) 
 ; 11B 
NMR (128.4 MHz, CDCl3)  16.8; IR (neat) 2975, 1686, 1366, 1144 cm–1; HRMS (ES+) 
calcd. for C15H29BNO4 [M+H]
+ 298.2190, found 298.2197. 
 
 
tert-Butyl Benzyl{(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl}carbamate. 
The reaction was carried out with tert-butyl benzylcarbamate (800 mg, 3.86 mmol, 1.1 
equiv) according to the general procedure for the preparation of Boc-protected secondary 
aminomethyl pinacolborates to obtain product (556 mg, 1.87 mmol) as a colorless oil in 
41% yield after column chromatography (hexanes/EtOAc = 10:1 to 5:1).  
1H NMR (500 MHz, CDCl3)  7.32–7.23 (m, 3H), 7.20–7.16 (m, 2H), 4.35 (s, 2H), 2.36 
(s, 2H), 1.52 (s, 9H), 1.21 (s, 12H); 13C NMR (125.8 MHz, CDCl3)  160.3, 136.3, 128.6, 
128.0, 127.7, 84.9, 81.0, 51.3, 28.5, 25.1, one carbon was not detected; 11B NMR (128.4 
MHz, CDCl3)  18.2; IR (neat) 2977, 2358, 1695, 1455, 1368, 1152 cm–1; HRMS (ES+) 
calcd. for C19H30BNO4Na [M+Na]
+ 370.2166, found 370.2170. 
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tert-Butyl 2-Methoxybenzyl{(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl} 
carbamate. 
The reaction was carried out with tert-butyl 2-methoxybenzylcarbamate (1.1 g, 4.64 mmol, 
1.2 equiv) according to the general procedure for the preparation of Boc-protected 
secondary aminomethyl pinacolborates to obtain product (877 mg, 2.32 mmol) as a white 
solid in 60% yield after column chromatography (hexanes/EtOAc = 8:1 to 2:1).  
mp: 78–81 °C; 1H NMR (500 MHz, CDCl3)  7.26–7.20 (m, 1H), 7.13–7.08 (m, 1H), 6.92–
6.87 (m, 1H), 6.86–6.81 (m, 1H), 4.38 (s, 2H), 3.80 (s, 3H), 2.34 (s, 2H), 1.52 (s, 9H), 1.20 
(s, 12H); 13C NMR (125.8 MHz, CDCl3)  160.8, 157.5, 129.4, 128.9, 124.2, 120.4, 110.3, 
84.9, 80.6, 55.2, 45.8, 28.5, 25.2, one carbon was not detected; 11B NMR (128.4 MHz, 
CDCl3)  17.0; IR (neat) 2970, 1610, 1532, 1158, 1158, 1140, 1110 cm–1; HRMS (ES+) 
calcd. for C20H33BNO5 [M+H]
+ 378.2452, found 378.2462. 
 
 
tert-Butyl (3,3-Diethoxypropyl){(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methyl}carbamate. 
The reaction was carried out with tert-butyl (3,3-diethoxypropyl)carbamate (1.5 g, 6.18 
mmol, 1.2 equiv) according to the general procedure for the preparation of Boc-protected 
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secondary aminomethyl pinacolborates to obtain product (1.5 g, 3.88 mmol) as a colorless 
oil in 49% yield after column chromatography (hexanes/EtOAc = 2:1).  
1H NMR (500 MHz, CDCl3)  4.48 (dd, J = 5.5, 5.5 Hz, 1H), 3.68–3.59 (m, 2H), 3.52–
3.44 (m, 2H), 3.26 (dd, J = 7.5, 7.5 Hz, 2H), 2.39 (s, 2H), 1.85–1.78 (m, 2H), 1.23 (s, 9H), 
1.23–1.18 (m, 18H); 13C NMR (125.8 MHz, CDCl3)  160.6, 100.5, 85.1, 80.5, 61.2, 42.9, 
31.4, 28.4, 25.0, 15.3, one carbon was not detected; 11B NMR (128.4 MHz, CDCl3)  16.3; 
IR (neat) 2975, 1693, 1611, 1371, 1141, 1062 cm–1; HRMS (ES+) calcd. for 
C19H38BNO6Na [M+Na]
+ 410.2690, found 410.2687. 
 
 
tert-Butyl Phenyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)carbamate. 
The reaction was carried out with tert-butyl phenylcarbamate (1.0 g, 5.17 mmol, 1.2 equiv) 
according to the general procedure for the preparation of Boc-protected secondary 
aminomethyl pinacolborates to obtain product (916 mg, 2.75 mmol) as a light yellow oil 
in 64% yield after column chromatography (hexanes/EtOAc = 7:1).  
1H NMR (500 MHz, CDCl3)  7.33–7.28 (m, 2H), 7.27–7.21 (m, 2H), 7.18–7.13 (m, 1H), 
2.93 (s, 2H), 1.50 (s, 9H), 1.25 (s, 12H); 13C NMR (125.8 MHz, CDCl3)  159.1, 140.9, 
128.6, 125.7, 124.1, 85.6, 81.3, 40.8, 28.4, 25.1; 11B NMR (128.4 MHz, CDCl3)  18.3; IR 
(neat) 2976, 1686, 1369, 1143 cm–1; HRMS (ES+) calcd. for C18H28BNO4Na [M+Na]
+ 
356.2009, found 356.2005. 
 
122 
 
General Procedure for the Preparation of Potassium Boc-Protected Secondary 
Aminomethyltrifluoroborates. 
 
Potassium tert-Butyl Butyl{(trifluoroborato)methyl}carbamate. 
The corresponding boronate ester (7.0 g, 22.2 mmol, 1.0 equiv) was dissolved in acetone 
(44 mL) and cooled to 0 ºC. KHF2 (5.2 g, 66.7 mmol, 3.0 equiv) was added to solution, 
and then H2O (15 mL) was added at 0 ºC.  The reaction mixture was stirred for 30 min at 
rt. The solution was concentrated in vacuo and then dried in vacuo overnight. The crude 
mixture was extracted with acetone (3 × 30 mL), and the extracts were combined and 
concentrated. Et2O (100 mL) was added to precipitate the product. The solution was 
sonicated for 15 min and stored in the refrigerator overnight. The solid was filtered and 
dried in vacuo to provide the product (4.4 g, 14.9 mmol) as a white solid in 67% yield. 
mp (transition): 135–138 °C; 1H NMR (500 MHz, acetone-d6)  3.21 (dd, J = 7.5, 7.5 Hz, 
2H), 2.35–2.29 (m, 2H), 1.55–1.47 (m, 2H), 1.41 (s, 9H), 1.31–1.23 (m, 2H), 0.90 (t, J = 
7.5 Hz, 3H); 13C NMR (125.8 MHz, acetone-d6)  156.6, 77.9, 48.6, 30.7, 28.9, 20.7, 14.3, 
one carbon was not detected; 19F NMR (470.8 MHz, acetone-d6)  –142.5; 11B NMR (128.4 
MHz, acetone-d6)  4.03; IR (neat) 2956, 2928, 1664 cm–1; HRMS (ES–) calcd. for 
C10H20BF3NO2 [M–K]– 254.1539, found 254.1538. 
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Potassium tert-Butyl Isopropyl{(trifluoroborato)methyl}carbamate. 
The reaction was carried out with the corresponding boronate ester (688 mg, 2.30 mmol, 
1.0 equiv) according to the general procedure for the preparation of potassium Boc-
protected secondary aminomethyltrifluoroborates to obtain product (456 mg, 1.63 mmol) 
as a white solid in 71% yield. 
mp: 203–206 °C; 1H NMR (500 MHz, acetone-d6)  4.02–3.91 (m, 1H), 2.21 (s, 2H), 1.41 
(s, 9H), 1.12 (d, J = 6.5 Hz, 6H); 13C NMR (125.8 MHz, acetone-d6)  156.4, 77.8, 49.1, 
29.1, 20.8, one carbon was not detected; 19F NMR (470.8 MHz, acetone-d6)  –141.6; 11B 
NMR (128.4 MHz, acetone-d6)  4.24; IR (neat) 2973, 1677, 1099 cm–1; HRMS (ES–) 
calcd. for C10H21BF2NO3 [M–(FK)+(OMe)]– 252.1583, found 252.1596. 
 
 
Potassium tert-Butyl Cyclohexyl{(trifluoroborato)methyl}carbamate. 
The reaction was carried out with the corresponding boronate ester (1.35 g, 3.98 mmol, 1.0 
equiv) according to the general procedure for the preparation of potassium Boc-protected 
secondary aminomethyltrifluoroborates to obtain product (1.11 g, 3.48 mmol) as a white 
solid in 87% yield. 
mp (transition): 207–210 °C; 1H NMR (500 MHz, MeOD)  3.66–3.59 (m, 1H), 2.34–2.21 
(m, 2H), 1.85–1.02 (m, 19H); 13C NMR (125.8 MHz, DMSO-d6)  162.8, 90.9, 79.3, 55.6, 
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31.6*, 30.9, 29.1, 28.5*, 27.5, 26.9*, 26.7, 26.2*; 19F NMR (470.8 MHz, acetone-d6)  –
144.4, –146.7*; 11B NMR (128.4 MHz, MeOD)  3.71; IR (neat) 2931, 1679, 1109 cm–1; 
HRMS (ES–) calcd. for C14H28BFNO4 [M–(F2K)+(OMe)]– 304.2095, found 304.2093. 
 
 
Potassium tert-Butyl Cyclopropyl{(trifluoroborato)methyl}carbamate. 
The reaction was carried out with the corresponding boronate ester (384 mg, 1.29 mmol, 
1.0 equiv) according to the general procedure for the preparation of potassium Boc-
protected secondary aminomethyltrifluoroborates to obtain product (322 mg, 1.16 mmol) 
as a white solid in 90% yield. 
mp (transition): 113–115 °C; 1H NMR (500 MHz, acetone-d6)  2.57–2.50 (m, 1H), 2.33–
2.25 (m, 2H), 1.41 (s, 9H), 0.61–0.51 (m, 4H); 13C NMR (125.8 MHz, acetone-d6)  158.1, 
78.0, 31.4, 29.0, 8.8, one carbon was not detected; 19F NMR (470.8 MHz, acetone-d6)  –
141.9; 11B NMR (128.4 MHz, acetone-d6)  4.01; IR (neat) 2976, 1669, 1408, 1128 cm–1; 
HRMS (ES–) calcd. for C9H16BF3NO2 [M–K]– 238.1226, found 238.1226. 
 
 
Potassium tert-Butyl Benzyl{(trifluoroborato)methyl}carbamate. 
The reaction was carried out with the corresponding boronate ester (439 mg, 1.26 mmol, 
1.0 equiv) according to the general procedure for the preparation of potassium Boc-
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protected secondary aminomethyltrifluoroborates to obtain product (305 mg, 0.93 mmol) 
as a white solid in 74% yield. 
mp: 210–213 °C; 1H NMR (500 MHz, acetone-d6)  7.29–7.14 (m, 5H), 4.48 (s, 2H), 2.37–
2.31 (m, 2H), 1.37 (s, 9H); 13C NMR (125.8 MHz, acetone-d6)  156.8, 141.2, 128.8, 128.1, 
127.1, 78.4, 51.9, 28.8, one carbon was not detected; 19F NMR (470.8 MHz, acetone-d6)  
–142.1; 11B NMR (128.4 MHz, acetone-d6)  4.16; IR (neat) 2987, 1665, 997 cm–1; HRMS 
(ES–) calcd. for C13H18BF3NO2 [M–K]– 288.1383, found 288.1386. 
 
 
Potassium tert-Butyl 2-Methoxybenzyl{(trifluoroborato)methyl}carbamate. 
The reaction was carried out with the corresponding boronate ester (613 mg, 1.62 mmol, 
1.0 equiv) according to the general procedure for the preparation of potassium Boc-
protected secondary aminomethyltrifluoroborates to obtain product (511 mg, 1.43 mmol) 
as a white solid in 88% yield. 
mp (transition): 158–161 °C; 1H NMR (500 MHz, acetone-d6)  7.17 (dd, J = 7.5, 7.5 Hz, 
1H), 7.08 (d, J = 7.0 Hz, 1H), 6.94–6.87 (m, 2H), 4.49 (s, 2H), 3.80 (s, 3H), 2.40–2.34 (m, 
2H), 1.33 (s, 9H); 13C NMR (125.8 MHz, acetone-d6)  158.0, 157.2, 128.6, 127.9, 127.4, 
120.8, 110.8, 78.2, 55.5, 47.4, 28.8, one carbon was not detected; 19F NMR (470.8 MHz, 
acetone-d6)  –142.4; 11B NMR (128.4 MHz, acetone-d6)  4.40; IR (neat) 2969, 1680, 
1240, 1000 cm–1; HRMS (ES–) calcd. for C14H20BF3NO3 [M–K]– 318.1488, found 
318.1493. 
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Potassium tert-Butyl (3,3-Diethoxypropyl){(trifluoroborato)methyl}carbamate. 
The corresponding boronate ester (787 mg, 2.03 mmol, 1.0 equiv) was dissolved in 
theacetone (4 mL) and cooled to 0 ºC. K2CO3 (280 mg, 2.03 mmol, 1.0 equiv) was added 
to the solution, then H2O (2 mL) was added at 0 ºC. After stirring for 10 min at 0 ºC, KHF2 
(793 mg, 10.15 mmol, 5 equiv) was added. The reaction mixture was stirred for 1.5 h at rt. 
The solution was concentrated in vacuo and then dried in vacuo overnight. The crude 
mixture was extracted with acetone (3 × 15 mL), and the extracts were combined and 
concentrated. Hexanes (40 mL) were added to precipitate the product. The solution was 
sonicated for 15 min and the solid was filtered and dried in vacuo to provide the product 
(395 mg, 1.08 mmol) as a white solid in 53% yield. 
mp (transition): 138–140 °C; 1H NMR (500 MHz, acetone-d6)  4.47 (dd, J = 5.5, 5.5 Hz, 
1H), 3.64–3.57 (m, 2H), 3.50–3.41 (m, 2H), 3.35–3.20 (m, 2H), 2.30 (s, 2H), 1.88–1.79 
(m, 2H), 1.42 (s, 9H), 1.14 (dd, J = 7.0, 7.0 Hz, 6H); 13C NMR (125.8 MHz, acetone-d6)  
156.5, 102.0, 78.0, 60.9, 45.3, 32.7, 28.9, 15.7, one carbon was not detected; 19F NMR 
(470.8 MHz, acetone-d6)  –142.3; 11B NMR (128.4 MHz, acetone-d6)  4.11; IR (neat) 
2975, 1660, 1061 cm–1; HRMS (ES–) calcd. for C13H26BF3NO4 [M–K]– 328.1907, found 
328.1898. 
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General Procedure for the Suzuki–Miyaura Cross-coupling Reaction of Boc-
Protected Primary Aminomethyltrifluoroborate with Aryl and Hetaryl Chlorides. 
A sealed tube was charged with potassium tert-butoxycarbonyl 
aminomethyltrifluoroborate (62 mg, 0.263 mmol, 1.05 equiv), an aryl or hetaryl chloride 
(0.25 mmol, 1.0 equiv), Pd(OAc)2 (3 mg, 0.013 mmol, 0.05 equiv), SPhos or XPhos ligand 
(0.03 mmol, 0.1 equiv) and K2CO3 (104 mg, 0.75 mmol, 3.0 equiv).  The mixture was then 
was purged 3 times with argon.  (Liquid electrophiles were added last, after purging with 
argon).  Toluene / H2O (4:1, 0.8 mL/0.2 mL) was then added to the reaction tube. The 
reaction mixture was stirred for 22 h at 85 °C and then cooled to rt. A solution of pH 7 
buffer (2 mL) was added, and the resulting mixture was extracted with EtOAc (2  3 mL). 
The organic layer was combined, dried (MgSO4) and filtered. The solvent was removed in 
vacuo and the product was purified by column chromatography. 
 
 
tert-Butyl Benzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 7:1). 
SPhos: 91% yield (47 mg, 0.23 mmol). 
XPhos: 74% yield (38 mg, 0.18 mmol). 
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1H NMR (500 MHz, CDCl3)  7.35–7.22 (m, 5H), 4.89 (br, 1H), 4.31 (d, J = 5.5 Hz, 2H), 
1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  156.0, 139.0, 128.7, 127.6, 127.4, 79.5, 44.8, 
28.5.  
Data is consistent with that reported in the literature.29 
 
 
tert-Butyl 2-Methylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 7:1). 
SPhos: 76% yield (42 mg, 0.19 mmol). 
XPhos: 90% yield (50 mg, 0.23 mmol). 
1H NMR (500 MHz, CDCl3)  7.27–7.12 (m, 4H), 4.71 (br, 1H), 4.31 (d, J = 5.5 Hz, 2H), 
2.31 (s, 3H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  155.8, 136.6, 136.4, 130.5, 
128.1, 127.6, 126.2, 79.5, 42.9, 28.5, 19.0.  
Data is consistent with that reported in the literature.30 
 
 
tert-Butyl 2,6-Dimethylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 10:1). 
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SPhos: 90% yield (53 mg, 0.23 mmol). 
XPhos: 76% yield (45 mg, 0.19 mmol). 
mp: 73–74 °C; 1H NMR (500 MHz, CDCl3)  7.12–7.00 (m, 3H), 4.39 (br, 1H), 4.35 (d, J 
= 4.0 Hz, 2H), 2.37 (s, 6H), 1.45 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  155.8, 137.5, 
134.5, 128.5, 127.9, 79.5, 39.2, 28.5, 19.8; IR (neat) 3385, 1682, 1504 cm-1; HRMS (ES+) 
calcd. for C14H21NO2Na [M+Na]
+ 258.1470, found 258.1475. 
 
 
tert-Butyl 4-Methoxybenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a colorless oil after flash chromatography (hexanes/EtOAc = 5:1). 
SPhos: 69% yield (41 mg, 0.17 mmol). 
XPhos: 88% yield (52 mg, 0.22 mmol). 
1H NMR (500 MHz, CDCl3)  7.20 (d, J = 8.0 Hz, 2H), 6.85 (d, J = 8.5 Hz, 2H), 4.84 (br, 
1H), 4.24 (d, J = 5.5 Hz, 2H), 3.79 (s, 3H), 1.45 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  
159.0, 156.0, 131.2, 128.9, 114.1, 79.5, 55.4, 44.3, 28.5.  
Data is consistent with that reported in the literature.31 
 
 
tert-Butyl 4-Methoxy-2,6-dimethylbenzylcarbamate. 
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According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 15:1). 
SPhos: 78% yield (52 mg, 0.20 mmol). 
XPhos: 71% yield (47 mg, 0.18 mmol). 
mp: 108–110 °C; 1H NMR (500 MHz, CDCl3)  6.57 (s, 2H), 4.36 (br, 1H), 4.29 (m, 2H), 
3.76 (s, 3H), 2.34 (s, 6H), 1.45 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  158.8, 155.8, 
139.0, 126.9, 113.7, 79.3, 55.2, 38.7, 28.5, 20.1; IR (neat) 3374, 3318, 1680, 1522 cm-1; 
HRMS (CI+) calcd. for C15H24NO3 [M+H]
+ 266.1756, found 266.1768. 
 
 
tert-Butyl 3,5-Dimethoxybenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 6:1). 
SPhos: 75% yield (50 mg, 0.19 mmol). 
XPhos: 79% yield (52 mg, 0.20 mmol). 
mp: 64–65 °C; 1H NMR (500 MHz, CDCl3)  6.44–6.41 (m, 2H), 6.35 (t, J = 2.0 Hz, 1H), 
4.89 (br, 1H), 4.25 (d, J = 6.0 Hz, 2H), 3.77 (s, 6H), 1.46 (s, 9H); 13C NMR (125.8 MHz, 
CDCl3)  161.1, 156.0, 141.5, 105.4, 99.4, 79.6, 55.4, 44.9, 28.5; IR (neat) 3318, 1677, 
1597, 1535 cm-1; HRMS (CI+) calcd. for C14H22NO4 [M+H]
+ 268.1549, found 268.1528. 
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tert-Butyl 4-(1H-Pyrrol-1-yl)benzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 5:1). 
SPhos: 86% yield (58 mg, 0.21 mmol). 
XPhos: 87% yield (59 mg, 0.22 mmol). 
mp: 118–119 °C; 1H NMR (500 MHz, CDCl3)  7.36–7.27 (m, 4H), 7.08–7.03 (m, 2H), 
6.34 (t, J = 2.5 Hz, 2H), 4.94 (br, 1H), 4.31 (d, J = 5.5 Hz, 2H), 1.46 (s, 9H); 13C NMR 
(125.8 MHz, CDCl3)  156.0, 140.0, 136.5, 128.7, 120.7, 119.4, 110.5, 79.7, 44.2, 28.5; IR 
(neat) 3385, 1685, 1520 cm-1; HRMS (ES+) calcd. for C16H20N2O2Na [M+Na]
+ 295.1422, 
found 295.1419. 
 
 
tert-Butyl 4-Cyanobenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 4:1). 
SPhos: 90% yield (52 mg, 0.22 mmol). 
XPhos: 88% yield (51 mg, 0.22 mmol). 
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1H NMR (500 MHz, CDCl3)  7.61 (d, J = 8.0 Hz, 2H), 7.39 (d, J = 8.5 Hz, 2H), 5.11 (br, 
1H), 4.37 (d, J = 6.0 Hz, 2H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  156.0, 144.8, 
132.5, 127.9, 118.9, 111.1, 80.1, 44.2, 28.4.  
Data is consistent with that reported in the literature.32 
 
 
tert-Butyl 4-Nitrobenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a yellow solid after flash chromatography (hexanes/EtOAc = 4:1). 
SPhos: 90% yield (57 mg, 0.23 mmol). 
XPhos: 88% yield (55 mg, 0.22 mmol). 
1H NMR (500 MHz, CDCl3)  8.18 (d, J = 8.5 Hz, 2H), 7.45 (d, J = 8.5 Hz, 2H), 5.13 (br, 
1H), 4.12 (d, J = 5.5 Hz, 2H), 1.47 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  156.0, 147.3, 
146.9, 127.9, 123.9, 80.2, 44.1, 28.4. 
Data is consistent with that reported in the literature.33 
 
 
Methyl 3-[{(tert-Butoxycarbonyl)amino}methyl]benzoate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 7:1). 
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SPhos: 90% yield (60 mg, 0.23 mmol). 
XPhos: 86% yield (57 mg, 0.22 mmol). 
mp: 86–90 °C; 1H NMR (500 MHz, CDCl3)  7.99–7.90 (m, 2H), 7.51–7.46 (m, 1H), 7.40 
(t, J = 7.5 Hz, 1H), 5.05 (br, 1H), 4.36 (d, J = 5.5 Hz, 2H), 3.91 (s, 3H), 1.46 (s, 9H); 13C 
NMR (125.8 MHz, CDCl3)  167.9, 156.0, 139.5, 132.1, 130.5, 128.8, 128.6, 128.5, 79.8, 
44.3, 28.5; IR (neat) 3380, 1713, 1698 cm-1; HRMS (ES+) calcd. for C14H19NO4Na 
[M+Na]+ 288.1212, found 288.1218. 
 
 
tert-Butyl 4-Formylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 4:1). 
SPhos: 70% yield (41 mg, 0.17 mmol). 
XPhos: 77% yield (45 mg, 0.19 mmol). 
1H NMR (500 MHz, CDCl3)  9.99 (s, 1H), 7.84 (d, J = 8.0 Hz, 2H), 7.44 (d, J = 7.5 Hz, 
2H), 5.09 (br, 1H), 4.40 (d, J = 5.5 Hz, 2H), 1.47 (s, 9H); 13C NMR (125.8 MHz, CDCl3) 
 192.0, 156.0, 146.3, 135.6, 130.2, 127.8, 80.0, 44.4, 28.5.  
Data is consistent with that reported in the literature.34 
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tert-Butyl 4-Acetylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 3:1). 
SPhos: 69% yield (43 mg, 0.17 mmol). 
XPhos: 71% yield (44 mg, 0.18 mmol). 
mp: 67–69 °C; 1H NMR (500 MHz, CDCl3)  7.91 (d, J = 8.5 Hz, 2H), 7.37 (d, J = 8.0 Hz, 
2H),  5.09 (br, 1H), 4.37 (d, J = 6.0 Hz, 2H), 2.59 (s, 3H), 1.46 (s, 9H); 13C NMR (125.8 
MHz, CDCl3)  197.8, 156.0, 144.7, 136.3, 128.8, 127.4, 79.9, 44.4, 28.5, 26.7; IR (neat) 
3318, 1677, 1530 cm-1; HRMS (CI+) calcd. for C14H20NO3 [M+H]
+ 250.1443, found 
250.1438. 
 
 
tert-Butyl (Thiophen-2-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a light yellow oil after flash chromatography (hexanes/EtOAc = 7:1). 
SPhos: 78% yield (42 mg, 0.20 mmol). 
XPhos: 60% yield (32 mg, 0.15 mmol). 
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1H NMR (500 MHz, CDCl3)  7.22–7.18 (m, 1H), 6.96–6.91 (m, 2H), 4.95 (br, 1H), 4.47 
(d, J = 5.0 Hz, 2H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  155.6, 142.0, 126.9, 
125.6, 125.0, 79.8, 39.6, 28.5.  
Data is consistent with that reported in the literature.35  
 
 
tert-Butyl {(5-Formylthiophen-2-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a yellow oil after flash chromatography (hexanes/EtOAc = 4:1). 
SPhos: 70% yield (42 mg, 0.17 mmol). 
XPhos: 75% yield (45 mg, 0.19 mmol). 
1H NMR (500 MHz, CDCl3)  9.84 (s, 1H), 7.63 (d, J = 4.0 Hz, 1H), 7.05 (d, J = 3.5 Hz, 
1H),  5.34 (br, 1H), 4.51 (d, J = 5.5 Hz, 2H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3) 
 183.0, 155.7, 154.1, 142.7, 136.9, 126.1, 80.2, 40.1, 28.4; IR (neat) 3333, 1697, 1665 cm-
1; HRMS (ES+) calcd. for C11H15NO3SNa [M+Na]
+ 264.0670, found 264.0671. 
 
 
tert-Butyl {(5-Acetylthiophen-2-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a yellow oil after flash chromatography (hexanes/EtOAc = 3:1). 
SPhos: 85% yield (54 mg, 0.21 mmol). 
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XPhos: 80% yield (51 mg, 0.20 mmol). 
1H NMR (500 MHz, CDCl3)  7.55 (d, J = 4.0 Hz, 1H), 6.97 (d, J = 3.5 Hz, 1H),  5.01 (br, 
1H), 4.48 (d, J = 5.5 Hz, 2H), 2.52 (s, 3H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  
190.7, 155.7, 152.1, 143.5, 132.8, 126.0, 80.2, 40.1, 28.5, 26.7; IR (neat) 3339, 1698, 1655 
cm-1; HRMS (ES+) calcd. for C12H17NO3SNa [M+Na]
+ 278.0827, found 278.0837. 
 
 
tert-Butyl (Thiophen-3-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 10:1). 
SPhos: 45% yield (24 mg, 0.11 mmol). 
XPhos: 73% yield (39 mg, 0.18 mmol). 
mp: 54–56 °C; 1H NMR (500 MHz, CDCl3)  7.29–7.25 (m, 1H), 7.12 (s, 1H), 7.04–7.00 
(m, 1H), 4.85  (br, 1H), 4.31–4.29 (m, 2H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  
155.9, 140.0, 127.3, 126.4, 121.9, 79.6, 40.0, 28.5; IR (neat) 3300, 1679, 1534 cm-1; HRMS 
(ES+) calcd. for C10H15NO2SNa [M+Na]
+ 236.0721, found 236.0714. 
 
 
tert-Butyl {(5-Formylfuran-2-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a dark brown oil after flash chromatography (hexanes/EtOAc = 3:1). 
137 
 
SPhos: 66% yield (37 mg, 0.16 mmol). 
XPhos: 73% yield (41 mg, 0.18 mmol). 
1H NMR (500 MHz, CDCl3)  9.57 (s, 1H), 7.20 (d, J = 3.0 Hz, 1H), 6.45 (s, 1H), 5.12  (br, 
1H), 4.40–4.35 (m, 2H), 1.45 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  177.5, 159.2, 155.6, 
152.4, 123.1, 109.9, 80.3, 38.0, 28.4; IR (neat) 3328, 1699, 1673 cm-1; HRMS (CI+) calcd. 
for C11H16NO4 [M+H]
+ 226.1079, found 226.1079. 
 
 
tert-Butyl {(6-Methoxypyridin-3-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 5:1). 
SPhos: 86% yield (51 mg, 0.21 mmol). 
XPhos: 62% yield (37 mg, 0.16 mmol). 
mp: 55–58 °C; 1H NMR (500 MHz, CDCl3)  8.05 (d, J = 1.5 Hz, 1H), 7.53 (d, J = 8.0 Hz, 
1H), 6.71 (d, J = 8.5 Hz, 1H), 4.93 (br, 1H), 4.23 (d, J = 5.0 Hz, 2H), 3.92 (s, 3H), 1.45 (s, 
9H); 13C NMR (125.8 MHz, CDCl3)  163.7, 155.9, 145.9, 138.6, 127.4, 111.0, 79.7, 53.5, 
41.7, 28.5; IR (neat) 3358, 1685, 1522, 1495 cm-1; HRMS (ES+) calcd. for C12H19N2O3 
[M+H]+ 239.1396, found 239.1404. 
 
 
138 
 
 
tert-Butyl {(6-Fluoropyridin-3-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a colorless oil after flash chromatography (hexanes/EtOAc = 3:1). 
SPhos: 67% yield (38 mg, 0.17 mmol). 
XPhos: 74% yield (42 mg, 0.19 mmol). 
1H NMR (500 MHz, CDCl3)  8.12 (s, 1H), 7.76 (dd, J = 7.0, 7.0 Hz, 1H), 6.90 (dd, J = 
8.5, 2.5 Hz, 1H), 5.12 (br, 1H), 4.31 (d, J = 5.0 Hz, 2H), 1.45 (s, 9H); 13C NMR (125.8 
MHz, CDCl3)  163.1 (d, J = 238.5 Hz), 156.0, 146.6 (d, J = 14.7 Hz), 140.8, 132.6 (d, J 
= 4.5 Hz), 109.6 ((d, J = 37.5 Hz), 80.1, 41.4, 28.4; IR (neat) 3323, 1697 cm-1; HRMS 
(ES+) calcd. for C11H16N2O2F [M+H]
+ 227.1196, found 227.1196. 
 
 
tert-Butyl (Pyridin-2-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a light yellow oil after flash chromatography (hexanes/EtOAc = 1:1). 
SPhos: 35% yield (18 mg, 0.09 mmol). 
XPhos: 33% yield (17 mg, 0.08 mmol). 
1H NMR (500 MHz, CDCl3)  8.54 (d, J = 5.0 Hz, 1H), 7.65 (ddd, J = 7.5, 7.5, 1.5 Hz, 
1H), 7.27 (dd, J = 4.0, 4.0 Hz, 1H), 7.18 (dd, J = 7.0, 5.0 Hz, 1H),  5.59 (br, 1H), 4.45 (d, 
J = 5.0 Hz, 2H), 1.47 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  157.6, 156.1, 149.2, 136.8, 
139 
 
122.3, 121.8, 79.6, 45.9, 28.5; IR (neat) 3344, 1781, 1709 cm-1; HRMS (ES+) calcd. for 
C11H16N2O2Na [M+Na]
+ 231.1109, found 231.1113. 
 
 
tert-Butyl (Quinolin-2-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a light yellow solid after flash chromatography (hexanes/EtOAc = 3:1). 
SPhos: 51% yield (33 mg, 0.13 mmol). 
XPhos: 36% yield (23 mg, 0.09 mmol). 
mp: 54–58 °C; 1H NMR (500 MHz, CDCl3)  8.11 (d, J = 8.5 Hz, 1H), 8.05 (d, J = 8.5 Hz, 
1H), 7.80 (d, J = 8.0 Hz, 1H), 7.71 (dd, J = 8.0, 8.0 Hz, 1H), 7.52 (dd, J = 8.0, 8.0 Hz, 1H), 
7.36 (d, J = 8.0 Hz, 1H),  5.96 (br, 1H), 4.63 (d, J = 4.5 Hz, 2H), 1.50 (s, 9H); 13C NMR 
(125.8 MHz, CDCl3)  157.4, 156.2, 147.5, 136.8, 129.8, 129.0, 127.7, 127.4, 126.4, 119.9, 
79.6, 46.3, 28.6; IR (neat) 3235, 1709 cm-1; HRMS (ES+) calcd. for C15H19N2O2 [M+H]
+ 
259.1447, found 259.1436. 
 
 
tert-Butyl (Isoquinolin-1-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a yellow oil after flash chromatography (hexanes/EtOAc = 5:1). 
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SPhos: 37% yield (24 mg, 0.09 mmol). 
XPhos: 62% yield (40 mg, 0.16 mmol). 
1H NMR (500 MHz, CDCl3)  8.43 (d, J = 5.5 Hz, 1H), 8.10 (d, J = 8.5 Hz, 1H), 7.85 (d, 
J = 8.0 Hz, 1H), 7.71 (dd, J = 7.0, 7.0 Hz, 1H), 7.65 (dd, J = 7.0, 7.0 Hz, 1H), 7.58 (d, J = 
5.5 Hz, 1H),  6.36 (br, 1H), 4.98 (d, J = 4.0 Hz, 2H), 1.51 (s, 9H); 13C NMR (125.8 MHz, 
CDCl3)  156.2, 155.2, 141.2, 136.1, 130.4, 127.8, 127.5, 126.0, 124.0, 120.5, 79.5, 43.3, 
28.6; IR (neat) 3344, 1776, 1706 cm-1; HRMS (ES+) calcd. for C15H19N2O2 [M+H]
+ 
259.1447, found 259.1447. 
 
 
tert-Butyl (Quinolin-6-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 1:1). 
SPhos: 57% yield (37 mg, 0.14 mmol). 
XPhos: 70% yield (45 mg, 0.17 mmol). 
mp: 75–77 °C; 1H NMR (500 MHz, CDCl3)  8.92–8.86 (m, 1H), 8.11 (d, J = 8.5 Hz, 1H), 
8.07 (d, J = 9.0 Hz, 1H), 7.69 (s, 1H), 7.64 (d, J = 8.5 Hz, 1H), 7.39 (dd, J = 8.5, 4.5 Hz, 
1H), 5.14  (br, 1H), 4.50 (d, J = 5.5 Hz, 2H), 1.48 (s, 9H); 13C NMR (125.8 MHz, CDCl3) 
 156.1, 150.4, 147.8, 137.5, 136.0, 130.0, 129.4, 128.3, 125.7, 121.5, 79.9, 44.6, 28.5; IR 
(neat) 3256, 1708 cm-1; HRMS (ES+) calcd. for C15H19N2O2 [M+H]
+ 259.1447, found 
259.1457. 
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tert-Butyl {(2-Methylquinolin-4-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a colorless oil after flash chromatography (hexanes/EtOAc = 1:1). 
SPhos: 59% yield (40 mg, 0.15 mmol). 
XPhos: 37% yield (25 mg, 0.09 mmol). 
1H NMR (500 MHz, CDCl3)  8.02 (d, J = 8.5 Hz, 1H), 7.91 (d, J = 8.5 Hz, 1H), 7.66 (dd, 
J = 7.5, 7.5 Hz, 1H), 7.49 (dd, J = 7.5, 7.5 Hz, 1H), 7.19 (s, 1H), 5.17 (br, 1H), 4.73 (d, J 
= 5.0 Hz, 2H), 2.69 (s, 3H), 1.48 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  158.9, 155.9, 
148.1, 144.0, 129.5, 129.4, 126.0, 124.7, 122.8, 120.2, 80.0, 41.5, 28.5, 25.5; IR (neat) 
3333, 1699 cm-1; HRMS (ES+) calcd. for C16H21N2O2 [M+H]
+ 273.1603, found 273.1595. 
 
 
tert-Butyl {(2-Methylquinolin-8-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a light yellow oil after flash chromatography (hexanes/EtOAc = 7:1). 
SPhos: 76% yield (52 mg, 0.19 mmol). 
XPhos: 87% yield (59 mg, 0.22 mmol). 
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1H NMR (500 MHz, CDCl3)  8.00 (d, J = 8.5 Hz, 1H), 7.68–7.61 (m, 2H), 7.40 (d, J = 
8.0 Hz, 1H), 7.26 (d, J = 8.0 Hz, 1H), 5.92 (br, 1H), 4.84 (d, J = 6.0 Hz, 2H), 2.73 (s, 3H), 
1.43 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  158.4, 156.2, 146.5, 136.4, 136.3, 128.9, 
127.2, 126.6, 125.5, 121.9, 79.1, 42.4, 28.6, 25.8; IR (neat) 3344, 1704 cm-1; HRMS (ES+) 
calcd. for C16H21N2O2 [M+H]
+ 273.1603, found 273.1596. 
 
 
tert-Butyl {(1H-Indol-5-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a light yellow solid after flash chromatography (hexanes/EtOAc = 4:1). 
SPhos: 65% yield (40 mg, 0.16 mmol). 
XPhos: 67% yield (41 mg, 0.17 mmol). 
mp: 86–89 °C; 1H NMR (500 MHz, CDCl3)  8.38 (br, 1H), 7.53 (s, 1H), 7.32 (d, J = 8.5 
Hz, 1H), 7.18 (dd, J = 2.5, 2.5 Hz, 1H), 7.11 (d, J = 8.0 Hz, 1H), 6.52–6.47 (m, 1H), 4.85 
(br, 1H), 4.39 (d, J = 5.0 Hz, 2H), 1.47 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  156.1, 
135.3, 130.2, 128.1, 124.9, 122.2, 119.9, 111.4, 102.5, 79.4, 45.4, 28.6; IR (neat) 3356, 
3318, 1697, 1655 cm-1; HRMS (ES+) calcd. for C14H18N2O2Na [M+Na]
+ 269.1266, found 
269.1265. 
 
 
143 
 
 
tert-Butyl {(1H-Indol-6-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a light yellow solid after flash chromatography (hexanes/EtOAc = 4:1). 
SPhos: 65% yield (41 mg, 0.17 mmol). 
XPhos: 70% yield (43 mg, 0.18 mmol). 
mp: 106–108 °C; 1H NMR (500 MHz, CDCl3)  8.33 (br, 1H), 7.58 (d, J = 8.5 Hz, 1H), 
7.29 (s, 1H),  7.17 (dd, J = 2.5, 2.5 Hz, 1H), 7.03 (d, J = 8.0 Hz, 1H), 6.54–6.49 (m, 1H), 
4.89 (br, 1H), 4.40 (d, J = 5.5 Hz, 2H), 1.47 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  
156.1, 136.1, 132.8, 127.3, 124.7, 120.9, 119.9, 110.4, 102.5, 79.5, 45.4, 28.6; IR (neat) 
3390, 3351, 1670 cm-1; HRMS (ES+) calcd. for C14H18N2O2Na [M+Na]
+ 269.1266, found 
269.1265. 
 
General Procedure for the Suzuki–Miyaura Cross-coupling Reaction of Boc-
Protected Secondary Aminomethyltrifluoroborates with Aryl and Hetaryl Chlorides. 
A sealed tube was charged with potassium tert-butyl 
butyl{(trifluoroborato)methyl}carbamate (77 mg, 0.263 mmol, 1.05 equiv), an aryl or 
hetaryl chloride (0.250 mmol, 1.0 equiv), XPhos-Pd-G2 (8 mg, 0.010 mmol, 0.04 equiv), 
and Cs2CO3 (244 mg, 0.750 mmol, 3.0 equiv).  The mixture was then was purged three 
times with argon. Toluene / H2O (0.5 M, 4:1, 0.4 mL/0.1 mL) was then added to the 
reaction tube. The reaction mixture was stirred for 3 or 18 h as denoted at 85 °C and then 
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cooled to rt. H2O (2 mL) was added, and the resulting mixture was extracted with EtOAc 
(2  3 mL). The organic layer was combined, dried (MgSO4) and filtered. The solvent was 
removed in vacuo and the product was purified by column chromatography. 
 
 
tert-Butyl Benzyl(butyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (60 
mg, 0.228 mmol) was obtained as a colorless oil in 91% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.37–7.18 (m, 5H), 
4.44 (s, 2H), 4.41* (s, 2H), 3.26–3.09 (m, 2H), 1.56–1.37 (m, 11H), 1.33–1.21 (m, 2H), 
0.89 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, 
CDCl3)  156.3, 155.8*, 139.0, 138.8*, 128.5, 127.8, 127.1, 79.6, 50.5, 49.8*, 46.6, 46.2*, 
30.3, 30.1*, 28.6, 20.1, 14.0.  
Data is consistent with that reported in the literature.36 
 
 
tert-Butyl Butyl(2-methylbenzyl)carbamate. 
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According to the general procedure for Suzuki–Miyaura cross-coupling, the product (62 
mg, 0.224 mmol) was obtained as a colorless oil in 89% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.18–7.09 (m, 4H), 
4.46 (s, 2H), 4.40* (s, 2H), 3.22–3.04 (m, 2H), 2.28 (s, 3H), 1.53–1.37 (m, 11H), 1.31–
1.22 (m, 2H), 0.88 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 
125.8 MHz, CDCl3)  155.9, 136.5, 136.0, 130.4, 127.7, 127.1, 126.0, 79.5, 48.3, 47.8*, 
46.3, 45.9*, 30.3, 28.5, 28.2*, 20.2, 19.1, 14.0; IR (neat) 2961, 1693, 1414, 1249, 1170, 
1143 cm–1; HRMS (ES+) calcd. for C17H27NO2Na [M+Na]
+ 300.1939, found 300.1949. 
 
 
tert-Butyl Butyl(2,6-dimethylbenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (69 
mg, 0.237 mmol) was obtained as a colorless oil in 95% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (500 MHz, CDCl3)  7.10–7.06 (m, 1H), 7.00 (d, J = 7.5 Hz, 2H), 4.58 (s, 2H), 
2.85 (s, 2H), 2.32 (s, 6H), 1.49 (s, 9H), 1.41–1.33 (m, 2H), 1.21–1.12 (m, 2H), 0.82 (t, J = 
7.5 Hz, 3H); 13C NMR (.8 MHz, CDCl3)  155.6, 138.1, 133.9, 128.6, 127.5, 79.4, 44.3, 
43.3, 30.5, 28.6, 20.2, 20.1, 13.9; IR (neat) 2961, 1692, 1413, 1172, 1141 cm–1; HRMS 
(ES+) calcd. for C18H29NO2Na [M+Na]
+ 314.2096, found 314.2084. 
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tert-Butyl Butyl(4-methoxybenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (71 
mg, 0.242 mmol) was obtained as a colorless oil in 97% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.16 (s, 2H), 6.85 (d, 
J = 9.0 Hz, 2H), 4.36 (s, 2H), 3.79 (s, 3H), 3.17* (s, 2H), 3.09 (s, 2H), 1.52–1.40 (m, 11H), 
1.31–1.21 (m, 2H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (asterisk denotes minor rotamer 
peaks, 125.8 MHz, CDCl3)  158.9, 130.9, 129.2, 128.5, 113.9, 79.5, 55.4, 49.8, 49.2*, 
46.2, 46.0*, 30.3, 28.6, 20.1, 14.0; IR (neat) 2960, 1690, 1512, 1412, 1247, 1170, 1141 
cm–1; HRMS (ES+) calcd. for C17H27NO3Na [M+Na]
+ 316.1889, found 316.1896. 
 
 
tert-Butyl Butyl(4-methoxy-2,6-dimethylbenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (80 
mg, 0.249 mmol) was obtained as a colorless oil in 100% yield after column 
chromatography (hexanes/EtOAc = 20:1). 
1H NMR (500 MHz, CDCl3)  6.57 (s, 2H), 4.52 (s, 2H), 3.77 (s, 3H), 2.84 (s, 2H), 2.30 
(s, 6H), 1.49 (s, 9H), 1.41–1.33 (m, 2H), 1.22–1.13 (m, 2H), 0.82 (t, J = 7.5 Hz, 3H); 13C 
NMR (125.8 MHz, CDCl3)  1158.4, 155.6, 139.5, 126.2, 113.8, 79.3, 55.1, 44.0, 42.8, 
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30.4, 28.6, 20.4, 20.2, 13.9; IR (neat) 2970, 1689, 1172, 1140 cm–1; HRMS (ES+) calcd. 
for C19H31NO3Na [M+Na]
+ 344.2202, found 344.2191. 
 
 
tert-Butyl Butyl(3,5-dimethoxybenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (78 
mg, 0.241 mmol) was obtained as a colorless oil in 96% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  6.42–6.33 (m, 3H), 
4.38 (s, 2H), 4.34* (s, 2H), 3.77 (s, 6H), 3.23–3.09 (m, 2H), 1.54–1.41 (m, 11H), 1.33–
1.23 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 
125.8 MHz, CDCl3)  161.0, 156.2, 155.7*, 141.5, 141.2*, 105.6, 105.1*, 99.0, 79.6, 55.4, 
50.6, 49.9*, 46.5, 46.3*, 30.4, 30.1*, 28.6, 20.1, 14.0; IR (neat) 2960, 1691, 1597, 1414, 
1205, 1156 cm–1; HRMS (ES+) calcd. for C18H29NO4Na [M+Na]
+ 346.1994, found 
346.1989. 
 
 
Methyl 3-[{(tert-Butoxycarbonyl)(butyl)amino}methyl]benzoate. 
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According to the general procedure for Suzuki–Miyaura cross-coupling, the product (78 
mg, 0.243 mmol) was obtained as a colorless oil in 97% yield after column chromatography 
(hexanes/EtOAc = 15:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.96–7.87 (m, 2H), 
7.49–7.36 (m, 2H), 4.49 (s, 2H), 4.44* (s, 2H), 3.91 (s, 3H), 3.32–3.08 (m, 2H), 1.57–1.37 
(m, 11H), 1.34–1.23 (m, 2H), 0.89 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes minor 
rotamer peaks, 125.8 MHz, CDCl3)  167.1, 156.2, 155.6*, 139.5, 139.2*, 132.2, 131.6, 
130.4, 128.6, 79.8, 52.2, 50.3, 49.6*, 46.8, 46.5*, 30.3, 30.2*, 28.5, 20.0, 13.9; IR (neat) 
2965, 2360, 2342, 1725, 1692, 1285, 1170 cm–1; HRMS (ES+) calcd. for C18H27NO4Na 
[M+Na]+ 344.1838, found 344.1843. 
 
 
tert-Butyl Butyl(4-cyanobenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (67 
mg, 0.232 mmol) was obtained as a colorless oil in 93% yield after column chromatography 
(hexanes/EtOAc = 10:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.62 (d, J = 8.0 Hz, 
2H), 7.33 (s, 2H), 4.54–4.41 (m, 2H), 3.25–3.15 (m, 2H), 1.62–1.23 (m, 13H), 0.90 (t, J = 
7.0 Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, CDCl3)  156.1, 
144.8*, 144.5, 132.4, 128.1, 127.5*, 118.9, 111.0, 80.5, 50.6*, 49.9, 47.0, 30.4, 28.4, 20.0, 
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13.9; IR (neat) 2961, 2359, 2228, 1691, 1409, 1169, 1146 cm–1; HRMS (ES+) calcd. for 
C17H24N2O2Na [M+Na]
+ 311.1735, found 311.1726. 
 
 
tert-Butyl Butyl(4-nitrobenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (66 
mg, 0.214 mmol) was obtained as a yellow oil in 86% yield after column chromatography 
(hexanes/EtOAc = 10:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.19 (d, J = 7.5 Hz, 
2H), 7.39 (s, 2H), 4.54–4.92 (m, 2H), 3.31–3.10 (m, 2H), 1.63–1.19 (m, 13H), 0.91 (t, J = 
7.5 Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, CDCl3)  156.1, 
147.2, 146.6*, 128.1, 127.5, 123.8, 80.2, 50.4*, 49.8, 47.4*, 47.1, 30.5, 28.5, 20.1, 13.9; 
IR (neat) 2963, 2360, 1692, 1521, 1344 cm–1; HRMS (ES+) calcd. for C16H24N2O4Na 
[M+Na]+ 331.1634, found 331.1629. 
 
 
tert-Butyl Butyl{4-(trifluoromethyl)benzyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (66 
mg, 0.199 mmol) was obtained as a colorless oil in 80% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
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1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.58 (d, J = 7.5 Hz, 
2H), 7.39–7.30 (m, 2H), 4.51–4.45 (m, 2H), 3.29–3.12 (m, 2H), 1.58–1.37 (m, 11H), 1.33–
1.25 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 
125.8 MHz, CDCl3)  156.3, 155.6*, 143.3*, 143.0, 129.5 (q, J = 32.2 Hz), 127.8, 127.2*, 
125.5 (q, J = 3.4 Hz), 124.3 (q, J = 271.7 Hz), 80.0, 50.4*, 49.7*, 46.7, 30.4, 28.5, 28.1*, 
20.1, 13.9; IR (neat) 2966, 2360, 1693, 1325, 1163, 1126 cm–1; HRMS (ES+) calcd. for 
C17H24F3NO2Na [M+Na]
+ 354.1657, found 354.1648. 
 
 
tert-Butyl 4-(1H-Pyrrol-1-yl)benzyl(butyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (77 
mg, 0.234 mmol) was obtained as a colorless oil in 94% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.34 (d, J = 8.5 Hz, 
2H), 7.32–7.25 (m, 2H), 7.09–7.05 (m, 2H), 6.36–6.31 (m, 2H), 4.47–4.39 (m, 2H), 3.26–
3.09 (m, 2H), 1.56–1.38 (m, 11H), 1.33–1.24 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H); 13C NMR 
(asterisk denotes minor rotamer peaks, 125.8 MHz, CDCl3)  156.3, 155.7*, 139.9, 136.3, 
128.9, 128.4*, 120.6, 119.4, 110.5, 79.8, 50.1*, 49.4, 46.7*, 46.5, 30.4, 30.3*, 28.6, 20.1, 
14.0; IR (neat) 2961, 2360, 1689, 1522, 1413, 1329, 1169, 1143 cm–1; HRMS (ES+) calcd. 
for C20H28N2O2Na [M+Na]
+ 351.2048, found 351.2037. 
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tert-Butyl Butyl(thiophen-3-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (63 
mg, 0.234 mmol) was obtained as a colorless oil in 94% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.28–7.24 (m, 1H), 
7.11–6.96 (m, 2H), 4.41 (s, 2H), 4.37* (s, 2H), 3.24–3.11 (m, 2H), 1.53–1.40 (m, 11H), 
1.31–1.22 (m, 2H), 0.81 (t, J = 7.0 Hz, 3H); 13C NMR (asterisk denotes minor rotamer 
peaks, 125.8 MHz, CDCl3)  156.0, 155.5*, 139.9, 127.7, 127.3*, 126.0, 122.1, 121.6*, 
79.5, 46.3, 46.0, 45.3*, 30.4, 30.2*, 28.6, 20.1, 14.0; IR (neat) 2961, 2931, 1689, 1169 cm–
1; HRMS (ES+) calcd. for C14H23NO2SNa [M+Na]
+ 292. 1347, found 292.1342. 
 
 
tert-Butyl Butyl(thiophen-2-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (54 
mg, 0.200 mmol) was obtained as a light yellow oil in 80% yield after column 
chromatography (hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.24–7.18 (m, 1H), 
6.95–6.88 (m, 2H), 4.56* (s, 2H), 4.51 (s, 2H), 3.33–3.15 (m, 2H), 1.55–1.43 (m, 11H), 
1.33–1.23 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes minor rotamer 
peaks, 125.8 MHz, CDCl3)  155.8*, 155.2, 141.8, 126.5, 126.0*, 125.8, 125.1, 80.0, 79.7*, 
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46.2, 45.6, 45.0*, 30.5*, 30.2, 28.6, 20.2, 14.0; IR (neat) 2960, 2932, 1693, 1154 cm–1; 
HRMS (ES+) calcd. for C14H23NO2SNa [M+Na]
+ 292.1347, found 292.1341. 
 
 
tert-Butyl Butyl{(5-formylthiophen-2-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (68 
mg, 0.229 mmol) was obtained as a yellow oil in 91% yield after column chromatography 
(hexanes/EtOAc = 6:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  9.85 (s, 1H), 7.64 (d, 
J = 3.5 Hz, 1H), 7.03 (s, 1H), 4.59 (s, 2H), 4.56* (s, 2H), 3.23 (s, 2H), 1.52–1.46 (m, 11H), 
1.34–1.27 (m, 2H), 0.91 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes minor rotamer 
peaks, 125.8 MHz, CDCl3)  182.9, 155.7, 154.8*, 153.5, 143.0, 136.6, 126.6, 80.5*, 80.3, 
47.0, 46.4*, 45.9, 30.6, 30.3*, 28.5, 20.0, 13.9; IR (neat) 2962, 2932, 1673, 1152 cm–1; 
HRMS (ES+) calcd. for C15H23NO3SNa [M+Na]
+ 320.1296, found 320.1287. 
 
 
tert-Butyl {(5-Acetylthiophen-2-yl)methyl}(butyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, 18 h instead of 3 
h, the product (71 mg, 0.228 mmol) was obtained as a light yellow oil in 93% yield after 
column chromatography (hexanes/EtOAc = 10:1). 
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1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.55 (s, 1H), 6.95 (s, 
1H), 4.56 (s, 2H), 4.54* (s, 2H), 3.22 (s, 2H), 2.52 (s, 3H), 1.52–1.44 (m, 11H), 1.32–1.25 
(m, 2H), 0.91 (t, J = 7.0 Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 
MHz, CDCl3)  190.6, 155.7*, 154.9, 151.6, 143.5, 132.5, 132.4*, 126.5, 126.3*, 80.4*, 
80.1, 46.8, 46.2*, 45.7, 30.5, 30.2*, 28.5, 26.6, 19.9, 13.9; IR (neat) 2960, 2931, 1691, 
1662, 1275, 1153 cm–1; HRMS (ES+) calcd. for C16H25NO3SNa [M+Na]
+ 334.1453, found 
334.1458. 
 
 
tert-Butyl Butyl{(5-formylfuran-2-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (64 
mg, 0.227 mmol) was obtained as a yellow oil in 91% yield after column chromatography 
(hexanes/EtOAc = 9:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  9.58 (s, 1H), 7.20 (d, 
J = 3.0 Hz, 1H), 6.46–6.44 (m, 1H), 4.42 (s, 2H), 4.43* (s, 2H), 3.32–3.25 (m, 2H), 1.54–
1.38 (m, 11H), 1.35–1.25 (m, 2H), 0.91 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes 
minor rotamer peaks, 125.8 MHz, CDCl3)  177.4, 159.5, 155.7, 155.1*, 152.3, 127.8, 
110.4, 109.6*, 80.3, 47.5, 44.6*, 43.9, 30.5, 29.8*, 28.5, 20.0, 13.9; IR (neat) 2962, 2932, 
1682, 1165 cm–1; HRMS (ES+) calcd. for C15H23NO4Na [M+Na]
+ 304.1525, found 
304.1524. 
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tert-Butyl Butyl(pyridin-3-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (56 
mg, 0.212 mmol) was obtained as a colorless oil in 85% yield after column chromatography 
(hexanes/EtOAc = 4:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.55–8.50 (m, 2H), 
7.64–7.55 (m, 1H), 7.27 (dd, J = 7.5, 4.5 Hz, 1H), 4.51–4.48 (m, 2H), 3.24–3.10 (m, 2H), 
1.57–1.37 (m, 11H), 1.33–1.22 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk 
denotes minor rotamer peaks, 125.8 MHz, CDCl3)  156.2, 149.1, 148.7, 135.7, 134.9*, 
134.4, 123.6, 80.0, 48.4*, 47.7, 47.0*, 46.6, 30.4, 28.5, 20.1, 13.9; IR (neat) 2961, 2932, 
1690, 1412, 1168, 1144 cm–1; HRMS (ES+) calcd. for C15H25N2O2 [M+H]
+ 265.1916, 
found 265.1909. 
 
 
tert-Butyl Butyl{(6-methoxypyridin-3-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (68 
mg, 0.231 mmol) was obtained as a light yellow oil in 92% yield after column 
chromatography (hexanes/EtOAc = 10:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.02 (d, J = 2.0 Hz, 
1H), 7.52 (s, 1H), 6.71 (d, J = 8.5 Hz, 1H), 4.35 (s, 2H), 3.93 (s, 3H), 3.23–3.09 (m, 2H), 
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1.51–1.45 (m, 11H), 1.32–1.26 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk 
denotes minor rotamer peaks, 125.8 MHz, CDCl3)  163.7, 156.1, 155.4*, 145.9, 138.8, 
138.2*, 127.0, 110.9, 79.7, 53.4, 47.5, 46.9*, 46.1, 30.4, 28.5, 20.1, 13.9; IR (neat) 2960, 
1691, 1493, 1289, 1169 cm–1; HRMS (ES+) calcd. for C16H27N2O3 [M+H]
+ 295.2022, 
found 295. 2020. 
 
 
tert-Butyl Butyl{(6-methoxypyridin-2-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (36 
mg, 0.122 mmol) was obtained  as a colorless oil in 49% yield after column 
chromatography (hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.51 (dd, J = 7.5, 7.5 
Hz, 1H), 6.76 (dd, J = 25.0, 6.0 Hz, 1H), 6.59 (d, J = 8.0 Hz, 1H), 4.45* (s, 2H), 4.38 (s, 
2H), 3.90 (s, 3H), 3.37–3.19 (m, 2H), 1.60–1.22 (m, 13H), 0.91 (t, J = 7.0 Hz, 3H); 13C 
NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, CDCl3)  163.8, 156.8, 156.4*, 
156.2*, 155.8, 139.1*, 138.9, 113.8*, 113.3, 108.6, 79.5, 53.3, 52.4, 51.8*, 47.6, 47.4*, 
30.6*, 30.4, 28.6*, 28.5, 20.3, 20.1*, 14.0; IR (neat) 2958, 2931, 1696, 1467, 1171 cm–1; 
HRMS (ES+) calcd. for C16H27N2O3 [M+H]
+ 295.2022, found 295. 2018. 
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tert-Butyl Butyl(isoquinolin-5-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (77 
mg, 0.245 mmol) was obtained as a light yellow oil in 98% yield after column 
chromatography (hexanes/EtOAc = 4:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  9.29 (s, 1H), 8.57 (d, 
J = 6.0 Hz, 1H), 8.01–7.78 (m, 2H), 7.62–7.54 (m, 2H), 4.90 (s, 2H), 3.29–3.02 (m, 2H), 
1.59–1.32 (m, 11H), 1.31–1.18 (m, 2H), 0.92–0.81 (m, 3H); 13C NMR (asterisk denotes 
minor rotamer peaks, 125.8 MHz, CDCl3)  155.9, 153.2, 143.3, 134.7, 133.5, 130.3, 129.0, 
128.6*, 127.7, 126.9, 117.2, 116.2*, 80.0, 47.6*, 47.2, 46.5*, 45.8, 30.1, 28.5, 20.1, 13.9; 
IR (neat) 2970, 1687, 1170, 1144 cm–1; HRMS (ES+) calcd. for C19H27N2O2 [M+H]
+ 
315.2073, found 315. 2072. 
 
 
tert-Butyl Butyl(quinolin-6-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (78 
mg, 0.248 mmol) was obtained as a light yellow oil in 99% yield after column 
chromatography (hexanes/EtOAc = 3:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.90 (s, 1H), 8.12 (d, 
J = 8.5 Hz, 1H), 8.08 (d, J = 8.5 Hz, 1H), 7.68–7.51 (m, 2H), 7.42–7.31 (m, 1H), 4.66–
157 
 
4.47 (m, 2H), 3.32–3.10 (m, 2H), 1.59–1.34 (m, 11H), 1.34–1.18 (m, 2H), 0.89 (t, J = 7.0 
Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, CDCl3)  156.3, 
155.7*, 150.2, 147.8, 137.2, 135.9, 129.8, 129.6, 129.0*, 128.3, 125.9, 125.2*, 121.4, 79.8, 
50.5*, 49.8, 46.8*, 46.5, 30.3, 28.5, 20.1, 13.9; IR (neat) 2961, 2931, 1690, 1170, 1145 
cm–1; HRMS (ES+) calcd. for C19H27N2O2 [M+H]
+ 315.2073, found 315.2064. 
 
 
tert-Butyl Butyl{(2-methylquinolin-8-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (63 
mg, 0.192 mmol) was obtained as a yellow oil in 77% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.06–8.98 (m, 1H), 
7.69–7.47 (m, 2H), 7.43 (dd, J = 7.5, 7.5 Hz, 1H), 7.29–7.21 (m, 1H), 5.16* (s, 2H), 5.12 
(s, 2H), 3.43–3.26 (m, 2H), 2.73 (s, 3H), 2.71* (s, 3H), 1.64–1.53 (m, 2H), 1.51* (s, 9H), 
1.40 (s, 9H), 1.38–1.25 (m, 2H), 0.90 (t, J = 7.0 Hz, 3H); 13C NMR (asterisk denotes minor 
rotamer peaks, 125.8 MHz, CDCl3)  158.0, 156.4, 146.3*, 146.1, 136.2, 127.6, 126.6, 
126.4, 126.3, 125.6*, 125.3, 121.9, 121.7*, 79.3, 79.2*, 47.2, 46.6, 45.7*, 30.7*, 30.4, 
28.6*, 28.5, 25.6, 20.3, 20.1*, 14.0; IR (neat) 2960, 2931, 1690, 1172, 1143 cm–1; HRMS 
(ES+) calcd. for C20H29N2O2 [M+H]
+ 329. 2229, found 329.2223. 
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tert-Butyl 6-[{(tert-Butoxycarbonyl)(butyl)amino}methyl]-1H-indole-1-carboxylate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (83 
mg, 0.206 mmol) was obtained as a colorless oil in 82% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.05 (s, 1H), 7.56 (s, 
1H), 7.49 (d, J =7.5 Hz, 1H), 7.18–7.04 (m, 1H), 6.53 (s, 1H), 4.58* (s, 2H), 4.54 (s, 2H), 
3.26–3.10 (m, 2H), 1.67 (s, 9H), 1.56–1.38 (m, 11H), 1.31–1.22 (m, 2H), 0.89 (t, J = 7.0 
Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, CDCl3)  156.2, 
155.7*, 149.8, 135.4, 135.1, 129.7, 122.0*, 121.0, 114.6, 114.1*, 107.2, 83.7, 79.4, 50.8*, 
50.1, 46.3*, 45.9, 30.3, 30.0*, 28.6, 28.3, 20.1, 14.0; IR (neat) 2973, 1735, 1693, 1168, 
1145 cm–1; HRMS (ES+) calcd. for C23H34N2O4 Na [M+Na]
+ 425.2416, found 425.2413. 
 
 
tert-Butyl 5-[{(tert-Butoxycarbonyl)(butyl)amino}methyl]-1H-indole-1-carboxylate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (96 
mg, 0.138 mmol) was obtained as a yellow oil in 95% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.12–8.05 (m, 1H), 
7.59–7.54 (m, 1H), 7.44–7.36 (m, 1H), 7.26–7.13 (m, 1H), 6.52 (d, J = 3.5 Hz, 1H), 4.56–
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4.47 (m, 2H), 3.26–3.18 (m, 2H), 1.66 (s, 9H), 1.52–1.44 (m, 11H), 1.29–1.23 (m, 2H), 
0.89 (t, J = 7.0 Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, 
CDCl3)  156.2, 155.8*, 149.8, 134.5, 133.1, 131.0, 126.3, 124.4, 123.7*, 120.2, 119.4*, 
115.2, 107.3, 83.7, 79.5, 50.4*, 49.8, 46.3, 45.9*, 30.2, 28.6, 28.3, 20.1, 14.0; IR (neat) 
2974, 1734, 1691, 1368, 1354, 1163 cm–1; HRMS (ES+) calcd. for C23H35N2O4 [M+H]
+ 
403.2597, found 403.2592. 
 
 
tert-Butyl Isopropyl(4-methoxybenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (58 
mg, 0.208 mmol) was obtained as a colorless oil in 83% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (500 MHz, CDCl3)  7.16 (d, J = 7.5 Hz, 2H), 6.83 (d, J = 8.5 Hz, 2H), 4.37–
4.25 (m, 3H), 3.79 (s, 3H), 1.42 (s, 9H), 1.09 (d, J = 7.0 Hz, 6H); 13C NMR (asterisk denotes 
minor rotamer peaks, 125.8 MHz, CDCl3)  158.4, 155.7, 132.6, 128.0, 113.7, 79.5, 55.3, 
48.5*, 47.2, 45.6, 28.6, 21.0; IR (neat) 2974, 1687, 1245, 1161 cm–1; HRMS (ES+) calcd. 
for C16H25NO3Na [M+Na]
+ 302.1732, found 302.1733. 
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tert-Butyl Cyclohexyl(4-methoxybenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (55 
mg, 0.172 mmol) was obtained as a colorless oil in 69% yield after column chromatography 
(hexanes/EtOAc = 25:1). 
1H NMR (500 MHz, CDCl3)  7.15 (d, J = 7.0 Hz, 2H), 6.83 (d, J = 8.5 Hz, 2H), 4.30 (s, 
2H), 3.99 (s, 1H), 3.79 (s, 3H), 1.78–0.94 (m, 19H); 13C NMR (125.8 MHz, CDCl3)  158.4, 
155.8, 132.7, 127.8, 113.6, 79.5, 57.2, 55.3, 46.1, 31.4, 28.6, 26.2, 25.7; IR (neat) 2932, 
1685, 1244, 1166 cm–1; HRMS (ES+) calcd. for C19H30NO3 [M+H]
+ 320.2226, found 
320.2233. 
 
 
tert-Butyl Cyclopropyl(4-methoxybenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (56 
mg, 0.202 mmol) was obtained as a colorless oil in 81% yield after column chromatography 
(hexanes/EtOAc = 25:1). 
1H NMR (500 MHz, CDCl3)  7.18 (d, J = 8.0 Hz, 2H), 6.85 (d, J = 8.0 Hz, 2H), 4.36 (s, 
2H), 3.79 (s, 3H), 2.40 (s, 1H), 1.46 (s, 9H), 0.71–0.63 (m, 4H); 13C NMR (125.8 MHz, 
CDCl3)  158.8, 156.9, 131.1, 128.9, 113.9, 79.7, 55.3, 50.9, 29.1, 28.6, 8.2.; IR (neat) 
2976, 1694, 1247, 1171 cm–1; HRMS (ES+) calcd. for C16H23NO3Na [M+Na]
+ 300.1576, 
found 300.1585. 
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tert-Butyl Benzyl(4-methoxybenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (74 
mg, 0.226 mmol) was obtained as a colorless oil in 90% yield after column chromatography 
(hexanes/EtOAc = 25:1). 
1H NMR (500 MHz, CDCl3)  7.35–7.06 (m, 7H), 6.85 (d, J = 8.5 Hz, 2H), 4.42–4.21 (m, 
4H), 3.79 (s, 3H), 1.50 (s, 9H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 
MHz, CDCl3)  159.0, 156.1, 138.3, 130.1, 129.5, 128.9*, 128.6, 128.1*, 127.5, 127.3, 
114.0, 80.1, 55.3, 49.1, 48.7, 48.5*, 28.6; IR (neat) 2974, 1690, 1245, 1163 cm–1; HRMS 
(ES+) calcd. for C20H25NO3Na [M+Na]
+ 350.1732, found 350.1724. 
 
 
tert-Butyl 2-Methoxybenzyl(4-methoxybenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (65 
mg, 0.182 mmol) was obtained as a colorless oil in 73% yield after column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.26–7.10 (m, 4H), 
6.93 (dd, J = 7.5, 7.5 Hz, 1H), 6.88–6.82 (m, 3H), 4.48–4.30 (m, 4H), 3.79 (s, 3H), 3.77 (s, 
3H), 1.48* (s, 9H), 1.46 (s, 9H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 
MHz, CDCl3)  158.8, 157.6*, 157.3, 156.4, 156.0*, 130.8*, 130.7, 129.3, 128.9*, 128.8, 
162 
 
128.2, 126.4, 120.6*, 120.5, 113.8, 110.2, 79.8, 55.3, 55.2, 49.5*, 49.0, 44.4, 44.1*, 29.8*, 
28.6; IR (neat) 2931, 1690, 1239, 1161 cm–1; HRMS (ES+) calcd. for C21H27NO4Na 
[M+Na]+ 300.1838, found 380.1826. 
 
 
tert-Butyl (3,3-Diethoxypropyl)(4-methoxybenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (78 
mg, 0.212 mmol) was obtained as a colorless oil in 85% yield after column chromatography 
(hexanes/EtOAc = 10:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.17 (s, 2H), 6.85 (d, 
J = 8.5 Hz, 2H), 4.51–4.41 (m, 1H), 4.41–4.32 (m, 2H), 3.79 (s, 3H), 3.65–3.58 (m, 2H), 
3.50–3.41 (m, 2H), 3.25* (s, 2H), 3.17 (s, 2H), 1.85–1.79 (m, 2H), 1.48 (s, 9H), 1.18 (t, J 
= 7.0 Hz, 6H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, CDCl3)  
158.9, 156.0, 155.6*, 130.7, 129.2, 128.7*, 113.9, 101.0, 79.6, 61.0, 55.3, 50.3*, 49.7, 42.5, 
32.4, 32.1*, 28.5, 15.4; IR (neat) 2975, 1691, 1247, 1169 cm–1; HRMS (ES+) calcd. for 
C20H33NO5Na [M+Na]
+ 390.2256, found 390.2261. 
 
General Procedure for the Suzuki–Miyaura Cross-coupling Reaction of Boc-
Protected Primary Aminomethyltrifluoroborate with Aryl and Hetaryl Mesylates. 
A sealed tube was charged with potassium tert-butoxycarbonyl 
aminomethyltrifluoroborate (65 mg, 0.275 mmol, 1.1 equiv), an aryl or hetaryl mesylates 
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(0.250 mmol, 1.0 equiv), PdCl2(cod) (4 mg, 0.013 mmol, 0.05 equiv), RuPhos or SPhos 
ligand (0.025 mmol, 0.1 equiv) and K3PO4 (371 mg, 1.750 mmol, 7.0 equiv).  The mixture 
was then was purged three times with argon. t-BuOH / H2O (1:1, 0.6 mL/0.6 mL) was then 
added to the reaction tube. The reaction mixture was stirred for 22 h at 95 °C and then 
cooled to rt. H2O (2 mL) was added, and the resulting mixture was extracted with EtOAc 
(2  3 mL). The organic layer was combined, dried (MgSO4) and filtered. The solvent was 
removed in vacuo and the product was purified by column chromatography. 
 
 
tert-Butyl (Naphthalen-1-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 6:1). 
RuPhos: 79% yield (51 mg, 0.198 mmol). 
mp: 97–98 °C (lit.: 99–100 °C); 1H NMR (500 MHz, CDCl3)  8.05 (d, J = 8.0 Hz, 1H), 
7.87 (d, J = 8.0 Hz, 1H), 7.79 (d, J = 7.5 Hz, 1H), 7.57–7.46 (m, 2H), 7.45–7.38 (m, 2H), 
4.83 (br, 1H), 4.77 (d, J = 4.5 Hz, 2H), 1.47 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  
155.9, 134.4, 134.1, 131.6, 129.0, 128.6, 126.7, 126.4, 126.1, 125.6, 123.7, 79.7, 43.0, 28.7.  
Data is consistent with that reported in the literature.37 
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tert-Butyl Benzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 7:1). 
RuPhos: 66% yield (34 mg, 0.164 mmol). 
mp: 54–56 °C (lit.: 57 °C); 1H NMR (500 MHz, CDCl3)  7.35–7.23 (m, 5H), 4.89 (br, 
1H), 4.31 (d, J = 5.5 Hz, 2H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  156.0, 139.0, 
128.7, 127.6, 127.4, 79.5, 44.8, 28.5.  
Data is consistent with that reported in the literature.29 
 
 
tert-Butyl 4-Methylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 7:1). 
RuPhos: 72% yield (40 mg, 0.181 mmol). 
mp: 72–74 °C (lit.: 72.5–73 °C); 1H NMR (500 MHz, CDCl3)  7.17 (d, J = 8.0 Hz, 2H), 
7.13 (d, J = 8.0 Hz, 2H), 4.81 (br, 1H), 4.27 (d, J = 5.0 Hz, 2H), 2.33 (s, 3H), 1.46 (s, 9H); 
13C NMR (125.8 MHz, CDCl3)  156.0, 137.1, 136.0, 129.4, 127.6, 79.5, 44.6, 28.5, 21.2.  
Data is consistent with that reported in the literature.33 
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tert-Butyl 2-Methylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 7:1). 
RuPhos: 72% yield (40 mg, 0.181 mmol). 
mp: 51–53 °C (lit.: 50–51 °C); 1H NMR (500 MHz, CDCl3)  7.6–7.13 (m, 4H), 4.72 (br, 
1H), 4.31 (d, J = 5.0 Hz, 2H), 2.32 (s, 3H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  
155.8, 136.6, 136.3, 130.5, 128.1, 127.6, 126.2, 79.5, 42.8, 28.5, 19.0.  
Data is consistent with that reported in the literature.30 
 
 
tert-Butyl 2,6-Dimethylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 10:1). 
RuPhos: 22% yield (13 mg, 0.055 mmol). 
mp: 73–75 °C (lit.: 73–74 °C); 1H NMR (500 MHz, CDCl3)  7.09 (dd, J = 8.0, 6.5 Hz, 
1H), 7.03 (d, J = 7.5 Hz, 2H), 4.42–4.33 (m, 3H), 2.37 (s, 6H), 1.45 (s, 9H); 13C NMR 
(125.8 MHz, CDCl3)  155.8, 137.5, 134.5, 128.5, 127.9, 79.5, 39.2, 28.6, 19.8.  
Data is consistent with that reported in the literature.38 
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tert-Butyl {(1,1'-Biphenyl)-4-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 7:1). 
RuPhos: 86% yield (61 mg, 0.215 mmol). 
mp: 102–105 °C (lit.: 101–103 °C); 1H NMR (500 MHz, CDCl3)  7.58–7.53 (m, 4H), 
7.45–7.40 (m, 2H), 7.36–7.30 (m,  3H), 4.92 (br, 1H), 4.35 (d, J = 5.5 Hz, 2H), 1.47 (s, 
9H); 13C NMR (125.8 MHz, CDCl3)  156.1, 140.9, 140.4, 138.1, 128.9, 128.0, 127.5, 
127.4, 127.2, 79.6, 44.5, 28.5. 
 Data is consistent with that reported in the literature.37 
 
 
tert-Butyl 4-Methoxybenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a colorless oil after flash chromatography (hexanes/EtOAc = 5:1). 
RuPhos: 59% yield (35 mg, 0.147 mmol). 
1H NMR (500 MHz, CDCl3)  7.20 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.5 Hz, 2H), 4.81 (br, 
1H), 4.24 (d, J = 5.5 Hz, 2H), 3.79 (s, 3H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  
159.0, 156.0, 131.2, 129.0, 114.1, 79.5, 55.4, 44.3, 28.5.  
Data is consistent with that reported in the literature.31 
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tert-Butyl {(4-Methoxynaphthalen-1-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a light brown solid after flash chromatography (hexanes/EtOAc = 7:1). 
RuPhos: 84% yield (60 mg, 0.209 mmol). 
mp: 85–88 °C; 1H NMR (500 MHz, CDCl3)  8.30 (d, J = 8.5 Hz, 1H), 7.97 (d, J = 8.5 Hz, 
1H), 7.55 (dd, J = 7.0, 7.0 Hz, 1H),  7.49 (dd, J = 7.0, 7.0 Hz, 1H), 7.31 (d, J = 8.0 Hz, 1H), 
6.71 (d, J = 8.0 Hz, 1H), 4.78 (br, 1H), 4.67 (d, J = 5.0 Hz, 2H), 3.97 (s, 3H), 1.46 (s, 9H); 
13C NMR (125.8 MHz, CDCl3)  155.8, 155.6, 132.4, 127.1, 126.8, 126.2, 126.1, 125.3, 
123.5, 122.8, 103.1, 79.5, 55.6, 42.8, 28.5; IR (neat) 3370, 1678, 1493, 1479, 1243, 1166 
cm-1; HRMS (ES+) calcd. for C17H21NO3Na [M+Na]
+ 310.1419, found 310.1422. 
 
 
tert-Butyl 4-Cyanobenzylcarbamate.  
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 4:1). 
SPhos: 72% yield (42 mg, 0.181 mmol). 
mp: 108–110 °C (lit.: 111–113 °C); 1H NMR (500 MHz, CDCl3)  7.61 (d, J = 8.0 Hz, 2H), 
7.39 (d, J = 8.5 Hz, 2H), 5.05 (br, 1H), 4.37 (d, J = 5.5 Hz, 2H), 1.46 (s, 9H); 13C NMR 
(125.8 MHz, CDCl3)  156.0, 144.8, 132.5, 127.9, 118.9, 111.2, 80.1, 44.3, 28.5.  
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Data is consistent with that reported in the literature.32 
 
 
tert-Butyl 4-Formylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 3:1). 
RuPhos: 46% yield (27 mg, 0.115 mmol). 
mp: 80–82 °C (lit.: 82–88 °C);1H NMR (500 MHz, CDCl3)  9.99 (s, 1H), 7.84 (d, J = 8.0 
Hz, 2H), 7.44 (d, J = 8.0 Hz, 2H), 5.04 (br, 1H), 4.40 (d, J = 5.5 Hz, 2H), 1.47 (s, 9H); 13C 
NMR (125.8 MHz, CDCl3)  192.0, 156.0, 146.3, 135.7, 130.2, 127.8, 80.0, 44.5, 28.5.  
Data is consistent with that reported in the literature.34 
 
 
Methyl 4-[{(tert-Butoxycarbonyl)amino}methyl]benzoate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 4:1). 
SPhos: 42% yield (28 mg, 0.106 mmol). 
mp: 88–90 °C; 1H NMR (500 MHz, CDCl3)  8.00 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 8.5 Hz, 
2H), 4.97 (br, 1H), 4.37 (d, J = 5.5 Hz, 2H), 3.91 (s, 3H), 1.47 (s, 9H); 13C NMR (125.8 
MHz, CDCl3)  167.0, 156.0, 144.4, 130.0, 129.3, 127.3, 79.9, 52.2, 44.5, 28.5; IR (neat) 
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3314, 2925, 1723, 1682, 1535, 1275, 1258, 1164 cm-1; HRMS (ES+) calcd. for 
C14H19NO4Na [M+Na]
+ 288.1212, found 288.1220. 
  
 
tert-Butyl 4-(Trifluoromethyl)benzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 6:1). 
RuPhos: 83% yield (57 mg, 0.207 mmol). 
mp: 72–74 °C (lit.: 70–71 °C);1H NMR (500 MHz, CDCl3)  7.58 (d, J = 8.0 Hz, 2H), 7.39 
(d, J = 8.0 Hz, 2H), 5.00 (br, 1H), 4.36 (d, J = 5.5 Hz, 2H), 1.46 (s, 9H); 13C NMR (125.8 
MHz, CDCl3)  156.0, 143.3, 129.7 (q, J = 32.4 Hz), 127.6, 125.7 (q, J = 3.8 Hz), 124.3 
(q, J = 270.0 Hz), 80.0, 44.3, 28.5.    
Data is consistent with that reported in the literature.39 
 
 
tert-Butyl 3-Acetylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a colorless oil after flash chromatography (hexanes/EtOAc = 3:1). 
RuPhos: 82% yield (51 mg, 0.205 mmol). 
170 
 
1H NMR (500 MHz, CDCl3)  7.87 (s, 1H), 7.85 (d, J = 7.5 Hz, 1H), 7.50 (d, J = 7.5 Hz, 
1H), 7.43 (dd, J = 7.5, 7.5 Hz, 1H), 5.04 (br, 1H), 4.37 (d, J = 6.0 Hz, 2H), 2.60 (s, 3H), 
1.47 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  198.2, 156.1, 139.8, 137.5, 132.2, 129.0, 
127.4, 127.1, 79.8, 44.4, 28.5, 26.8; IR (neat) 3347, 1682, 1367, 1270, 1251, 1164 cm-1; 
HRMS (ES+) calcd. for C14H19NO3Na [M+Na]
+ 272.1263, found 272.1255. 
 
 
tert-Butyl 4-Acetylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 3:1). 
SPhos: 80% yield (50 mg, 0.201 mmol). 
mp: 68–72 °C (lit.: 67–69 °C); 1H NMR (500 MHz, CDCl3)  7.91 (d, J = 8.5 Hz, 2H), 
7.37 (d, J = 8.0 Hz, 2H),  5.10 (br, 1H), 4.37 (d, J = 5.5 Hz, 2H), 2.59 (s, 3H), 1.46 (s, 9H); 
13C NMR (125.8 MHz, CDCl3)  197.9, 156.0, 144.7, 136.2, 128.8, 127.4, 79.9, 44.4, 28.5, 
26.7.  
Data is consistent with that reported in the literature.38 
 
 
tert-Butyl 4-Acetyl-3-methylbenzylcarbamate. 
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According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a colorless oil after flash chromatography (hexanes/EtOAc = 4:1). 
RuPhos: 81% yield (53 mg, 0.201 mmol). 
1H NMR (500 MHz, CDCl3)  7.67 (d, J = 8.0 Hz, 1H), 7.17 (d, J = 8.0 Hz, 1H), 7.14 (s, 
1H), 5.04 (br, 1H), 4.31 (d, J = 6.0 Hz, 2H), 2.56 (s, 3H), 2.52 (s, 3H), 1.46 (s, 9H); 13C 
NMR (125.8 MHz, CDCl3)  201.3, 156.0, 142.8, 139.2, 136.5, 131.0, 130.1, 124.5, 79.8, 
44.3, 29.6, 28.5, 21.8; IR (neat) 3351, 1680, 1251, 1166 cm-1; HRMS (ES+) calcd. for 
C15H21NO3Na [M+Na]
+ 286.1419, found 286.1418. 
 
 
tert-Butyl 4-Benzoylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 5:1). 
RuPhos: 86% yield (67 mg, 0.215 mmol). 
mp: 124–127 °C (lit.: 127–130 °C); °C; 1H NMR (500 MHz, CDCl3)  7.80–7.74 (m, 4H), 
7.60–7.55 (m, 1H), 7.50–7.44 (m, 2H), 7.39 (d, J = 8.0 Hz, 2H), 5.07 (br, 1H), 4.40 (d, J = 
5.5 Hz, 2H), 1.47 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  196.4, 156.1, 144.0, 137.8, 
136.7, 132.5, 130.6, 130.1, 128.4, 127.2, 79.9, 44.4, 28.5.  
Data is consistent with that reported in the literature.40 
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tert-Butyl (Pyridin-3-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a colorless oil after flash chromatography (hexanes/EtOAc = 1:1). 
SPhos: 52% yield (27 mg, 0.130 mmol). 
1H NMR (500 MHz, CDCl3)  8.56–8.47 (m, 2H), 7.64 (d, J = 7.5 Hz, 1H), 7.30–7.24 (m, 
1H), 5.04 (br, 1H), 4.34 (d, J = 5.0 Hz, 2H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3) 
 156.0, 149.1, 148.9, 135.4, 134.7, 123.6, 80.0, 42.3, 28.5.  
Data is consistent with that reported in the literature.41 
 
 
tert-Butyl ((6-Fluoro-5-methylpyridin-3-yl)methyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 3:1). 
RuPhos: 78% yield (47 mg, 0.196 mmol). 
mp: 37–39 °C; 1H NMR (500 MHz, CDCl3)  7.92 (s, 1H), 7.55 (d, J = 9.5 Hz, 1H), 5.00 
(br, 1H), 4.27 (d, J = 5.0 Hz, 2H), 2.27 (s, 3H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3) 
 161.8 (d, J = 238.0 Hz), 156.0, 143.6 (d, J = 14.6 Hz), 141.3, 132.6 (d, J = 4.5 Hz), 119.7 
(d, J = 32.7 Hz), 80.0, 41.4, 28.4, 14.5; IR (neat) 3359, 1676, 1512, 1249, 1164, 1144 cm-
1; HRMS (ES+) calcd. for C12H18N2O2F [M+H]
+ 241.1352, found 241.1355. 
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tert-Butyl (Quinolin-6-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 1:1). 
SPhos 84% yield (54 mg, 0.209 mmol). 
mp: 75–78 °C (lit.: 75–77 °C);1H NMR (500 MHz, CDCl3)  8.87 (d, J = 3.0 Hz, 1H), 8.10 
(d, J = 8.0 Hz, 1H), 8.05 (d, J = 8.5 Hz, 1H), 7.68 (s, 1H), 7.63 (d, J = 8.5 Hz, 1H), 7.37 
(dd, J = 8.5, 4.5 Hz, 1H), 5.25  (br, 1H), 4.49 (d, J = 5.5 Hz, 2H), 1.48 (s, 9H); 13C NMR 
(125.8 MHz, CDCl3)  156.1, 150.3, 147.8, 137.5, 136.0, 129.9, 129.3, 128.2, 125.7, 121.4, 
79.8, 44.6, 28.5.  
Data is consistent with that reported in the literature.38 
 
 
tert-Butyl (Quinolin-8-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a colorless oil after flash chromatography (hexanes/EtOAc = 3:1). 
RuPhos: 87% yield (56 mg, 0.217 mmol). 
1H NMR (500 MHz, CDCl3)  8.89 (dd, J = 4.5, 2.0 Hz, 1H), 8.13 (dd, J = 8.5, 2.0 Hz, 
1H), 7.73–7.65 (m, 2H), 7.47 (dd, J = 8.0, 8.0 Hz, 1H), 7.39 (dd, J = 8.0, 4.0 Hz, 1H), 5.85 
(br, 1H), 4.87 (d, J = 6.0 Hz, 2H), 1.43 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  156.1, 
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149.7, 146.9, 137.0, 136.5, 129.0, 128.5, 127.5, 126.5, 121.2, 79.1, 42.3, 28.6; IR (neat) 
3343, 1706, 1498, 1164 cm-1; HRMS (ES+) calcd. for C15H18N2O2Na [M+Na]
+ 281.1266, 
found 281.1262. 
 
 
tert-Butyl (Isoquinolin-5-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 1:1). 
SPhos: 57% yield (37 mg, 0.143 mmol). 
mp: 156–160 °C; 1H NMR (500 MHz, CDCl3)  9.31 (s, 1H), 8.59 (d, J = 6.0 Hz, 1H), 
7.94 (d, J = 8.5 Hz, 1H), 7.88 (d, J = 5.5 Hz, 1H), 7.68 (d, J = 7.0 Hz, 1H), 7.58 (dd, J = 
7.5, 7.5 Hz, 1H), 4.89 (br, 1H), 4.76 (d, J = 5.5 Hz, 2H), 1.47 (s, 9H); 13C NMR (125.8 
MHz, CDCl3)  155.8, 153.1, 143.5, 134.2, 133.9, 130.0, 129.0, 127.8, 127.0, 116.6, 79.9, 
42.0, 28.5; IR (neat) 3351, 1680, 1529, 1383, 1251, 1164 cm-1; HRMS (ES+) calcd. for 
C15H19N2O2 [M+H]
+ 259.1447, found 259.1454. 
 
 
tert-Butyl{(1H-Indol-5-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a light yellow solid after flash chromatography (hexanes/EtOAc = 3:1). 
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SPhos: 75% yield (46 mg, 0.187 mmol). 
mp: 86–89 °C (lit.: 86–89 °C); 1H NMR (500 MHz, CDCl3)  8.37 (br, 1H), 7.53 (s, 1H), 
7.32 (d, J = 8.5 Hz, 1H), 7.18 (dd, J = 3.0, 3.0 Hz, 1H), 7.11 (d, J = 8.0 Hz, 1H), 6.56–6.43 
(m, 1H), 4.85 (br, 1H), 4.39 (d, J = 5.5 Hz, 2H), 1.47 (s, 9H); 13C NMR (125.8 MHz, CDCl3) 
 156.1, 135.3, 130.2, 128.1, 124.9, 122.2, 119.9, 111.4, 102.5, 79.4, 45.4, 28.6.  
Data is consistent with that reported in the literature.38 
 
 
tert-Butyl {(2-Methylbenzo[d]thiazol-5-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 3:1). 
SPhos: 91% yield (63 mg, 0.226 mmol). 
mp: 93–95 °C; 1H NMR (500 MHz, CDCl3)  7.83 (s, 1H), 7.75 (d, J = 8.5 Hz, 1H), 7.28 
(d, J = 9.5 Hz, 1H), 5.03 (br, 1H), 4.44 (d, J = 5.5 Hz, 2H), 2.82 (s, 3H), 1.47 (s, 9H); 13C 
NMR (125.8 MHz, CDCl3)  167.7, 156.0, 153.8, 137.5, 134.6, 124.5, 121.6, 121.0, 79.7, 
44.6, 28.5, 20.3; IR (neat) 3367, 1680, 1521, 1253, 1177 cm-1; HRMS (ES+) calcd. for 
C14H18N2O2SNa [M+Na]
+ 301.0987, found 301.0981. 
 
 
tert-Butyl (Dibenzo[b,d]thiophen-4-ylmethyl)carbamate. 
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According to the general procedure for Suzuki–Miyaura cross-coupling, the product was 
obtained as a white solid after flash chromatography (hexanes/EtOAc = 7:1). 
SPhos: 91% yield (71 mg, 0.227 mmol). 
mp: 150–151 °C; 1H NMR (500 MHz, CDCl3)  8.15–8.09 (m, 1H), 8.04 (d, J = 7.5 Hz, 
1H), 7.87–7.82 (m, 1H), 7.47–7.35 (m, 4H), 5.03 (br, 1H), 4.58 (d, J = 5.0 Hz, 2H), 1.48 
(s, 9H); 13C NMR (125.8 MHz, CDCl3)  156.0, 139.3, 138.2, 136.2, 135.8, 133.0, 126.9, 
125.6, 124.9, 124.6, 122.9, 121.8, 120.8, 79.8, 44.0, 28.6; IR (neat) 3355, 1678, 1521, 1282, 
1168 cm-1; HRMS (ES+) calcd. for C18H19NO2SNa [M+Na]
+ 336.1034, found 336.1020. 
 
General Procedure A for the Synthesis of Sulfamates. 
 
4-Cyano-2-methoxyphenyl Dimethylsulfamate. 
A round bottomed flask was charged with 4-hydroxy-3-methoxybenzonitrile (300 mg, 1.0 
equiv) and DMAP (12 mg, 0.10 mmol, 0.05 equiv) in CH2Cl2 (7 mL). Et3N (244 mg, 2.41 
mmol, 1.2 equiv) was slowly added to reaction flask at rt and the reaction mixture was 
stirred for 10 min. Dimethylsulfamoyl chloride (342 mg, 2.41 mmol, 1.2 equiv) was slowly 
added to reaction flask at rt, then the reaction was stirred at rt for 16 h. The reaction mixture 
was extracted with CH2Cl2 (10 mL) and H2O (8 mL). The organic layer was washed with 
1 M KOH (5 mL), then washed with H2O (10 mL). The combined aqueous layers were 
extracted with CH2Cl2 (10 mL). All organic layers were combined, washed with brine (5 
mL), and dried (MgSO4). The crude mixture was concentrated under vacuo and purified 
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by column chromatography (hexanes/EtOAc = 3:1) to afford the product (494 mg, 2.01 
mmol) as a white solid in quantitative yield. 
mp: 64–66 °C; 1H NMR (500 MHz, CDCl3)  7.46 (d, J = 8.5 Hz, 1H), 7.29 (dd, J = 8.5, 
2.0 Hz, 1H), 7.23 (d, J = 2.0 Hz, 1H), 3.93 (s, 3H), 3.01 (s, 6H); 13C NMR (125.8 MHz, 
CDCl3)  152.1, 142.9, 125.5, 124.4, 118.1, 116.1, 111.1, 56.5, 38.8; IR (neat) 2231, 1380, 
1169, 838, 759 cm-1; HRMS (ES+) calcd. for C10H13N2O4S [M+H]
+ 257.0596, found 
257.0593. 
 
General Procedure B for the Synthesis of Sulfamates. 
 
4-Fluorophenyl Dimethylsulfamate. 
A round bottomed flask was charged with NaH (60% in mineral oil, 107 mg, 1.2 equiv) 
and the flask was cooled to 0 °C. 4-fluorophenol (250 mg, 2.23 mmol, 1 equiv) in DME (7 
mL) was slowly added to reaction flask at 0 °C. The reaction mixture was warmed to rt for 
10 min, then cooled to 0 °C again. Dimethylsulfamoyl chloride (320 mg, 2.23 mmol, 1 
equiv) was slowly added to reaction flask at 0 °C and stirred at rt for 16 h. The reaction 
was quenched by addition of H2O (5 mL). The crude mixture was extracted with Et2O (15 
mL). The organic layer was washed with 1 M KOH (5 mL), then washed with H2O (10 
mL). The combined aqueous layers were extracted with Et2O (10 mL). All organic layers 
were combined, washed with brine (5 mL), and dried (MgSO4). The crude mixture was 
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concentrated under vacuo and purified by column chromatography (hexanes/EtOAc = 4:1) 
to afford the product (485 mg, 2.21 mmol) as a white solid in 99% yield. 
mp: 52–55 °C; 1H NMR (500 MHz, CDCl3)  7.26 (dd, J = 8.5, 4.0 Hz, 2H), 7.07 (dd, J = 
8.5, 8.5 Hz, 2H), 2.98 (s, 6H); 13C NMR (125.8 MHz, CDCl3)  160.9 (d, J = 246.1 Hz), 
146.1 (d, J =2.6 Hz), 125.1 (d, J = 8.4 Hz), 116.6 (d, J = 23.6 Hz), 38.9; IR (neat) 2923, 
1498, 1360, 1185, 844, 797 cm-1; HRMS (CI+) calcd. for C8H11NO3SF [M+H]
+ 220.0444, 
found 220.0439. 
 
 
4-Acetylphenyl Dimethylsulfamate. 
According to the general procedure B for the synthesis of sulfamates, the product was 
obtained as a white solid in 70% isolated yield after column chromatography 
(hexanes/EtOAc = 3:1). 
mp: 65–67 °C; 1H NMR (500 MHz, CDCl3)  8.01 (d, J = 9.0 Hz, 2H), 7.37 (d, J = 8.5 Hz, 
2H), 3.01 (s, 6H), 2.61 (s, 3H); 13C NMR (125.8 MHz, CDCl3)  196.8, 154.0, 135.4, 130.4, 
121.7, 38.9, 26.8; IR (neat) 1690, 1361, 1171, 848, 763 cm-1; HRMS (ES+) calcd. for 
C10H14NO4S [M+H]
+ 244.0644, found 244.0644. 
 
 
4-Nitrophenyl Dimethylsulfamate. 
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According to the general procedure A for the synthesis of sulfamates, the product was 
obtained as a white solid in 90% isolated yield after column chromatography 
(hexanes/EtOAc = 4:1). 
mp: 120–123 °C; 1H NMR (500 MHz, CDCl3)  8.29 (d, J = 9.5 Hz, 2H), 7.45 (d, J = 9.5 
Hz, 2H), 3.05 (s, 6H); 13C NMR (125.8 MHz, CDCl3)  155.0, 145.8, 125.7, 122.2, 38.9; 
IR (neat) 2980, 1521, 1361, 1172, 1146, 862, 748 cm-1; HRMS (CI+) calcd. for 
C8H11N2O5S [M+H]
+ 247.0389, found 247.0388. 
 
 
4-Chlorophenyl Dimethylsulfamate. 
According to the general procedure B for the synthesis of sulfamates, the product was 
obtained as a light yellow oil in quantitative yield after column chromatography 
(hexanes/EtOAc = 7:1). 
1H NMR (500 MHz, CDCl3)  7.36 (d, J = 9.0 Hz, 2H), 7.23 (d, J = 9.0 Hz, 2H), 2.98 (s, 
6H); 13C NMR (125.8 MHz, CDCl3)  148.8, 132.4, 130.0, 123.3, 38.9; IR (neat) 1484, 
1371, 1171, 856, 754 cm-1; HRMS (ES+) calcd. for C8H11NO3SCl [M+H]
+ 236.0148, 
found 236.0149. 
 
 
1H-Indol-5-yl Dimethylsulfamate. 
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According to the general procedure B for the synthesis of sulfamates, the product was 
obtained as a white solid in 80% isolated yield after column chromatography 
(hexanes/EtOAc = 3:1). 
mp: 77–80 °C; 1H NMR (500 MHz, CDCl3)  8.28 (br, 1H), 7.54 (s, 1H), 7.33 (d, J =8.5 
Hz, 1H), 7.26–7.23 (m, 1H), 7.13–7.06 (m, 1H), 6.54 (s, 1H), 2.96 (s, 6H); 13C NMR (125.8 
MHz, CDCl3)  144.1, 134.3, 128.3, 126.1, 116.4, 113.5, 111.8, 103.3, 38.9; IR (neat) 3384, 
1350, 1169, 843 cm-1; HRMS (ES-) calcd. for C10H11N2O3S [M-H]
- 239.0490, found 239. 
0503. 
 
 
2-Methylbenzo[d]thiazol-5-yl Dimethylsulfamate. 
According to the general procedure B for the synthesis of sulfamates, stirred for 18 h at 
70 °C instead of rt, the product was obtained as a white solid in 89% isolated yield after 
column chromatography (hexanes/EtOAc = 3:1 to 2:1). 
mp: 95–97 °C; 1H NMR (500 MHz, CDCl3)  7.84 (d, J = 2.5 Hz, 1H), 7.81 (d, J = 8.5 Hz, 
1H), 7.34 (dd, J = 9.0, 2.5 Hz, 1H), 3.00 (s, 6H), 2.85 (s, 3H); 13C NMR (125.8 MHz, 
CDCl3)  169.6, 154.2, 148.9, 134.1, 122.2, 119.3, 115.7, 38.9, 20.4; IR (neat) 1365, 1176, 
815, 750 cm-1; HRMS (CI+) calcd. for C10H13N2O3S2 [M+H]
+ 273.0368, found 273.0361. 
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1H-Indazol-5-yl Dimethylsulfamate. 
According to the general procedure B for the synthesis of sulfamates, stirred for 18 h at 
70 °C instead of rt, the product was obtained as a white solid in 32% isolated yield after 
column chromatography (hexanes/EtOAc = 1:1). 
mp: 143–145 °C; 1H NMR (500 MHz, CDCl3)  10.11 (br, 1H), 8.10 (s, 1H), 7.65 (d, J = 
2.0 Hz, 1H), 7.51 (d, J = 9.0 Hz, 1H), 7.35 (dd, J = 9.0 2.5 Hz, 1H), 3.01 (s, 6H); 13C NMR 
(125.8 MHz, CD2Cl2)  144.7, 138.8, 135.2, 123.5, 122.1, 113.6, 111.2, 39.0; IR (neat) 
3152, 1502, 1360, 1170, 838 cm-1; HRMS (ES+) calcd. for C9H12N3O3S [M+H]
+ 242.0599, 
found 242.0591. 
 
General Procedure for the Suzuki–Miyaura Cross-coupling Reaction of Boc-
Protected Primary Aminomethyltrifluoroborate with Aryl and Hetaryl Sulfamates. 
A microwave vial was charged with potassium tert-butoxycarbonyl 
aminomethyltrifluoroborate (62 mg, 0.263 mmol, 1.05 equiv), aryl or hetaryl sulfamates 
(0.250 mmol, 1.0 equiv), XPhos-Pd-G2 (8 mg, 0.010 mmol, 0.04 equiv), and K2CO3 (3.0, 
5.0, or 7.0 equiv).  The vial was capped, and then the mixture was degassed under vacuum 
and purged with argon. This procedure was repeated three times. t-BuOH / H2O (0.5 M, 
1:1, 0.25 mL/0.25 mL) was then added to the reaction vial. The reaction mixture was stirred 
for 3 h at 85 °C and then cooled to rt. H2O (2 mL) was added, and the resulting mixture 
was extracted with EtOAc (2  3 mL). The organic layer was combined, dried (MgSO4) 
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and filtered. The solvent was removed in vacuo and the product was purified by column 
chromatography. 
 
 
tert-Butyl (Naphthalen-1-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (60 
mg, 0.233 mmol) was obtained as a white solid in 93% isolated yield after column 
chromatography (hexanes/EtOAc = 7:1). 
mp: 95–98 °C (lit.: 99–100 °C); 1H NMR (500 MHz, CDCl3)  8.04 (d, J = 8.0 Hz, 1H), 
7.86 (d, J = 8.0 Hz, 1H), 7.80–7.75 (m, 1H), 7.56–7.46 (m, 2H), 7.44–7.37 (m, 2H), 4.85 
(br, 1H), 4.76 (d, J = 5.0 Hz, 2H), 1.47 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  155.8, 
134.3, 134.0, 131.5, 128.9, 128.9, 126.6, 126.2, 126.0, 125.5, 123.6, 79.6, 42.9, 28.5.  
Data is consistent with that reported in the literature.37 
 
 
 
tert-Butyl Benzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (44 
mg, 0.212 mmol) was obtained as a white solid in 85% isolated yield after column 
chromatography (CH2Cl2/hexanes = 9:1). 
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mp: 54–56 °C (lit.: 57 °C); 1H NMR (500 MHz, CDCl3)  7.36–7.23 (m, 5H), 4.86 (br, 
1H), 4.31 (d, J = 4.0 Hz, 2H), 1.46 (s, 9H); 13C NMR (125.8 MHz, CDCl3)  156.0, 139.1, 
128.7, 127.6, 127.4, 79.6, 44.8, 28.5.  
Data is consistent with that reported in the literature.29 
 
 
tert-Butyl 4-Cyanobenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (51 
mg, 0.220 mmol) was obtained as a white solid in 88% isolated yield after column 
chromatography (hexanes/EtOAc = 4:1). 
mp: 106–109 °C (lit.: 111–113 °C); 1H NMR (500 MHz, CDCl3)  7.62 (d, J = 8.0 Hz, 2H), 
7.39 (d, J = 8.0 Hz, 2H), 5.04 (br, 1H), 4.37 (d, J = 5.5 Hz, 2H), 1.46 (s, 9H); 13C NMR 
(125.8 MHz, CDCl3)  156.0, 144.8, 132.5, 127.9, 118.9, 111.2, 80.1, 44.3, 28.5.  
Data is consistent with that reported in the literature.32 
 
 
tert-Butyl (4-Cyano-2-methoxybenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (59 
mg, 0.225 mmol) was obtained as a white solid in 90% isolated yield after column 
chromatography (hexanes/EtOAc = 4:1). 
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mp: 100–102 °C; 1H NMR (500 MHz, CDCl3)  7.36 (d, J = 7.0 Hz, 1H), 7.24 (d, J = 7.5 
Hz, 1H), 7.07 (s, 1H), 5.08 (br, 1H), 4.32 (d, J = 5.5 Hz, 2H), 3.88 (s, 3H), 1.44 (s, 9H); 
13C NMR (125.8 MHz, CDCl3)  157.4, 155.9, 133.2, 129.3, 125.0, 118.9, 113.1, 111.9, 
79.8, 55.8, 40.0, 28.5; IR (neat) 3363, 3323, 2982, 2227, 1696, 1504, 1282, 1152 cm-1; 
HRMS (ES+) calcd. for C14H19N2O3 [M+H]
+ 263.1396, found 263.1392. 
 
 
Methyl 4-[{(tert-Butoxycarbonyl)amino}methyl]benzoate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (62 
mg, 0.234 mmol) was obtained as a white solid in 93% isolated yield after column 
chromatography (hexanes/EtOAc = 4:1). 
mp: 86–89 °C(lit.: 88–90 °C); 1H NMR (500 MHz, CDCl3)  7.99 (d, J = 8.0 Hz, 2H), 7.34 
(d, J = 8.0 Hz, 2H), 4.97 (br, 1H), 4.37 (d, J = 5.0 Hz, 2H), 3.91 (s, 3H), 1.47 (s, 9H); 13C 
NMR (125.8 MHz, CDCl3)  167.0, 156.0, 144.4, 130.0, 129.3, 127.3, 79.9, 52.2, 44.5, 
28.5. 
Data is consistent with that reported in the literature.42 
  
 
tert-Butyl 4-(Trifluoromethyl)benzylcarbamate. 
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According to the general procedure for Suzuki–Miyaura cross-coupling, the product (52 
mg, 0.189 mmol) was obtained as a white solid in 76% isolated yield after column 
chromatography (hexanes/EtOAc = 6:1). 
mp: 70–72 °C (lit.: 70–71 °C); 1H NMR (500 MHz, CDCl3)  7.58 (d, J = 8.0 Hz, 2H), 
7.39 (d, J = 8.0 Hz, 2H), 5.03 (br, 1H), 4.36 (d, J = 6.0 Hz, 2H), 1.46 (s, 9H); 13C NMR 
(125.8 MHz, CDCl3)  156.0, 143.3, 129.7 (q, J = 32.5 Hz), 127.6, 125.6 (q, J = 3.5 Hz), 
124.3 (q, J = 271.9 Hz), 80.0, 44.3, 28.5.    
Data is consistent with that reported in the literature.39 
 
 
tert-Butyl (4-Fluorobenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, n-PrOH instead 
of t-BuOH, the product (50 mg, 0.222 mmol) was obtained as a white solid in 89% isolated 
yield after column chromatography (hexanes/EtOAc = 10:1). 
mp: 64–66 °C (lit.: 68–70 °C); 1H NMR (500 MHz, CDCl3)  7.27–7.21 (m, 2H), 7.03–
6.97 (m, 2H), 4.84 (br, 1H), 4.27 (d, J = 5.0 Hz, 2H), 1.46 (s, 9H); 13C NMR (125.8 MHz, 
CDCl3)  162.3 (d, J = 245.0 Hz), 156.0, 134.9, 129.2 (d, J = 7.5 Hz), 115.5 (d, J = 21.4 
Hz), 79.8, 44.2, 28.5. 
Data is consistent with that reported in the literature.37 
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tert-Butyl 4-Acetylbenzylcarbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (54 
mg, 0.217 mmol) was obtained as a white solid in 87% isolated yield after column 
chromatography (hexanes/EtOAc = 3:1). 
mp: 69–71 °C (lit.: 67–69 °C); 1H NMR (500 MHz, CDCl3)  7.92 (d, J = 7.5 Hz, 2H), 
7.37 (d, J = 8.0 Hz, 2H),  5.04 (br, 1H), 4.37 (d, J = 5.0 Hz, 2H), 2.59 (s, 3H), 1.46 (s, 9H); 
13C NMR (125.8 MHz, CDCl3)  197.9, 156.0, 144.7, 136.3, 128.8, 127.4, 79.9, 44.4, 28.5, 
26.7.  
Data is consistent with that reported in the literature.38 
 
 
tert-Butyl (4-Nitrobenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (38 
mg, 0.151 mmol) was obtained as a yellow solid in 60% isolated yield after column 
chromatography (hexanes/EtOAc = 10:1). 
mp: 107–109 °C (lit.: 109–110 °C); 1H NMR (500 MHz, CDCl3)  8.19 (d, J = 8.5 Hz, 2H), 
7.45 (d, J = 8.0 Hz, 2H), 5.08 (br, 1H), 4.42 (d, J = 5.5 Hz, 2H), 1.47 (s, 9H); 13C NMR 
(125.8 MHz, CDCl3)  156.0, 147.3, 146.8, 127.9, 123.9, 80.3, 44.1, 28.5. 
Data is consistent with that reported in the literature.33 
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4-[{(tert-Butoxycarbonyl)amino}methyl]phenyl Dimethylsulfamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (64 
mg, 0.194 mmol) was obtained as a white solid in 77% isolated yield after column 
chromatography (hexanes/EtOAc = 3:1). 
When the solvents were toluene / H2O (0.5 M, 4:1, 0.4 mL/0.1 mL), obtained product (67 
mg, 0.203 mmol) as a white solid in 81% isolated yield after column chromatography 
(hexanes/EtOAc = 3:1). 
mp: 94–96 °C; 1H NMR (500 MHz, CDCl3)  7.30 (d, J = 8.5 Hz, 2H), 7.23 (d, J = 8.5 Hz, 
2H), 4.93 (br, 1H), 4.30 (d, J = 5.0 Hz, 2H), 2.96 (s, 6H), 1.45 (s, 9H); 13C NMR (125.8 
MHz, CDCl3)  156.0, 149.5, 137.9, 128.9, 122.0, 79.8, 44.1, 38.8, 28.5; IR (neat) 3328, 
2976, 1676, 1356, 1170, 1149 cm-1; HRMS (ES+) calcd. for C14H22N2O5SNa [M+Na]
+ 
353.1147, found 353.1131. 
 
 
tert-Butyl (Pyridin-3-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (43 
mg, 0.206 mmol) was obtained as a colorless oil in 83% isolated yield after column 
chromatography (CH2Cl2/EtOAc = 2:1). 
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1H NMR (500 MHz, CDCl3)  8.52 (s, 1H), 8.50 (d, J = 4.5 Hz, 1H), 7.63 (d, J = 7.5 Hz, 
1H), 3.84 (dd, J = 7.5, 5.0 Hz, 1H), 5.17 (br, 1H), 4.32 (d, J = 4.0 Hz, 2H), 1.45 (s, 9H); 
13C NMR (125.8 MHz, CDCl3)  156.0, 149.1, 148.8, 135.3, 134.7, 123.6, 79.9, 42.3, 28.5.  
Data is consistent with that reported in the literature.41 
 
 
tert-Butyl (Pyridin-2-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (30 
mg, 0.144 mmol) was obtained as a colorless oil in 58% isolated yield after column 
chromatography (hexanes/EtOAc = 1:1). 
1H NMR (500 MHz, CDCl3)  8.53 (d, J = 4.5 Hz, 1H), 7.68–7.62 (m, 1H), 7.28 (d, J = 
7.5 Hz, 1H), 7.20–7.17 (m, 1H), 5.65 (br, 1H), 4.45 (d, J = 5.0 Hz, 2H), 1.47 (s, 9H); 13C 
NMR (125.8 MHz, CDCl3)  157.6, 156.1, 149.2, 136.8, 122.3, 121.8, 79.6, 45.9, 28.5. 
Data is consistent with that reported in the literature.38 
 
 
tert-Butyl (Quinolin-6-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (57 
mg, 0.221 mmol) was obtained as a white solid in 88% isolated yield after column 
chromatography (hexanes/EtOAc = 1:1). 
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mp: 78–81 °C (lit.: 75–77 °C); 1H NMR (500 MHz, CDCl3)  8.90–8.85 (m, 1H), 8.09 (d, 
J = 8.0 Hz, 1H), 8.05 (d, J = 8.5 Hz, 1H), 7.67 (s, 1H), 7.63 (d, J =  8.5 Hz, 1H), 7.37 (dd, 
J =  8.0, 4.0 Hz, 1H), 5.26 (br, 1H), 4.49 (d, J = 5.5 Hz, 2H), 1.48 (s, 9H); 13C NMR (125.8 
MHz, CDCl3)  156.1, 150.3, 147.8, 137.5, 135.9, 129.9, 129.3, 128.2, 125.7, 121.4, 79.8, 
44.6, 28.5.  
Data is consistent with that reported in the literature.38 
 
 
tert-Butyl (Isoquinolin-5-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (59 
mg, 0.228 mmol) was obtained as a white solid in 91% isolated yield after column 
chromatography (hexanes/EtOAc = 1:1). 
mp: 155–158 °C (lit.: 156–160 °C); 1H NMR (500 MHz, CDCl3)  9.22 (s, 1H), 8.54 (d, J 
= 5.5 Hz, 1H), 7.89 (d, J = 8.0 Hz, 1H), 7.83 (d, J = 5.5 Hz, 1H), 7.65 (d, J = 7.0 Hz, 1H), 
7.54 (dd, J = 7.5, 7.5 Hz, 1H), 5.17 (br, 1H), 4.75 (d, J = 5.5 Hz, 2H), 1.47 (s, 9H); 13C 
NMR (125.8 MHz, CDCl3)  155.8, 153.1, 143.5, 134.2, 133.9, 129.9, 128.9, 127.7, 126.9, 
116.5, 79.8, 42.0, 28.5. 
Data is consistent with that reported in the literature.42 
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tert-Butyl {(1H-Indol-5-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (42 
mg, 0.171 mmol) was obtained as a brown solid in 68% isolated yield as a light yellow 
solid after column chromatography (CH2Cl2/hexanes = 40:1). 
mp: 86–89 °C (lit.: 86–89 °C); 1H NMR (500 MHz, CDCl3)  8.31 (br, 1H), 7.54 (s, 1H), 
7.34 (d, J = 8.0 Hz, 1H), 7.20 (dd, J = 2.5, 2.5 Hz, 1H), 7.12 (d, J = 8.0 Hz, 1H), 6.53–6.49 
(m, 1H), 4.84 (br, 1H), 4.40 (d, J = 5.5 Hz, 2H), 1.47 (s, 9H); 13C NMR (125.8 MHz, CDCl3) 
 156.0 135.3, 130.2, 128.1, 124.9, 122.3, 119.9, 111.4, 102.6, 79.4, 45.4, 28.6.  
Data is consistent with that reported in the literature.38 
 
 
tert-Butyl {(2-Methylbenzo[d]thiazol-5-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (59 
mg, 0.212 mmol) was obtained as a white solid in 85% isolated yield after column 
chromatography (CH2Cl2/EtOAc = 6:1 to 4:1). 
mp: 93–95 °C (lit.: 93–95 °C); 1H NMR (500 MHz, CDCl3)  7.82 (s, 1H), 7.74 (d, J = 8.0 
Hz, 1H), 7.28 (d, J = 7.5 Hz, 1H), 5.10 (br, 1H), 4.43 (d, J = 5.5 Hz, 2H), 2.82 (s, 3H), 1.46 
(s, 9H); 13C NMR (125.8 MHz, CDCl3)  167.6, 156.0, 153.7, 137.5, 134.5, 124.4, 121.5, 
121.0, 79.6, 44.5, 28.5, 20.2. 
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Data is consistent with that reported in the literature.42 
 
General Procedure for the Suzuki–Miyaura Cross-coupling Reaction of Boc-
Protected Secondary Aminomethyltrifluoroborates with Aryl and Hetaryl 
Sulfamates. 
A microwave vial was charged with potassium tert-butyl 
butyl{(trifluoroborato)methyl}carbamate secondary (77 mg, 0.263 mmol, 1.05 equiv), aryl 
or hetaryl sulfamates (0.250 mmol, 1.0 equiv), XPhos-Pd-G2 (8 mg, 0.010 mmol, 0.04 
equiv), and K2CO3 (7.0 equiv).  The vial was capped, and then the mixture was degassed 
under vacuum and purged with argon. This procedure was repeated three times. t-BuOH / 
H2O (0.5 M, 1:1, 0.25 mL/0.25 mL) was then added to the reaction vial. The reaction 
mixture was stirred for 18 h at 85 °C and then cooled to rt. H2O (2 mL) was added, and the 
resulting mixture was extracted with EtOAc (2  3 mL). The organic layer was combined, 
dried (MgSO4) and filtered. The solvent was removed in vacuo and the product was 
purified by column chromatography. 
 
 
tert-Butyl Butyl(naphthalen-1-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (72 
mg, 0.230 mmol) was obtained as a colorless oil in 92% isolated yield after column 
chromatography (hexanes/EtOAc = 20:1). 
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1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.18–7.98 (m, 1H), 
7.89–7.81 (m, 1H), 7.77 (d, J = 8.0 Hz, 1H), 7.54–7.46 (m, 2H), 7.46–7.39 (m, 1H), 7.34–
7.28 (m, 1H), 5.00–4.89 (m, 2H), 3.22* (s, 2H), 3.07 (s, 2H), 1.57–1.36 (m, 11H), 1.29–
1.18 (m, 2H), 0.88–0.82 (m, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 
MHz, CDCl3)  155.9, 155.7*, 133.9, 133.7, 131.9, 131.4*, 128.7, 128.2, 127.8*, 126.3*, 
126.2, 125.8, 125.3, 124.5*, 124.0, 123.1, 79.6, 48.2*, 47.7, 46.3*, 45.4, 30.1, 28.6, 20.1, 
13.9; IR (neat) 2962, 1689, 1415, 1171, 1142 cm-1; HRMS (ES+) calcd. for C20H28NO2 
[M+H]+ 314.2120, found 314.2122. 
 
 
tert-Butyl Benzyl(butyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (22 
mg, 0.084 mmol) was obtained as a colorless oil in 33% isolated yield after column 
chromatography (hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.38–7.19 (m, 5H), 
4.45 (s, 2H), 4.41* (s, 2H), 3.23–3.10 (m, 2H), 1.59–1.397 (m, 11H), 1.35–1.22 (m, 2H), 
0.89 (t, J = 7.0 Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, 
CDCl3)  156.3, 155.8*, 139.0*, 138.7, 128.5, 127.8, 127.1, 79.6, 50.5*, 49.8, 46.6*, 46.2, 
30.4*, 30.1, 28.6, 20.1, 14.0.  
Data is consistent with that reported in the literature.36 
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tert-Butyl Butyl(4-cyanobenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, 5 equiv of K2CO3 
instead of 7 equiv, the product (38 mg, 0.132 mmol) was obtained as a colorless oil in 53% 
isolated yield after column chromatography (hexanes/EtOAc = 15:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.60 (d, J = 8.0 Hz, 
2H), 7.35–7.27 (m, 2H), 4.50–4.39 (m, 2H), 3.28–3.08 (m, 2H), 1.56–1.34 (m, 11H), 1.34–
1.22 (m, 2H), 0.88 (t, J = 7.0 Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 
125.8 MHz, CDCl3)  156.2, 155.4*, 144.9*, 144.5, 132.4, 128.1, 127.5*, 118.9, 111.0, 
80.1, 50.6*, 49.9, 47.3*, 47.0, 30.4, 28.5, 20.0, 13.9. 
Data is consistent with that reported in the literature.43 
 
 
tert-Butyl Butyl(4-cyano-2-methoxybenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (50 
mg, 0.157 mmol) was obtained as a white solid in 63% isolated yield after column 
chromatography (hexanes/EtOAc = 10:1). 
mp: 63–66 °C; 1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.27–
7.17 (m, 2H), 7.09–7.04 (m, 1H), 4.46 (s, 2H), 4.41* (s, 2H), 3.86 (s, 3H), 3.28–3.14 (m, 
2H), 1.52–1.36 (m, 11), 1.36–1.24 (m, 2H), 0.91 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk 
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denotes minor rotamer peaks, 125.8 MHz, CDCl3)  157.3, 157.0*, 156.1, 155.7*, 133.3*, 
133.0, 128.3, 127.8*, 124.9, 124.8*, 119.1, 123.0, 111.4, 79.8, 55.7, 47.4, 45.6*, 45.0, 30.6, 
30.3*, 28.5, 28.4*, 20.2*, 20.0, 13.9; IR (neat) 2969, 2229, 1677, 1406, 1142 cm–1; HRMS 
(ES+) calcd. for C18H26N2O3Na [M+Na]
+ 341.1841, found 341.1847. 
 
 
Methyl 4-[{(tert-Butoxycarbonyl)(butyl)amino}methyl]benzoate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (61 
mg, 0.190 mmol) was obtained as a colorless oil in 76% isolated yield after column 
chromatography (hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.99 (d, J = 8.0 Hz, 
2H), 7.32–7.26 (m, 2H), 4.49 (s, 2H), 4.44* (s, 2H), 3.91 (s, 3H), 3.29–3.10 (m, 2H), 1.55–
1.34 (m, 11), 1.34–1.23 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes minor 
rotamer peaks, 125.8 MHz, CDCl3)  167.0, 156.2, 155.6*, 144.5, 144.2*, 129.9, 129.1, 
127.5, 126.9*, 79.9, 52.2, 50.6*, 49.9, 47.1*, 46.7, 30.4, 28.5, 20.1, 13.9; IR (neat) 2961, 
1724, 1693, 1277, 1174 cm–1; HRMS (ES+) calcd. for C18H27NO4Na [M+Na]
+ 344.1838, 
found 344.1839. 
 
 
tert-Butyl Butyl{4-(trifluoromethyl)benzyl}carbamate. 
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According to the general procedure for Suzuki–Miyaura cross-coupling, the product (35 
mg, 0.106 mmol) was obtained as a colorless oil in 42% isolated yield after column 
chromatography (hexanes/EtOAc = 20:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.58 (d, J = 8.0 Hz, 
2H), 7.34 (s, 2H), 4.49 (s, 2H), 4.46* (s, 2H), 3.24* (s, 2H), 3.14 (s, 2H), 1.55–1.38 (m, 
11H), 1.35–1.26 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes minor 
rotamer peaks, 125.8 MHz, CDCl3)  156.2, 155.6*, 143.3*, 143.0, 129.5 (q, J = 32.3 Hz), 
127.8, 127.2*, 125.5 (q, J = 3.5 Hz), 124.3 (q, J = 271.6 Hz), 80.0, 50.3*, 49.7, 47.0*, 46.8, 
30.4, 30.3*, 28.5, 20.1, 13.9. 
Data is consistent with that reported in the literature.43 
 
 
tert-Butyl Butyl(4-fluorobenzyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (33 
mg, 0.117 mmol) was obtained as a colorless oil in 47% isolated yield after column 
chromatography (hexanes/EtOAc = 30:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.26–7.15 (m, 2H), 
7.00 (dd, J = 8.5, 8.5 Hz, 2H), 4.48–4.32 (m, 2H), 3.22–3.07 (m, 2H), 1.55–1.42 (m, 11H), 
1.33–1.25 (m, 2H), 0.89 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes minor rotamer 
peaks, 125.8 MHz, CDCl3)  162.1 (d, J = 244.7), 156.2, 155.6*, 134.5, 129.4, 128.8*, 
115.5, 115.3*, 79.7, 49.9*, 49.3, 46.6*, 46.3, 30.4, 28.6, 20.1, 14.0; IR (neat) 2961, 2929, 
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1692, 1509, 1410, 1222, 1171, 1143 cm–1; HRMS (ES+) calcd. for C16H24NO2FNa 
[M+Na]+ 304.1689, found 304.1689. 
 
 
tert-Butyl (4-Acetylbenzyl)(butyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (32 
mg, 0.105 mmol) was obtained as a colorless oil in 42% isolated yield after column 
chromatography (hexanes/EtOAc = 10:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.92 (d, J = 8.0 Hz, 
2H), 7.31 (s, 2H), 4.49 (s, 2H), 4.45* (s, 2H), 3.28–3.11 (m, 2H), 2.60 (s, 3H), 1.55–1.37 
(m, 11H), 1.33–1.25 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk denotes minor 
rotamer peaks, 125.8 MHz, CDCl3)  197.9, 156.2, 144.7*, 144.4, 136.2, 128.7, 127.7, 
127.1*, 79.9, 50.6*, 49.9, 47.1*, 46.8, 30.3, 28.5, 26.7, 20.1, 13.9; IR (neat) 2960, 2929, 
1685, 1408, 1266, 1170, 1144cm–1; HRMS (ES+) calcd. for C18H27NO3Na [M+Na]
+ 
328.1889, found 328.1886. 
 
 
tert-Butyl Butyl(quinolin-6-ylmethyl)carbamate. 
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According to the general procedure for Suzuki–Miyaura cross-coupling, the product (66 
mg, 0.210 mmol) was obtained as a colorless oil in 84% isolated yield after column 
chromatography (CH2Cl2/EtOAc = 7:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.90 (s, 1H), 8.12 (d, 
J = 8.5 Hz, 1H), 8.08 (d, J = 9.0 Hz, 1H), 7.67–7.58 (m, 2H), 7.43–7.37 (m, 1H), 4.63 (s, 
2H), 4.60* (s, 2H), 3.29* (s, 2H), 3.18 (s, 2H), 1.59–1.37 (m, 11H), 1.36–1.25 (m, 2H), 
0.89 (t, J = 7.0 Hz, 3H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, 
CDCl3)  156.3, 155.7*, 150.2, 147.8, 137.3, 135.9, 129.8, 129.6, 129.0*, 128.2, 125.9, 
125.1*, 121.4, 79.8, 50.5*, 49.8, 46.8*, 46.4, 30.3, 28.5, 20.1, 13.9. 
Data is consistent with that reported in the literature.43 
 
 
tert-Butyl Butyl(isoquinolin-5-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (65 
mg, 0.207 mmol) was obtained as a colorless oil in 83% isolated yield after column 
chromatography (hexanes/EtOAc = 5:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  9.27 (s, 1H), 8.57 (d, 
J = 6.0 Hz, 1H), 8.00–7.78 (m, 2H), 7.61–7.53 (m, 2H), 4.90 (s, 2H), 3.26–3.04 (m, 2H), 
1.59–1.38 (m, 11H), 1.36–1.21 (m, 2H), 0.91–0.85 (m, 3H); 13C NMR (asterisk denotes 
minor rotamer peaks, 125.8 MHz, CDCl3)  155.8, 153.2, 143.5, 134.6, 133.4, 130.1, 129.0, 
128.6, 127.3*, 126.7, 116.9, 116.1*, 79.9, 47.6*, 47.1, 46.5*, 45.7, 30.1, 28.5, 20.1, 13.9. 
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Data is consistent with that reported in the literature.43 
 
 
tert-Butyl Butyl{(2-methylbenzo[d]thiazol-5-yl)methyl}carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (71 
mg, 0.212 mmol) was obtained as a colorless oil in 85% isolated yield after column 
chromatography (hexanes/EtOAc = 7:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  7.80 (s, 1H), 7.77 (d, 
J = 8.0 Hz, 1H), 7.30–7.21 (m, 1H), 4.58 (s, 2H), 4.53* (s, 2H), 3.30–3.13 (m, 2H), 2.83 
(s, 3H), 1.58–1.42 (m, 11H), 1.33–1.23 (m, 2H), 0.89 (t, J = 7.5 Hz, 3H); 13C NMR (asterisk 
denotes minor rotamer peaks, 125.8 MHz, CDCl3)  167.4, 156.2, 155.5*, 153.7, 137.2*, 
137.0, 134.3, 124.7, 124.1*, 121.4, 121.1, 121.0*, 79.6, 50.4*, 49.7, 46.5*, 46.2, 30.3, 
30.1*, 28.5, 20.2, 20.1*, 20.0, 13.9; IR (neat) 2966, 2929, 1691, 1412, 1171 cm-1; HRMS 
(ES+) calcd. for C18H27N2O2S [M+H]
+ 335.1793, found 335.1782. 
 
 
tert-Butyl Isopropyl(naphthalen-1-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (53 
mg, 0.177 mmol) was obtained as a colorless oil in 71% isolated yield after column 
chromatography (hexanes/EtOAc = 25:1). 
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1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.03 (s, 1H), 7.86 (d, 
J = 8.0 Hz, 1H), 7.73 (d, J = 8.0 Hz, 1H), 7.54–7.46 (m, 2H), 7.43 (dd, J = 8.0, 8.0 Hz, 1H), 
7.37–7.33 (m, 1H), 4.82 (s, 2H), 4.53 (s, 1H), 3.98* (s, 1H), 1.62–1.23 (m, 9H), 1.17–1.08 
(m, 6H); 13C NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, CDCl3)  155.9, 
135.0, 133.7, 131.0, 128.9, 127.2, 126.0, 125.6, 125.4, 123.4, 122.6, 79.7, 48.5*, 47.3, 
45.7*, 43.5, 28.5, 20.7; IR (neat) 2973, 1690, 1365, 1164 cm-1; HRMS (ES+) calcd. for 
C19H25NO2Na [M+Na]
+ 322.1783, found 322.1786. 
 
 
tert-Butyl Cyclohexyl(naphthalen-1-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (58 
mg, 0.171 mmol) was obtained as a colorless oil in 68% isolated yield after column 
chromatography (hexanes/EtOAc = 25:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.00 (s, 1H), 7.86 (d, 
J = 7.5 Hz, 1H), 7.72 (d, J = 8.0 Hz, 1H), 7.54–7.46 (m, 2H), 7.42 (dd, J = 8.0, 8.0 Hz, 1H), 
7.36 (d, J = 7.0 Hz, 1H), 4.84 (s, 2H), 4.16 (s, 1H), 3.67* (s, 1H), 1.88–0.93 (m, 19H); 13C 
NMR (asterisk denotes minor rotamer peaks, 125.8 MHz, CDCl3)  156.0, 135.1, 133.6, 
130.6, 128.9, 127.0, 125.9, 125.5, 125.3, 123.2, 122.4, 79.6, 57.2*, 55.4, 45.4*, 44.0, 31.0, 
28.4, 26.0, 25.6; IR (neat) 2929, 1687, 1364, 1246, 1167 cm-1; HRMS (ES+) calcd. for 
C22H29NO2Na [M+Na]
+ 362.2096, found 362.2094. 
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tert-Butyl Benzyl(naphthalen-1-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (64 
mg, 0.184 mmol) was obtained as a colorless oil in 74% isolated yield after column 
chromatography (hexanes/EtOAc = 30:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.17–7.94 (m, 1H), 
7.88–7.83 (m, 1H), 7.78 (d, J = 8.5 Hz, 1H), 7.53–7.37 (m, 3H), 7.35–7.15 (m, 6H), 4.93 
(s, 2H), 4.84* (s, 2H), 4.44* (s, 2H), 4.28 (s, 2H), 1.52 (s, 9H); 13C NMR (asterisk denotes 
minor rotamer peaks, 125.8 MHz, CDCl3)  155.9, 138.2, 134.0, 133.1, 132.0, 131.6*, 
128.9*, 128.7, 128.6, 128.4*, 128.0, 127.5*, 127.3, 126.8*, 126.4, 126.2*, 125.9, 125.3, 
124.9, 124.1, 123.2, 80.3, 48.8, 47.1, 28.6; IR (neat) 2970, 1691, 1245, 1163 cm-1; HRMS 
(ES+) calcd. for C23H25NO2Na [M+Na]
+ 370.1783, found 370.1784. 
 
 
tert-Butyl (2-Methoxybenzyl)(naphthalen-1-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (77 
mg, 0.204 mmol) was obtained as a light yellow oil in 82% isolated yield after column 
chromatography (hexanes/EtOAc =20:1). 
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1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.19–7.82 (m, 2H), 
7.75 (d, J = 8.0 Hz, 1H), 7.53–7.17 (m, 6H), 6.95–6.77 (m, 2H), 4.99 (s, 2H), 4.91* (s, 2H), 
4.53* (s, 2H), 4.35 (s, 2H), 3.68 (s, 3H), 3.62* (s, 3H), 1.48 (s, 9H); 13C NMR (asterisk 
denotes minor rotamer peaks, 125.8 MHz, CDCl3)  157.6*, 157.4, 156.4, 134.0, 133.6, 
132.0, 131.5*, 128.9*, 128.8, 128.4*, 128.2, 128.1, 127.7*, 126.3, 126.1, 125.9, 125.8*, 
125.6*, 125.4, 124.3*, 124.0, 123.4*, 123.2, 120.7, 120.5, 110.8*, 110.3, 80.1, 55.2, 48.1*, 
47.7, 44.5*, 44.4, 28.6; IR (neat) 1689, 1242, 1159 cm-1; HRMS (ES+) calcd. for 
C24H27NO3Na [M+Na]
+ 400.1889, found 400.1895. 
 
 
tert-Butyl (3,3-Diethoxypropyl)(naphthalen-1-ylmethyl)carbamate. 
According to the general procedure for Suzuki–Miyaura cross-coupling, the product (83 
mg, 0.214 mmol) was obtained as a colorless oil in 86% isolated yield after column 
chromatography (hexanes/EtOAc = 20:1 to 10:1). 
1H NMR (asterisk denotes minor rotamer peaks, 500 MHz, CDCl3)  8.14 (s, 1H), 8.04* 
(s, 1H), 7.85 (d, J = 7.5 Hz, 1H), 7.77 (d, J = 8.5 Hz, 1H), 7.53–7.45 (m, 2H), 7.418 (dd, J 
= 7.0, 7.0 Hz, 1H), 7.37–7.28 (m, 1H), 4.93 (s, 2H), 4.46* (s, 1H), 4.37 (s, 1H), 3.59–3.11 
(m, 6H), 1.88–1.74 (m, 2H), 1.56–1.44 (m, 9H), 1.14 (t, J = 7.0 Hz, 6H); 13C NMR (asterisk 
denotes minor rotamer peaks, 125.8 MHz, CDCl3)  155.7, 133.9, 133.5, 131.9, 131.5*, 
128.7, 128.3, 128.0*, 126.5*, 126.3, 125.8, 125.3, 124.9*, 124.0, 123.1, 101.0, 79.9, 61.0, 
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48.7*, 48.2, 42.6*, 41.9, 32.1, 28.5, 15.3; IR (neat) 2975, 1690, 1167, 1136, 1062 cm-1; 
HRMS (ES+) calcd. for C23H33NO4Na [M+Na]
+ 410.2307, found 410.2307. 
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Appendix A1 
Spectra Relevant to Chapter 2 
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Appendix A2 
Spectra Relevant to Chapter 3 
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